ࡱ>  q` R\bjbjqPqP::&&&&&&&&'ttt84'#L,$"N$N$N$%vc''Dh`&4%"%44&&N$N$}HHH4l&N$&N$H4HH.'yH&&~N$# PE5t<o{@K0{>T ~~v&+(|*Hm,l-+(+(+(cHX+(+(+(4444'' 2ąP$V''2P'''&&&&&& Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.q\qge兡N gPlQSShandong Xinhua Pharmaceutical Company Limiteda joint stock company established in the People s Republic of China with limited liability Stock Code: 0719 2013 INTERIM RESULTS ANNOUNCEMENTThe board of directors (the  Board ) and directors (Directors) of Shandong Xinhua Pharmaceutical Company Limited (the Company or Xinhua Pharm) hereby announce the unaudited consolidated results of the Company and its subsidiaries (the Group) for the six months ended 30 June 2013 (the Reporting Period). The following financial information has been prepared in accordance with Hong Kong Generally Accepted Accounting Principles (HKGAAP) and PRC accounting standards. This results announcement (the Announcement) is summarised from the Companys 2013 interim report (the Interim Report) and investors are advised to read the full text of the Interim Report for full information. The Announcement is published in Chinese and English. The Chinese version shall prevail if there are discrepancies between the Chinese version and the English version. I. COMPANY INFORMATIONChinese Name of the Company : q\qge兡N gPlQSEnglish Name of the Company: SHANDONG XINHUA PHARMACEUTICALCOMPANY LIMITEDLegal Representative: Mr. Zhang DaimingCompany Secretaries: Mr. Cao Changqiu, Ms. Guo LeiTelephone Number: 86-533-2196024Facsimile Number: 86-533-2287508E-mail Address of Company Secretaries: cqcao@xhzy.com, H HYPERLINK "mailto:guolei@xhzy.com" guolei@xhzy.comRegistered Address: Chemical Industry Area of Zibo Hi-tech Industry Development Zone, Zibo City, Shandong Province, the Peoples Republic of China (the PRC)Office Address: No. 1 Lutai Ave., Hi-tech Industry Development Zone, Zibo City, Shandong Province, the PRCPostal Code: 255086Website of the Company: H HYPERLINK "" E-mail Address of the Company: H HYPERLINK "mailto:xhzy@xhzy.com" Uxhzy@xhzy.comUPRC newspaper for information disclosure: Securities TimesWebsite designated by the China Securities Regulatory Commission (the CSRC): H HYPERLINK "http://www.cninfo.com.cn" http://www.cninfo.com.cnListing InformationH SharesStock Exchange: The Stock Exchange of Hong Kong Limited (the SEHK)Abbreviated Name: Shandong XinhuaStock Code: 0719A SharesStock Exchange: Shenzhen Stock ExchangeAbbreviated Name: Xinhua PharmStock Code: 000756a!. SUMMARY OF FINANCIAL RESULTS(i) In accordance with PRC accounting standards (Renminbi ( RMB ))ItemAs at 30 June 2013(Unaudited)As at 31 December 2012 (the  End of Last Year )(Audited)Change as compared to the End of Last Year (%)Total assets3,625,856,788.80 3,628,270,364.03 (0.07)Total equity attributable to equity holders of Company1,703,391,898.29 1,737,287,914.32 (1.95)Capital457,312,830.00457,312,830.00-Net assets per share attributable to equity holders of Company3.723.80(2.11)Asset-liability ratio (%)51.9051.02Increase 0.88 points Six months ended 30 June 2013(Unaudited)Six months ended 30 June 2012 (the Same Period Last Year)(Unaudited)Change as compared to the Same Period Last Year (%)Total operating income1,617,134,270.43 1,537,930,023.235.15Operating profit(13,046,260.32 )25,524,759.04(151.11)Profit before taxation9,280,671.77 40,002,473.65(76.80)Profit attributable to the equity holders of Company4,987,774.39 31,195,182.82(84.01)Profit attributable to the equity holders of Company after extraordinary items (Note)(16,444,797.62)18,012,640.74(191.30)Basic earnings per share 0.010.07(85.71)Diluted earnings per share 0.010.07(85.71)Basic earnings per share after extraordinary loss(0.04)0.04(200.00)Return on equity of weighted average (%)0.291.81Decrease 1.52 pointsFully diluted return on equity (%)0.291.79Decrease 1.50 pointsReturn on equity of weighted average after extraordinary loss (%)(0.95)1.04Decrease 1.99 pointsFully diluted return on equity after extraordinary loss (%)(0.97)1.03Decrease 2.00 pointsNet cash flow from operating activities5,378,264.18(42,186,834.32)112.75Net cash flow from operating activities per share 0.01(0.09)111.11Note:Extraordinary items include:ItemAmount (RMB)Notes (if applicable)Profit or loss from disposal of non-current assets(119,826.73)Loss of disposal of fixed assetsGovernment subsidies recognised in current profit and loss, (excluding those closely related to the Companys normal operations and granted on an ongoing basis under the national policies according to certain fixed quota of amount or volume) 23,798,900.08Received government subsidies reckoned into current termGains (losses) from fair value changes of trading financial assets and trading financial liabilities, and investment income from disposal of trading financial assets, trading financial liabilities and available-for-sale financial assets, except effective hedging activities related to the Companys normal operations 174,625.00Dividends from available-for-sale financial assetsOther non-operating income or cost except the above items(1,352,141.26)-Non-controlling interests 12,900.22-Income tax expense(1,081,885.30)-Total 21,432,572.01-(ii) In accordance with HKGAAP (RMB 000)Consolidated Income StatementItemSix months ended 30 June 2013Unaudited Six months ended 30 June 2012Unaudited Revenue1,600,002 1,525,008 Profit before tax8,719 39,087 Income tax expense(3,086)(6,831)Profit for the period5,633 32,256 Includes: Profit attributable to owners of the Company4,510 30,416 Non-controlling interests1,123 1,840 Consolidated Statement of Financial PositionItemAs at 30 June 2013Unaudited As at 31 December 2012Audited Total assets3,636,675 3,639,490 Total liabilities(1,886,246)(1,855,699)Non-controlling interests(40,713)(39,701)Equity attributable to owners of the Company1,709,716 1,744,090 (iii) Reconciliation of accounts prepared in accordance with PRC accounting standards and HKGAAP (RMB) (Unaudited)ItemProfit attributable to the equity holders of CompanyTotal equity attributable to equity holders of Companythe Reporting PeriodSame Period Last YearAs at 30 June 2013As at 1 January 2013Prepared under PRC accounting standards4,987,774.3931,195,182.821,703,391,898.29 1,737,287,914.32HKGAAP adjustments:Provision for education fund(562,000.00)(916,000.00)7,439,000.00 8,002,000.00Deferred taxation84,225.61 136,817.18(1,114,898.29)(1,199,914.32)Total of the difference between the PRC accounting standards and HKGAAP(477,774.39)(779,182.82)6,324,101.71 6,802,085.68 Prepared under HKGAAP4,510,000.00 30,416,000.00 1,709,716,000.00 1,744,090,000.00 Explanation of the difference between the PRC accounting standards and HKGAAP:1. Education fees are set out as per the actual expenses, without the need of provision under HKGAAP. As at 30 June 2013 provision made for the balance of education fees under the PRC accounting standards was RMB7,439,000 with an amount in education fees of RMB562,000 for this period.2. Education fees also led to the difference in the Companys deferred income tax, with the difference in accumulated deferred income tax of RMB1,114,898.29 and that in deferred income tax of the current period of RMB84,225.61. III. CHANGES IN SHARE CAPITAL STRUCTURE AND INFORMATION ON SHAREHOLDERS1. Share Capital structure30 Jun 20131 Jan 2013Class of sharesNumber of shares (share)% of the total share capitalNumber of shares (share)% of the total share capital1. Total number of conditional tradable shares96109610Stated-owned shares0000Domestic legal person shares0000Conditional tradable senior management A shares96109610Others00002. Total number of unconditional tradable shares457,311,869100.00457,311,869100.00Renminbi ordinary shares (A shares)307,311,86967.20307,311,86967.20Overseas listed foreign shares (H shares)150,000,00032.80150,000,00032.803. Total number of shares457,312,830100.00457,312,830100.002. As at 30 June 2013, the Company had on record a total of 38,266 shareholders, including 58 holders of H Shares and 38,208 holders of A Shares.3. As at 30 June 2013, the ten largest shareholders of the Company were as follows: Unit: shareName of ShareholderTypes of shareholdersNumber of shares held% of the total share capitalNumber of conditional tradable shares heldNumber of shares being charged or frozenShandong Xinhua Pharmaceutical Group Company Limited (SXPGC)State-owned shareholder, A shares166,115,72036.3200HKSCC (Nominees) LimitedListed H shares148,027,99832.3700Qingdao Haowei Investment Development Company LimitedDomestic general legal person shares9,386,8512.0509,380,000Hongyuan Securities Company Limited Customer credit transaction backed securities accountDomestic general legal person shares1,286,3510.2800Chen YuguiDomestic person1,184,3000.2600Wang GuohuaDomestic person641,2980.1400Liu ShidaDomestic person616,0000.1300Guangfa Securities Company Limited Customer credit transaction backed securities accountDomestic general legal person shares614,7130.1300Zhang LinlinDomestic person600,0000.1300Zheng HuidanDomestic person499,9900.11004. As at 30 June 2013, the ten largest shareholders of the unconditional tradable shares of the Company were as follows:Name of ShareholderNumber of unconditional listed shares (share)Class of sharesSXPGC166,115,720A SharesHKSCC (Nominees) Limited148,027,998H SharesQingdao Haowei Investment Development Company Limited9,386,851A SharesHongyuan Securities Company Limited Customer credit transaction backed securities account1,286,351A SharesChen Yugui1,184,300A SharesWang Guohua641,298A SharesLiu Shida616,000A SharesGuangfa Securities Company Limited Customer credit transaction backed securities account614,713A SharesZhang Linlin600,000A SharesZheng Huidan499,990 A SharesNote:1. The Directors are not aware as to whether there is any association amongst the ten largest shareholders of the Company, nor the persons acting in concert as defined in the Rules for the information Disclosure of Changes in the Shareholding of Listed Companies (CSRC Rules) issued by the CSRC. In addition, the Directors do not know whether there is any association amongst the shareholders of H Shares of the Company or persons acting in concert as defined in the CSRC Rules. The Directors do not know whether there is any association amongst the ten largest shareholders of unconditional tradable shares of the Company, or any association between ten largest shareholders of unconditional tradable shares and the ten largest shareholders of the Company or if there are any persons acting in concert as defined in the CSRC Rules.2. The only domestic shareholder with more than 5% of the total issued shares of the Company is SXPGC.3. There was no change of controlling shareholder of the Company during the Reporting Period.4. Save as disclosed above and so far as the Directors are aware, as at 30 June 2013, no other person (other than the Directors, supervisors of the Company (the Supervisors), chief executives or members of senior management of the Company (the Senior Officers)) had an interest or short position in the Companys shares or underlying shares (as the case may be) which would fall to be disclosed to the Company and the SEHK under the provisions of Divisions 2 and 3 of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong (SFO) and as recorded in the register required to be kept under section 336 of the SFO), or was otherwise a substantial shareholder (as defined in the Rules Governing the Listing of Securities on the SEHK (the Listing Rules)) of the Company.IV. DIRECTORS, SUPERVISORS AND SENIOR OFFICERSThe number of shares held by the Directors, Supervisors and Senior Officers of the Company were as follows:NamePositionNumber of Shares (share) as at 1 January 2013Change in number of SharesNumber of Shares (share) as at 30 June 2013Directors:Mr. Zhang DaimingChairmanNilNilNilMr. Ren FulongNon-executive DirectorNilNilNilMr. Du DepingExecutive Director, General ManagerNilNilNilMr. Zhao SongguoExecutive Director, Deputy generalmanager & Financial ControllerNilNilNilMr. Xu LieNon-executive Director NilNilNilMr. Zhao BinNon-executive Director NilNilNilMr. Zhu BaoquanIndependent non-executive DirectorNilNilNilMr. Bai HuiliangIndependent non-executive DirectorNilNilNilMr. Kwong Chi Kit, VictorIndependent non-executive Director NilNilNilSupervisors:Mr. Li TianzhongChairman of Supervisory CommitteeNilNilNilMr. Zhang YueshunIndependent SupervisorNilNilNilMr. Tao ZhichaoIndependent SupervisorNilNilNilMs. Hu YanhuaEmployee SupervisorNilNilNilSenior Officers:Mr. Dou XuejieDeputy General ManagerNilNilNilMr. Du DeqingDeputy General Manager NilNilNilMr. He TongqingDeputy General Manager NilNilNilMr. Cao ChangqiuCompany Secretary1,281Nil1,281Ms. Guo LeiCompany SecretaryNilNilNilTotal1,281Nil1,281All shares held by the Directors, Supervisors and Senior Officers are A shares. The number of shares held by the Directors, Supervisors and Senior Officers has no change during this Reporting period.So far as the Directors, Senior Officers and Supervisors are aware, save as disclosed above, as at 30 June 2013, no Director, Senior Officer or Supervisor had any interest or short position in the shares, underlying shares and / or debentures (as the case may be) of the Company or any of its associated corporations (as defined in Part XV of the SFO) which was required to be notified to the Company and the SEHK pursuant to Divisions 7 and 8 of Part XV of the SFO (including any interest or short position which any such Director, Senior Officer or Supervisor is taken or deemed to have under such provisions of the SFO) or which was required to be entered in the register required to be kept by the Company pursuant to Section 352 of the SFO or which was otherwise required to be notified to the Company and the SEHK pursuant to the Model Code for Securities Transactions by Directors of Listed Issuers as contained in Appendix 10 to the Listing Rules.CHANGES OF DIRECTORS, SUPERVISORS AND SENIOR OFFICERSDuring this Reporting Period, there were no changes of Directors, Supervisors and Senior Officers.V. CHAIRMANS STATEMENTDear shareholders,I am pleased to report the operating results of the Company for the six months ended 30 June 2013.For the six months ended 30 June 2013, pursuant to the PRC accounting standards, the operating income of the Group was RMB1,617,134,000 and net profit attributable to equity holders of the Company was RMB4,988,000, representing an increase of 5.15% and a decrease of 84.01% respectively, as compared to that of the Same Period Last Year.The Group had a turnover of RMB1,600,002,000 and profit attributable to owners of the Company of RMB4,510,000 for the six months ended 30 June 2013 under HKGAAP, representing an increase of 4.92% and a decrease of 85.17% respectively, as compared with that of the Same Period Last Year.The Board did not recommend the payment of an interim dividend for the six months ended 30 June 2013.BUSINESS REVIEWIn the first half of 2013, when faced with various difficulties such as a continuous downturn of international market demands, the appreciation of RMB, the increasing downward pressure on the domestic economy, price competitions of pharmaceutical products, bidding of preparation products, as well as the increasing pressures on environmental protection, price drop of the Companys products, the increase of financial expenses arising from products relocation and the rise of production costs resulted from the initial operation stage of new production lines, the Group actively took measures to expand sales, reduce non-production expenses, strengthen research and development and accelerate the construction of relocation projects. In the first half of 2013, the Group realized a minor increase in indicators such as sales revenue and exports earnings on a year-on-year basis; however, the Groups profit witnessed a significant decline. The major business review is set out below.1. Actively explored markets and expanded sales scale During the first half of 2013, the Group actively explored the domestic and international markets and made efforts to expand the scale of operations, achieving a 5.15% year-on-year increase in operating income. The Group took a differentiated marketing approach to focus on preparation products, endeavored to develop untapped terminals and enhanced market cultivation, recording a 47.2% year-on-year increase in the sales income of new key preparation products, 0.26% year-on-year increase in export earnings, which amounted to US$94,614,000, and 90% year-on-year increase in preparation products exports, which amounted to RMB53,000,000.2. Applied scientific and technological innovation and consolidated development potentialDuring the first half of 2013, the Group adhered to technological innovation, improving efficiency in the use of materials and saving RMB1,720,000 in respect of raw materials.The Group carried out in-depth energy saving and emission reduction activities, and implemented 18 energy saving projects, which led to a year-on-year 0.75% decrease in the energy consumption per RMB10,000 production value in the first half of 2013.The Group attached great importance to product quality management. During the first half of 2013, the Group accomplished 9 breakthrough projects in respect of quality and technology, and successfully passed the examinations of three international official bodies including EDQM and 60 quality audits by manufacturers both from home and abroad. During the first half of the year, the Group accelerated the strategic reserve of new products. 6 bulk pharmaceuticals have completed pilot scale testing (or qualified for full production), and 7 bulk pharmaceuticals have completed pre-pilot scale testing. Production testing of 6 preparation products has been completed or nearly completed, and pre-pilot testing of 6 preparation products has been completed.During the first half of the year, the Company was granted 5 invention patents and 3 new utility model patent.3. Accelerating construction of the relocation project and improving the product mixBy leveraging the opportunity of product relocation at the old factory, we endeavored to fulfill product mix adjustment and industrial upgrade through intense technological renovation and application of the four new energy-saving technologies, facilitated the industrialization of several new products developed in recent years and fostered new profit drivers. The commissioning of salicylic acid and aspirin as well as the multi-functional industrialization center all achieved success at the first attempt, and such products and projects also passed the GMP certification and relevant international certifications. The principal part of the relocation project for the analgin series product was completed, and the installation of relevant equipment is close to completion. New techniques and technologies have been utilized, which would help boost the market competitiveness of products.MAJOR WORKS FOR THE SECOND HALF OF THE YEAR 2013Various unfavorable factors that affect corporate development still persist in the second half of 2013, and the Company also faces great pressure on capital as it is currently in the critical stage of relocation. As such, in the second half of 2013, the Group will continue to step up market development and sales of products, actively proceed with the relocation of products, accelerate research and development, improve the management of business fundamentals, and unswervingly strengthen team building.1. Firmly focus on operationThe Company will further enhance the strategic cooperation partnership with its clients, design new marketing models, fully step up the development and maintenance of the markets for economically viable products, practically press ahead with market expansion and distribution of strategic products, and put additional efforts in marketing and the promotion of featured products.The Company will make full preparation for tenders for preparation products at all the related regions, proactively supplement the catalogues of basic drugs at provincial levels, and practically strengthen the building of marketing teams.The Company will step up cooperation with strategic suppliers, actively implement the purchase model of factory-to-factory direct supply, find new suppliers, continue to reduce exclusive supply of raw materials, and lower the purchase cost.2. Place emphasis on the relocation of products and productionThe second half of 2013 is a critical stage for the relocation of products, and the Company will safeguard the smooth relocation of the analgin series products, and strive for a successful production at the first attempt. The Company will proactively proceed with the change of the production license for Hutian Park, and make full preparation for the on-site inspection and certification of a number of products, including the relocation project.The Company will push for fundraising, ensure the supply of raw materials and power for key products by closely studying and leveraging relevant policies, adjust its marketing tactics in accordance with changes in costs and in the market, and properly organize its production.3. Accelerate research and development progress and highlight technological breakthroughsThe Company will speed up the research and development progress to complete the research and development as well as on-site inspection over the production of 6 new medicines and 2 health care products; strive to complete the pilot scale testing of 9 new medicines, lab research of 8 new medicines, and manufacturing and technical upgrade of the clinical samples of 3 products; and aggressively push forward the trial production of 4 new preparation products.The Company will actively carry out technological breakthroughs by concentrating on the technological and quality breakthrough targets set at the beginning of the year, accelerate the application of technological achievements, improve quality, lower costs and enhance the market competitiveness of its products.4. Focus on improving management of the business fundamentals to ensure healthy production and operationWe will strengthen efforts in energy saving and emission reduction through implementing a series of measures in respect of energy-saving and environmental protection with a focus on point source control. We will endeavor to make technological breakthroughs for our products, to enhance product quality and reduce energy consumptions, with a view to minimize the impact of adverse factors on the performance of the Company. With regard to expenses control and budget management, we will implement a centralized capital management system to enhance risk control.VI. MANAGEMENT DISCUSSION AND ANALYSISThe Group is mainly engaged in the development, manufacturing and sale of bulk pharmaceuticals, pharmaceutical preparations, chemicals and other products. The profit of the Group is mainly attributable to its principal businesses.1. LIQUIDITY AND ANALYSIS OF FINANCIAL RESOURCES AND CAPITAL STRUCTURE UNDER HKGAAPAs at 30 June 2013, the liquidity ratio of the Group was 126.95%, the quick ratio was 83.07%, the turnover ratio of account receivables was 387.39% (turnover ratio of account receivables = turnover / average account receivables and net value of bills x 100%) and the turnover ratio of inventory was 297.53% (inventory turnover ratio = cost of sales / average net value of inventory x 100%).There was no significant seasonal effect on the capital demand of the Group.The main sources of funds for the Group were loans from financial institutions and funds provided by the ultimate holding company of the Company. As at 30 June 2013, the total amount of bank loans was RMB450,731,000, which were floating rate loans based on Hong Kong inter-bank offered rates or rates issued by the Peoples Bank of China, and the total amount of loans from the ultimate holding company was RMB693,250,000. As at 30 June 2013, cash on hand and in bank amounted to RMB213,385,000 (including bank acceptance drafts deposits of RMB59,820,000).As of 30 June 2013, the Groupcharged the land use rights in Hutianzhen,Zhangdian,to a bankforloans. Thebook valueof the land use rightsis RMB67,371,000.There was no charge on the Groups assets except the above charged assets.The Group has stringent internal control systems for cash and fund management in order to strengthen financial management. The Group has sound liquidity and repayment ability.The clarification of the performance results of the Group is referred to in the section headed Results and Financial Analysis under PRC Accounting Standards.As at 30 June 2013, the number of employees of the Group was 5,904. The total salaries for employees in the first half of 2013 amounted to RMB116,962,000.The main investment projects in the second half of 2013 will be Hutian Park project and Shouguang Park project.As at 30 June 2013, the capital debt ratio of the Group was 66.91% (capital debt ratio = total borrowings / equity attributable to owners of the Company x 100%).The cash and bank balances of the Company will mainly be used as working capital for production, operation, projects and research development.The assets and debts of the Group were denominated in RMB. However, the Group achieved USD94,641,000 in its export for the first half of 2013. Therefore, there was a greater impact from foreign exchange. The Group adopted the following measures to minimise the foreign exchange fluctuation risk: (1) raising the export price in order to minimise foreign exchange fluctuation risk; and (2) when the Group enters into larger export contracts, the Group will seek the prior agreement of the purchaser that both parties shall jointly bear the foreign exchange fluctuation risk should the foreign exchange fluctuation exceed the contractual limit as agreed by both parties.2. RESULTS AND FINANCIAL ANALYSIS UNDER PRC ACCOUNTING STANDARDSIn the first half of 2013, the Groups operating income wasRMB1,617,134,000, representing an increase of 5.15% as compared to the Same Period Last Year. The increase in operating income was mainly attributable to the increase in marketing, leading to a rise in the sales of certain products. The net decrease in cash and cash equivalents was RMB221,979,000, while there was a net increase of RMB101,099,000 in the Same Period Last Year. The main reason for the change was due to the decrease in net cash flow of RMB373,993,000 from fundraising activities as compared to the Same Period Last Year. Operating loss amounted to RMB13,046,000, whereas there was an operating profit of RMB25,525,000 in the Same Period Last Year. The main reasons for the decrease include the formation of fixed assets in the new park area which resulted in an increase in depreciation charges, an increase in costs caused by the fluctuating raw material and power consumption during the initial production stage of production lines, an increase in management costs as more resources have been allocated to environmental protection, a foreign exchange loss caused by the appreciation of the RMB, an increase in financial expenses due to increased borrowings and an increase in expenses caused by increased investment in the research and development of new products.The total assets of the Group as at 30 June 2013 amounted to RMB3,625,857,000, representing a decrease of RMB2,413,000 or 0.07% as compared to that of RMB3,628,270,000 as at the beginning of this year. The decrease was mainly due to a decrease of cash and cash equivalents during the Reporting Period. The Groups loan amount as at 30 June 2013 was RMB1,143,982,000, representing a decrease of RMB67,035,000 from RMB1,211,017,000 at the beginning of this year. This decrease was mainly attributable to the repayment of some bank loans during the Reporting Period. The total equity attributable to equity holders of the Company as at 30 June 2013 was RMB1,703,392,000, representing a decrease of RMB33,896,000 or 1.95% from RMB1,737,288,000 at the beginning of this year. The decrease was mainly attributable to a decrease of Available-for-sale financial assets fair value during the Reporting Period, leading to a temporary drop in the capital reserve of the Company.An analysis of the Groups turnover from principal operations is as follows (RMB000):By geographical location of customersFirst half of 2013First half of 2012Total turnoverCostsTotal turnoverCostsPRC (incl. Hong Kong)949,671783,290911,697733,860Europe249,676199,817249,443220,276Americas291,165262,985256,616199,318Others109,49097,97398,98586,118Total1,600,0021,344,0651,516,7411,239,572By industry and By productIncome from principal operationsCosts of sales of principal operationsGross profit margin(%)Bulk pharmaceutical781,092657,492 15.82 Preparations303,471180,951 40.37 Commercial circulations411,502392,093 4.72 Chemical products and other products103,937113,529 (9.23) Total1,600,0021,344,065 16.00 An analysis of profit as compared to 2012 is as follows:ItemsAmount (RMB000)% of total profitJan.-Jun. 20132012Jan.-Jun. 20132012Operating profit(13,046)(18,705)(140.57)(53.47)Net profit/loss from non-operation activities22,327 53,686 240.57 153.47 Profit before taxation9,281 34,981 100.00 100.00 3. USE OF PROCEEDSOn 3 September 2001, the Company raised an amount of RMB370,517,000 from the public offer and issue of 33,000,000 A Shares (including the sale of 3,000,000 State-owned shares). As at 30 June 2013, RMB363,830,000 were used in the following projects: Name of projectPlanned investmentRMB000Actual investment Jan.-Jun. 2013RMB000Accumulated amount of investmentRMB000% of the investmentRemarksState-level technical center renovation74,5003,57053,89772.34%-Injection GMP renovation80,000 - 80,226100.28%completedCaffeine technical renovation160,000 - 188,201117.63%completedL-350 technical renovation29,980 - 23,44278.19%completedAnalgin GMP renovation39,800 - 46,265116.24%completedTotal384,2803,570392,031--(1) Injection GMP renovation project did not reach its projected profit level due to the decrease in pharmaceutical prices.(2) Caffeine technical renovation did not reach its projected profit level because of the effects of the drop in both prices and the export tax rebate rate.(3) The principal portion of the state-level technical center renovation project has been completed.The remaining proceeds were deposited with banks and will be used in accordance with the Companys project commitments.VII. REVIEW OF MAJOR EVENTSSave as disclosed herein:1. There is no material deviation between the actual corporate governance implemented by the Company and the rules and requirements of corporate governance required to be observed by listed companies in the PRC.2. The Board did not recommend the payment of any interim dividend, nor any transfer from reserves to share capital, for the half year ended 30 June 2013.3. The Group was not involved in any material litigation or arbitration, whether pending or threatened during the Reporting Period.4. There was no material purchase of assets or disposal of the Companys assets, nor did any material mergers or acquisitions involving the Company occur during the Reporting Period. Similarly, no transactions of such nature occurred during the last reporting period and were carried over to the Reporting Period.5. During the Reporting Period, there was no material trust, subcontract and lease of assets between the Company and other companies.6. The independent non-executive directors special explanation and independent opinions in respect of the use of funds by related parties and external security provided are as follows:During the Reporting Period, there was no non-operational use of the Companys funds by the controlling shareholder and other related parties.During the Reporting Period, no material guarantee was provided by the Company, nor has there been any obligations that have not been performed in full by the Company. There were no guarantees provided in favour of any controlling shareholders, non-legal entities or individuals which were prejudicial to the interests of the Company and its shareholders, in particular the minority shareholders of the Company. As at 30 June 2013, the Company had no overdue external guarantee debts and the Company had no liability arising from any guarantee due to the default of a guaranteed party.7. The Company and its shareholders holding more than 5% of total number of issued shares of the Company have provided undertakings for information disclosure as follows: Nil8. Purchase, Sales and Redemption of the Companys listed securitiesDuring the Reporting Period, neither the Company nor its subsidiaries purchased, sold or redeemed any of the Companys listed securities.9. Management of FundsDuring the Reporting Period, the Company did not appoint any person to manage the Companys funds. No such appointment was made in the preceding reporting period and carried over to the Reporting Period.10. Information about holding equity in other listed companies (RMB)Stock CodeAbbreviated NameInitial investment amountProportion of equity interest in investeeBook value of end of the Reporting PeriodProfit/loss in the Reporting PeriodChange of shareholders equity in the Reporting PeriodAccounting coursesShare source601601China Pacific Insurance7,000,000.000.06%79,650,000.00-(32,850,000.00)Available-for-sale financial assetsPurchase601328BANKCOMM14,225,318.000.02%33,452,144.00-(7,150,704.00) Available-for-sale financial assetsPurchaseTotal21,225,318.00-113,102,144.00-(40,000,704.00)--11. Index of important information which has been disclosedThe announcement of the 2012 Annual Results Announcement was published on the HKExnews, in the Securities Times C26 in the PRC, on the website: http://www.cninfo.com.cn and on the Companys website on 25 March 2013.The announcement of the The First Quarter Report of 2013 was published on the HKExnews, in the Securities Times B63 in the PRC, on the website: http://www.cninfo.com.cn and on the Companys website on 27 April 2013.The announcement of the The Notice of Annual General Meeting for the 2012 was published on the HKExnews, in the Securities Times B23 in the PRC, on the website: http://www.cninfo.com.cn and on the Companys website on 9 April 2013.The announcement of the Announcement of 2012 Annual General Meeting Resolutions was published on the HKExnews, in the Securities Times B32 in the PRC, on the website: http:// www.cninfo.com.cn and on the Companys website on 25 May 2013.12. Information of reception research, communications and interviews during the Reporting Period: NilVIII. CORPORATE GOVERNANCECOMPLIANCE WITH THE CODE ON CORPORATE GOVERNANCE PRACTICESThe Directors confirmed that the Company was in compliance with the Code on Corporate Governance Practices (the Code) and has not deviated from the Code during the six months ended 30 June 2013. The Code includes the provisions contained in Appendix 14 to the Listing Rules.AUDIT COMMITTEEThe Company set up the audit committee under the Board in accordance with Rule 3.21 of the Listing Rules.The audit committee along with the management of the Company has reviewed the accounting standards, principles and methods adopted by the Group, and considered matters regarding auditing, internal control and financial reporting including the unaudited interim accounts for the six months ended 30 June 2013.The audit committee agreed to the accounting standards, principles and methods adopted by the Group for the unaudited interim accounts for the six months ended 30 June 2013, and it has been disclosed fully.INDEPENDENT NON-EXECUTIVE DIRECTORThe Company has complied with Rules 3.10(1), 3.10(2) and 3.10A of the Listing Rules relating to the appointment of a sufficient number of independent non-executive Directors and at least one independent non-executive Director with appropriate professional qualifications, or accounting or related financial management expertise. The Company has appointed three independent non-executive Directors including one with financial management expertise; details of their biographies were set out in the 2012 Annual Report of the Company.MODEL CODE FOR SECURITIES TRANSACTIONS BY DIRECTORS OF LISTED ISSUERS (MODEL CODE)During the Reporting Period, the Company has adopted a code of conduct regarding transactions by Directors on terms no less exacting than the required standards set out in the Model Code. After having made specific enquiries to the Directors and Supervisors, the Company has confirmed that during the Reporting Period, all Directors and Supervisors have complied with the required standard set out in the Model Code in relation to directors securities transactions and they did not have any non-compliance with the Mode Code. h!. FINANCIAL REPORTS1. Profit and loss account prepared in conformity with PRC accounting standards (Unaudited) Unit: RMBItem First half of 2013First half of 20120ConsolidatedParent companyConsolidatedParent company1.Total operating income1,617,134,270.43 951,197,344.70 1,537,930,023.23908,225,960.78 Includes: Operating income1,617,134,270.43 951,197,344.70 1,537,930,023.23908,225,960.782.Total operating costs1,631,787,333.60 956,068,458.63 1,516,606,553.73873,375,989.93 Includes: Operating cost1,363,733,658.96 812,783,451.22 1,264,175,647.52752,763,409.61 Taxes and surcharges10,366,384.78 7,096,493.05 8,253,025.715,078,863.76 Selling expenses109,963,731.83 14,769,801.49 117,149,652.7610,309,344.33 Administrative expenses101,448,392.30 79,735,424.77 99,584,460.2377,135,903.56 Financial expenses46,275,165.73 41,683,288.10 27,443,767.5128,088,468.67 Assets Impairment loss -  - -- Add: Gain or loss from changes in fair value -  - -- Investment gain or loss1,606,802.85 1,606,802.85 4,201,289.544,187,410.09 Includes: Investment gain or loss from related ventures and joint ventures1,432,177.85 1,432,177.85 1,615,490.091,615,490.09 Exchange gain or loss -  - --3. Operating profit(13,046,260.32)(3,264,311.08)25,524,759.0439,037,380.94 Add: Non-operating income24,778,778.41 8,972,598.86 24,632,607.1010,172,180.36 Less: Non-operating cost2,451,846.32 1,709,409.97 10,154,892.498,777,307.26 Includes: Loss from the disposal of non-current assets119,826.73 119,826.73 6,559,471.226,559,471.224. Profit before taxation9,280,671.77 3,998,877.81 40,002,473.6540,432,254.04 Less: Income tax expense3,169,924.91 2,282,582.13 6,967,721.575,523,789.225. Profit after taxation6,110,746.86 1,716,295.68 33,034,752.0834,908,464.82 Includes: Net Profit attributable to the equity holders of the parent company4,987,774.39  - 31,195,182.82- Minority interest1,122,972.47  - 1,839,569.26-6. Earnings per share00 1) Basic earnings per share0.01 0.004 0.070.08 2) Diluted earnings per share0.01 0.004 0.070.087.Other comprehensive income(34,421,999.76)(34,000,598.40)13,318,667.8213,776,885.608. Total comprehensive income(28,311,252.90)(32,284,302.72)46,353,419.9048,685,350.42 Includes: Total comprehensive income attributable to the equity holders of the parent company(29,322,887.73) - 44,674,226.86- Total comprehensive income attributable to the minority interest1,011,634.83  - 1,679,193.04-NOTES:xe "s, 1. compared with the latest annual reportA th"1. During the Reporting Period, there was no change in accounting policies and accounting estimates.xe "nfluences, 2. in the range of consolidation as co"2. During the Reporting Period, Shandong Xinhua Pharmaceutical (USA) Company Limited was added into the scope of consolidated financial statements of the Company.2. FINANCIAL STATEMENTS PREPARED UNDER HKGAAPCondensed consolidated income statementNotesSix months ended 30 June20132012RMB000RMB000(unaudited)(unaudited)Revenue31,600,0021,525,008Cost of sales(1,354,431)(1,247,825)Gross profit245,571277,183Investment income1,3314,057Other income41,80146,607Other expenses(27,468)(32,823)Distribution and selling expenses(109,964)(125,417)Administrative expenses(106,996)(103,989)Finance costs(36,988)(28,146)Share of profit of an associate1,4321,615Profit before tax48,71939,087Income tax expense5(3,086)(6,831)Profit for the period5,63332,256Profit for the period attributable to:Owners of the Company4,51030,416Non-controlling interests1,1231,8405,63332,256Earnings per share - basic and diluted 6RMB0.010RMB0.067Condensed consolidated statement of comprehensive incomeSix months ended 30 June20132012RMB000RMB000(unaudited)(unaudited)Profit for the period5,63332,256Other comprehensive (expense) income:Items that may be subsequently reclassified to profit or loss: Exchange differences arising on translation (421)(460) Fair value (loss) gain on available-for-sale investments (40,001)15,343Income tax relating to components of other comprehensive income (expense)6,000(1,566)Other comprehensive (expense) income for the period, net of tax(34,422)13,317Total comprehensive (expense) income for the period(28,789)45,573Total comprehensive (expense) income attributable to:Owners of the Company(29,801)43,894Non-controlling interests1,0121,679(28,789)45,573 Condensed consolidated statement of financial positionNotes30 June 201331 December 2012RMB000RMB000(unaudited)(audited)Non-current assetsTechnical know-how13,24614,686Property, plant and equipment1,382,1521,426,187Construction in progress458,854273,977Prepaid lease payments on land use rights305,403235,658Investment properties66,41668,906Interest in an associate26,39524,963Available-for-sale investments116,302156,303Deferred tax assets19,16819,168Goodwill2,7162,716 Prepayments for acquisition of land use rights28,55563,5552,419,2072,286,119Current assetsInventories420,777489,673Trade and other receivables8567,962428,468Prepaid lease payments on land use rights7,3325,840Amounts due from fellow subsidiaries3,9453,971Tax recoverable4,0673,275Restricted bank balances59,82046,600Bank balances and cash153,565375,5441,217,4681,353,371Current liabilitiesTrade and other payables9574,866522,747Dividend payables5,3115,311Amounts due to fellow subsidiaries4,0451,484Amount due to an associate338514Amount due to ultimate holding company15,00013,500Tax payable1,123883Borrowings358,354493,370959,0371,037,809Net current assets258,431315,562Total assets less current liabilities2,677,6382,601,68130 June 201331 December 2012RMB000RMB000(unaudited)(audited)Capital and reservesShare capital457,313457,313Reserves1,252,4031,282,204Proposed final dividend-4,573Equity attributable to owners of the Company1,709,7161,744,090Non-controlling interests40,71339,701Total equity1,750,4291,783,791Non-current liabilitiesDeferred tax liabilities5,78912,331Loan from ultimate holding company693,250496,500Borrowings92,377221,147Deferred income135,79387,912927,209817,8902,677,6382,601,681NOTES TO THE CONDENSED INTERIM FINANCIAL INFORMATION UNDER HKGAAP1. Basis of preparation Shandong Xinhua Pharmaceutical Company Limited (the Company) is a joint stock limited company established in the Peoples Republic of China (the PRC) with limited liability. The H shares of the Company were listed on The Stock Exchange of Hong Kong Limited (the Stock Exchange) in December 1996 and its A shares were listed on Shenzhen Stock Exchange in July 1997.The directors of the Company regard Hualu Holdings Company Limited, a state-owned limited liability company established in the PRC, as the ultimate holding company and Shandong Xinhua Pharmaceutical Group Company Limited (SXPGC), a wholly state-owned limited liability company established in the PRC, as the immediate holding company.The addresses of the registered office and principal place of business of the Company are disclosed in the Company Information section to the interim report.The unaudited condensed interim financial information are presented in Renminbi (RMB), which is also the functional currency of the Company and its principal subsidiaries. The Company and its subsidiaries (collectively referred to as the Group) are principally engaged in the development, production and sales of bulk pharmaceuticals, preparations, chemical and other products, and commerce circulations.The Groups unaudited condensed interim financial information has been prepared in accordance with the applicable disclosure provisions of Appendix 16 to the Listing Rules and with Hong Kong Accounting Standard (HKAS) 34, Interim Financial Reporting, issued by the Hong Kong Institute of Certified Public Accountants (HKICPA). The unaudited condensed consolidated interim financial information should be read in conjunction with the annual financial statements for the year ended 31 December 2012.Principal accounting policies The condensed consolidated interim financial information has been prepared on the historical cost basis except for certain financial instruments, which are measured at fair values, as explained in the accounting policies set out below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.Except as described below, the accounting policies and methods of calculation used in the condensed consolidated interim financial information for the six months ended 30 June 2013 are consistent with those followed in the preparation of the Groups annual financial statements for the year ended 31 December 2012.In the current interim period, the Group has applied the following amendments to Hong Kong Financial Reporting Standards (HKFRSs) issued by the HKICPA.HKFRSs (Amendments)Annual Improvements 2009-2011 CycleHKFRS 1 (Amendments)Government loansHKFRS 7 (Amendments)Disclosures Offsetting Financial Assets and Financial LiabilitiesHKFRS 10, HKFRS 11 and HKFRS 12 (Amendments)Consolidated Financial Statements, Joint Arrangements and Disclosure of Interests in Other Entities: Transition GuidanceHKFRS 10Consolidated Financial StatementsHKFRS 11Joint ArrangementHKFRS 12Disclosures of Interests in Other EntitiesHKFRS 13Fair Value MeasurementHKAS 19 (as revised in 2011)Employee BenefitsHKAS 27 (as revised in 2011)Separate Financial StatementsHKAS 28 (as revised in 2011)Investments in Associate and Joint VenturesHKAS 1 (Amendments)Presentation of Items of Other Comprehensive IncomeHK(IFRIC) Interpretation (INT) 20Stripping Costs in the Production Phase of a Surface MineThe Group has not early applied the following new and revised standards, amendments or interpretations that have been issued but are not yet effective.HKFRS 9 and HKFRS 7 (Amendments)Mandatory Effective Date of HKFRS 9 and Transition Disclosures1HKFRS 10, HKFRS 12 and HKAS 27 (Amendments)Investment Entities2HKFRS 9Financial Instruments1HKAS 32 (Amendments)Offsetting Financial Assets and Financial Liabilities2HKAS 36 (Amendments)Recoverable Amount Disclosures for Non-Financial Assets2HKAS 39 (Amendments)Financial Instruments: Recognition and Measurement Novation of Derivatives and Continuation of Hedge Accounting2 HK(IFRIC) INT 21Levies21 Effective for annual periods beginning on or after 1 January 2015.2 Effective for annual periods beginning on or after 1 January 2014.Amendments to HKAS 32 Offsetting Financial Assets and Financial LiabilitiesThe amendments to HKAS 32 clarify existing application issues relating to the offset of financial assets and financial liabilities requirements. Specifically, the amendments clarify the meaning of currently has a legally enforceable right of set-off and simultaneous realisation and settlement.The directors of the Company anticipate that the application of these amendments to HKAS 32 may result in more disclosures being made with regard to offsetting financial assets and financial liabilities in the future. HKFRS 9 Financial InstrumentsHKFRS 9 Financial Instruments issued in November 2009 and amended in October 2011 introduces new requirements for the classification and measurement of financial assets and financial liabilities and for derecognition.HKFRS 9 requires all recognised financial assets that are within the scope of HKAS 39 Financial Instruments: Recognition and Measurement to be subsequently measured at amortised cost or fair value. Specifically, debt investments that are held within a business model whose objective is to collect the contractual cash flows, and that have contractual cash flows that are solely payments of principal and interest on the principal outstanding are generally measured at amortised cost at the end of subsequent accounting periods. All other debt investments and equity investments are measured at their fair values at the end of subsequent accounting periods. In addition, under HKFRS 9, entities may make an irrevocable election to present subsequent changes in the fair value of an equity investment (that is not held for trading) in other comprehensive income, with only dividend income generally recognised in profit or loss.The most significant effect of HKFRS 9 regarding the classification and measurement of financial liabilities relates to the presentation of changes in fair value of a financial liability (designated as at fair value through profit or loss) attributable to changes in the credit risk of that liability. Specifically, under HKFRS 9, for financial liabilities that are designated as at fair value through profit or loss, the amount of change in the fair value of the financial liability that is attributable to changes in the credit risk of that liability is presented in other comprehensive income, unless the recognition of the effects of changes in the liabilitys credit risk in other comprehensive income would create or enlarge an accounting mismatch in profit or loss. Changes in fair value attributable to a financial liabilitys credit risk are not subsequently reclassified to profit or loss. Previously, under HKAS 39, the entire amount of the change in the fair value of the financial liability designated as at fair value through profit or loss was recognised in profit or loss.HKFRS 9 is effective for annual periods beginning on or after 1 January 2015, with earlier application permitted.The directors of the Company anticipate that HKFRS 9 that will be adopted in the Groups consolidated financial statements for the annual period beginning 1 January 2015 and that the application of the new standard will have no significant impact on amounts reported in respect of the Groups financial assets and financial liabilities.Amendments to HKFRS 10, HKFRS 12 and HKAS 27 Investment EntitiesThe amendments to HKFRS 10 introduce an exception to consolidating subsidiaries for an investment entity, except where the subsidiaries provide services that relate to the investment entitys investment activities. Under the amendments to HKFRS 10, an investment entity is required to measure its interests in subsidiaries at fair value through profit or loss.To qualify as an investment entity, certain criteria have to be met. Specifically, an entity is required to: obtain funds from one or more investors for the purpose of providing them with professional investment management services; commit to its investor(s) that its business purpose is to invest funds solely for returns from capital appreciation, investment income, or both; and measure and evaluate performance of substantially all of its investments on a fair value basis.Consequential amendments to HKFRS 12 and HKAS 27 have been made to introduce new disclosure requirements for investment entities.The amendments to HKFRS 10, HKFRS 12 and HKAS 27 are effective for annual periods beginning on or after 1 January 2014, with early application permitted. The directors of the Company anticipate that the application of the amendments will have no effect on the Group as the Company is not an investment entity.Other than disclosed above, the directors of the Company anticipate that the application of the new or revised standards and interpretations will have no material impact on the result and the financial position of the Group.3. Segment informationDescription of segmentsThe Groups operating segments, based on information reported to the board of directors of the Company, being the chief operating decision maker, for the purposes of resource allocation and assessment of segment performance focuses on the types of goods supplied. The principal types of goods supplied are bulk pharmaceuticals, preparations, chemical and other products and commerce circulations. The Groups reportable segments under HKFRS 8 are as follows:Bulk pharmaceuticals:Development, production and sales of bulk pharmaceuticalsPreparations:Development, production and sales of preparations (e.g. tablets and injections)Chemical and other products:Production and sales of chemical and other products Commerce circulations:Trading of pharmaceutical products (including retail and wholesale)Information regarding the above segments is reported below. Segment turnover and results The following is an analysis of the Groups turnover and results by reportable segment.For the six months ended 30 June 2013 (Unaudited)Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other products EliminationsTotalRMB000RMB000RMB000RMB000RMB000RMB000REVENUE External sales781,091303,471411,502103,938-1,600,002Inter-segment sales6,006151,6489,642142,785(310,081)-Total 787,097455,119421,144246,723(310,081)1,600,002Segment profit (loss)43,51017,6693,222(9,500)54,901Unallocated income 19,333Unallocated expenses(29,959) Finance costs (36,988)Share of profits of an associate1,432Profit before tax 8,719For the six months ended 30 June 2012 (Unaudited)Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other products EliminationsTotalRMB000RMB000RMB000RMB000RMB000RMB000REVENUE External sales750,812291,004387,86195,331-1,525,008Inter-segment sales3,758182,7531,301128,972(316,784)-Total 754,570473,757389,162224,303(316,784)1,525,008Segment profit (loss)80,7797,013(147)(16,135)71,510Unallocated income28,560Unallocated expenses(34,452)Finance costs(28,146)Share of profits of an associate1,615Profit before tax 39,087The accounting policies of the reportable segments are the same as the Groups accounting policies. Segment profit represents the profit earned by each segment without allocation of investment and other income (exclude government grants), other expenses, deprecation for investment properties, finance costs and share of profit of an associate. This is the measure reported to the chief operating decision maker for the purposes of resource allocation and performance assessment.Inter-segment sales are charged at prevailing market rates.Segment assetsThe following is an analysis of the Groups assets by reportable segment.At 30 June 2013 (Unaudited)Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other products TotalRMB000RMB000RMB000RMB000RMB000Segment assets1,828,688374,268223,535764,4513,190,942Unallocated corporate assets445,733Consolidated assets3,636,675At 31 December 2012 (Audited)Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other products TotalRMB000RMB000RMB000RMB000RMB000Segment assets1,600,335569,590135,428639,3782,944,731Unallocated corporate assets694,759Consolidated assets 3,639,490For the purposes of monitoring segment performances and allocating resources among segments: all assets are allocated to reportable segments other than deferred tax assets, interest in an associate, available-for-sale investments, investment properties, tax recoverable, restricted bank balances and bank balances and cash. Assets used jointly by reportable segments are allocated on the basis of revenues earned by individual reportable segments.4. Profits before taxProfit before tax has been arrived at after charging (crediting):Six months ended 30 June20132012RMB000RMB000(unaudited)(unaudited)Depreciation for property, plant and equipment80,87082,634Depreciation for investment properties2,4901,629Amortisation of prepaid lease payments on land use rights3,3592,645Amortisation of technical know-how (included in administrative expenses)1,440820Total depreciation and amortisation88,15987,728Cost of inventories recognised as an expense 1,354,4311,247,825Dividends and interest income(2,763)(4,057)Loss on disposal of property, plant and equipment1206,3005. Income tax expenseThe major components of income tax expense in the condensed consolidated income statement are:Six months ended 30 June20132012RMB000RMB000(unaudited)(unaudited) Current income tax PRC Enterprise Income Tax (EIT)3,6286,968Deferred income tax(542)(137)Income tax expense3,0866,831Under the Law of the PRC on Enterprise Income Tax (the EIT Law) and Implementation Regulation of the EIT Law, the tax rate of the PRC companies is 25% for both periods. Pursuant to the relevant laws and regulations in the PRC, the Company was accredited as a high-tech enterprise. The accreditation is valid for three years. The Company is entitled to the preferential tax rate of 15% for a period of three years commencing from 1 January 2011 to 31 December 2013.Pursuant to the relevant laws and regulations in the PRC, the Groups subsidiary, SINO-USA Zibo Xinhua - Perrigo Pharmaceutical Company Limited, operating in the PRC is entitled to exemption from the PRC income tax for the two years ended 31 December 2009, followed by a 50% reduction of the PRC income tax for the three years ended 31 December 2012. No extension on this tax reduction after 31 December 2012.6. Earnings per shareThe calculation of the basic earnings per share is based on the Groups profit for the period attributable to the owners of the Company of RMB4,510,000 (2012: RMB30,416,000) and based on the weighted average of 457,312,830 shares (2012 : 457,312,830 shares) in issue during the period.Basic earnings per share and diluted earnings per share for the six months ended 30 June 2013 and 2012 are the same as there were no dilutive events existed during both periods.7. Dividends(a) The board of the directors of the Company did not recommend the payment of an interim dividend for the six months ended 30 June 2013 (2012: Nil).(b) Dividends attributable to the previous financial year, approved during the interim period.Six months ended 30 June20132012RMB000RMB000(unaudited)(unaudited) Final dividend in respect of the financial year ended 31 December 2012, approved during the following interim period, of RMB 0.01 per share (year ended 31 December 2011: RMB0.03 per share)4,57313,7198. Trade and other receivables30 June 201331 December 2012RMB000RMB000(unaudited)(audited) Trade and bills receivables548,737403,563Less : Allowance for doubtful debts of trade receivables(63,125)(63,125)485,612340,438Other receivables, deposits and prepayments83,903 53,096VAT recoverable7,23714,737Consideration receivable on disposal of land-28,987-p r s t   x z 2 ª”pbL7L(h9%hCJOJPJQJaJnHtH+h9%hCJOJPJQJaJnHo(tHh9%hCJQJaJo(h9%h5CJQJaJo(&h9%h5CJQJaJnHo(tH*h9%h5CJPJQJaJnHo(tH.jh9%h5CJQJUmHnHo(uh9%h5CJQJo(h9%h5CJOJQJ"h9%h6KHOJPJQJ]h9%h6KHOJQJ]q r s u v  x 2 X 01HI  $v dWD`v a$$da$^ $dT^a$$a$n\\2 X \ ^ ` b p  H O P T U a b s ׽׽׽{{{k\J\A{h9%hua5CJ"h9%hT5CJPJnHo(tHh9%hTCJPJnHtHh9%hTCJPJnHo(tHh9%h5CJ\h9%hCJ$h9%hB*PJnHo(phtH2h9%h 5B*CJPJ\aJnHo(phtH2h9%h5B*CJPJ\aJnHo(phtH#h9%h5B*CJ\aJph,h9%hB*CJKHOJQJaJo(ph   $(_`ahin0134GHIg޼vvndndh9%h5o(h9%h5h9%h h CJo(h9%h h CJh9%hCJo(h9%h5CJh9%h5CJ\%h9%h5CJPJ\nHo(tH"h9%h5CJPJ\nHtHh9%h CJPJnHo(tHh9%hCJPJnHo(tHh9%hCJh9%h!CJ'VZ  pt567[\]lmoyz{ݏvݏh9%h CJPJnHo(tHh9%h CJh9%hT,?CJPJnHo(tHjh9%hCJUjh9%hCJU h9%hCJOJQJ^JaJh9%hB5CJPJnHo(tHh9%hCJPJnHo(tHh9%hCJo(h9%hCJ. rtnoz{9:uv $rdWD^r`a$gdT,?$~dWD^~`a$gdT,? $d7$a$$da$&'()678:KLtv  ٯwٿٿkw[wjh9%hCJUh9%h5CJ\h9%hCJPJnHo(tH0h9%h0J.>*B*CJOJQJ^JaJphh9%h0J.B*CJphjh9%hCJUh9%hCJo(jh9%hCJUh9%hCJjh9%hCJU h9%hCJOJQJ^JaJ#   )*op "$&(*$da$   (*abhlnpRTVXsgYh9%h5CJaJo(h9%h5CJaJ&h9%h5CJPJaJnHo(tHh9%h5h9%h5h9%h5o(h9%h5PJnHo(tH+h9%hCJOJPJQJaJnHo(tHh9%hCJPJnHo(tHh9%h h CJh9%h5CJ\h9%hCJh9%hCJo("*,.02468:<>@BDFHJLNPR&Ld $$1$Ifa$$da$  FHJLdϭoUoH4'h9%h&6CJKHPJaJnHo(tHh9%hCJKHaJ2h9%h5CJKHOJPJQJaJnHo(tH2h9%h5CJKHOJPJQJaJnHo(tH#h9%h5CJKHOJQJaJ#h9%hCJPJaJnHo(tH&h9%hno5CJPJaJnHo(tHh9%h5CJaJo(#h9%hno5CJPJaJnHtH#h9%h25CJPJaJnHtHh9%h5CJaJ);TU޹ޖ|||o]Lo h9%h+CJOJPJQJaJ#h9%h+5CJOJPJQJaJh9%h+CJKHaJ2h9%h5CJKHOJPJQJaJnHo(tH#h9%h5CJKHOJQJaJ!h9%h5CJKH\aJo(-h9%h5CJKHPJ\aJnHo(tHh9%hCJKHaJo(h9%hCJKHaJ'h9%hCJKHPJaJnHo(tHd);MT{sggg $$Ifa$gd8$1$Ifxkd$$Ifl\ (#  p(#644 lal $$1$Ifa$TU~rrr $$Ifa$gd8$1$Ifxkd"$$Ifl\ (#  p(#644 lalU %12LRXaelnp̻޲̻̻̻ނhZh9%h+CJKHaJo(2h9%h+5CJKHOJPJQJaJnHo(tH#h9%h+5CJKHOJQJaJh9%h+CJPJaJ h9%h1"CJPJaJnHtHh9%h+CJ h9%h+CJOJPJQJaJ#h9%h+5CJOJPJQJaJh9%h+CJKHaJ'h9%h+CJKHPJaJnHo(tHxlll $$Ifa$gd8w00$IfXDYDxkd$$Ifl\ (#  p(#644 lal %*1~rrr $$Ifa$gd8$1$Ifxkdr$$Ifl\ (#  p(#644 lal12LRXn~rrd$$4$Ifa$gd1" $$Ifa$gd8$1$Ifxkd$$Ifl\ (#  p(#644 lalnop~sssss $$1$Ifa$$1$Ifxkd$$Ifl\ (#  p(#644 lal .?@Qʼʪ|hVGh9%hX>CJOJQJaJ#h9%hX>5CJOJQJ^JaJ&h9%hX>5CJOJQJ^JaJo('h9%hX>CJKHPJaJnHo(tH2h9%h+5CJKHOJPJQJaJnHo(tH#h9%h+5CJKHOJQJaJh9%h+CJKHaJo(h9%h+CJKHaJ-h9%h+5CJKHPJ\aJnHo(tH!h9%h+5CJKH\aJo(.@QV~rrr $$Ifa$gd8$1$Ifxkdd$$Ifl\ (#  p(#644 lalQUVhxy%&.[ou}3ϻϻφϻφxφφφφh9%hX>CJKHaJo('h9%hX>CJKHPJaJnHo(tHh9%hX>CJOJQJaJ#h9%hX>5CJOJQJ^JaJ&h9%hX>5CJOJQJ^JaJo(h9%hX>CJKHaJ h9%hX>CJOJQJ^JaJ#h9%hX>CJOJQJ^JaJo(/VWhy~rrr $$Ifa$gd8$1$Ifxkd$$Ifl\ (#  p(#644 lal~rrr $$Ifa$gd8$1$Ifxkd$$Ifl\ (#  p(#644 lal&~rrr $$Ifa$gd8$1$IfxkdV $$Ifl\ (#  p(#644 lal&'}~rrr $$Ifa$gd8$1$Ifxkd $$Ifl\ (#  p(#644 lal~rrr $$Ifa$gd8$1$Ifxkd $$Ifl\ (#  p(#644 lal~rrr $$Ifa$gd8$1$IfxkdN $$Ifl\ (#  p(#644 lal3:?H~rrr $$Ifa$gd8$1$Ifxkd $$Ifl\ (#  p(#644 lal3:?GHZnrvw|ۼ옉ss`L?Lh9%h\CJKHaJ'h9%h\CJKHPJaJnHo(tH$h9%h\CJKHPJaJnHtH+h9%hX>CJOJPJQJaJnHo(tHh9%hX>CJOJQJaJh9%hX>5CJOJQJaJ'h9%hX>CJKHPJaJnHo(tHh9%hX>CJKHaJ#h9%hX>CJOJQJ^JaJo( h9%hX>CJOJQJ^JaJ&h9%hX>5CJOJQJ^JaJo(HIrw|~rrd$$4$Ifa$gdX> $$Ifa$gd8$1$Ifxkd $$Ifl\ (#  p(#644 lal~rrd$$4$Ifa$gd\Sc $$Ifa$gd8$1$IfxkdF$$Ifl\ (#  p(#644 lal#+.0789>GXq٧o٧\H;Hh9%h\CJKHaJ'h9%h\CJKHPJaJnHo(tH$h9%h\CJKHPJaJnHtHh9%hX>5CJOJQJaJ&h9%hX>5CJOJQJ^JaJo('h9%hX>CJKHPJaJnHo(tHh9%hX>CJKHaJ+h9%h\ScCJOJPJQJaJnHo(tHh9%hX>CJOJQJaJ+h9%hX>CJOJPJQJaJnHo(tHh9%hX>CJOJQJaJo(#8~rrd$$4$Ifa$gd\Sc $$Ifa$gd8$1$Ifxkd$$Ifl\ (#  p(#644 lal89u|~rrr $$Ifa$gd8$1$Ifxkd$$Ifl\ (#  p(#644 lalqtu|!*+¬‡ucOu'h9%hX>CJKHPJaJnHo(tH#h9%hX>CJOJQJ^JaJo("h9%hX>5CJOJQJaJo(+h9%h\ScCJOJPJQJaJnHo(tHh9%hX>CJOJQJaJ+h9%hX>CJOJPJQJaJnHo(tHh9%hX>CJOJQJaJo(&h9%hX>5CJOJQJ^JaJo(h9%hX>CJKHaJh9%h\CJKHaJ~rrr $$Ifa$gd8$1$Ifxkd>$$Ifl\ (#  p(#644 lal#*~rrr $$Ifa$gd8$1$Ifxkd$$Ifl\ (#  p(#644 lal*+,-./017TYzzzzzzm\-00$IfXDYDgd{/ -00XDYDgdF -00XDYDxkd$$Ifl\ (#  p(#644 lal +,17TXYfkm|}~;j[I7#h9%h]>CJOJQJ^JaJo(#h9%h]>CJhmH nHsH tHh9%hFKHPJnHtH2h9%hed5B*CJPJ\aJnHo(phtH&h9%hed5B*CJ\aJo(ph&h9%hF5B*CJ\aJo(ph#h9%hF5B*CJ\aJphh9%hFB*CJaJphh9%hB*CJaJph h9%h)iB*CJaJo(ph#h9%hCJPJaJnHo(tHYfm}~P?w00$IfXDYDgd{/fkd6$$IflF" U t6    44 la-$00$IfXDYD]a$gded-$00$4$IfXDYD]a$gd{/-$00$4$IfXDYDa$gd{/ xgw00$IfXDYDgd{/fkd$$IflF" U t6    44 law$00$IfXDYDa$gd) $$Ifa$gd8    " $ * + Z!k!u!!!!!!!!!!!!! "(","ӿөӗӗөӗpӗp+h9%h]>CJOJPJQJaJnHo(tH h9%h]>CJOJQJ^JaJ#h9%h]>CJOJQJ^JaJo(*h9%h]>CJPJhmH nHo(sH tH'h9%h]>CJPJhmH nHsH tH#h9%h]>CJhmH nHsH tH h9%h]>&h9%h]>CJhmH nHo(sH tH(  Z!k!!{gw$00$IfXDYDa$gd) $$Ifa$gd8w00$IfXDYDgd{/fkd,$$IflF" U t6    44 la!!!!!{o $$Ifa$gd) $$Ifa$gd8w00$IfXDYDgd{/fkd$$IflF" U t6    44 la!! "(","ym $$Ifa$gd) $$Ifa$gd8w00$IfXDYDgd{/hkd"$$Ifl\F" U t6    44 la,"."T"r"v"{o $$Ifa$gd) $$Ifa$gd8w00$IfXDYDgd{/fkd$$IflF" U t6    44 la,"."B"T"r"v"x""""""""""""##>#@#B#ϽpdVdVdVMdVCh9%hFCJo(h9%hFCJh9%hF5CJaJo(h9%hF5CJaJ&h9%h@w5CJPJaJnHo(tH#h9%hFCJPJaJnHo(tH h9%h]>CJKHaJnHtH+h9%h]>CJOJPJQJaJnHo(tH#h9%h]>CJOJQJ^JaJo(&h9%h]>CJhmH nHo(sH tH#h9%h]>CJhmH nHsH tHh9%h]>CJaJv"x""""w $$Ifa$gd) $$Ifa$gd8 $Ifgd{/fkd$$IflF" U t6    44 la""""##@#B#L###|pp $$Ifa$gd{/ $$Ifa$gd{/ $da$gdFgdFfkd$$IflF" U t6    44 la B#J#L#############$°švfQQ>*'h9%h1SCJKHPJaJnHo(tH$h9%hFCJKHOJQJ^JaJ(h9%hFCJKHOJPJQJnHtHh9%hfCJKHOJQJo(h9%hFCJKHOJQJ(h9%hFCJKHOJPJQJnHtH+h9%hF5CJKHOJPJQJnHtH"h9%hf5CJKHOJQJo(.h9%hF5CJKHOJPJQJnHo(tH#h9%hF5CJKHOJQJaJ&h9%hF5CJKHOJQJaJo(##$ $$$$1$Ifa$gd8 $Ifgd{/ekd$$Ifl,F3 > O6    44 la$$ $ $$$$)$*$0$1$8$9$:$L$M$T$U$\$]$^$s$t$z${$$$$$ï{nï{nï{nïZ'h9%h1SCJKHPJaJnHo(tHh9%h1SCJKHaJh9%h1SCJKHaJo($h9%h1SCJKHOJQJ^JaJ$h9%h1SCJKHOJQJ^JaJ'h9%h1SCJKHOJQJ^JaJo('h9%h1S5CJKHOJQJ^JaJ*h9%h1S5CJKHOJQJ^JaJo($h9%h1SCJKHPJaJnHtH$$*$1$9$$$1$Ifa$gd8 $Ifgd{/ekd$$Ifl,F3 > O6    44 la9$:$M$U$]$$$1$Ifa$gd8 $Ifgd{/ekd$$Ifl,F3 > O6    44 la]$^$t${$$$$1$Ifa$gd8 $Ifgd{/ekd$$Ifl,F3 > O6    44 la$$$$$vv$$1$Ifa$gd8$IfVDKWDY^`gd (ekd $$Ifl,F3 > O6    44 la$$$$$$$$$$$$$$$%%%&%ïïwcWC5h9%hF5CJaJo(&h9%hF5CJPJaJnHo(tHh9%hF5CJaJ&h9%h)i5CJPJaJnHo(tH#h9%hFCJPJaJnHo(tH$h9%h1SCJKHOJQJ^JaJ$h9%h1SCJKHOJQJ^JaJ'h9%h1SCJKHOJQJ^JaJo('h9%h1S5CJKHOJQJ^JaJ*h9%h1S5CJKHOJQJ^JaJo(#h9%h1SCJKHaJnH o(tH $$$$$vv$$1$Ifa$gd8$IfVDKWDY^`gd (ekd$$Ifl,F3 > O6    44 la$$$$$$$&%'%zzzzzR(<TPL HD@< ^gdF $da$gdFTQ gdFekd$$Ifl,F3 > O6    44 la&%'%+%,%<%=%&&&&@&B&D&F&V&ëq[K;K[h9%hfCJKHOJQJo(h9%hFCJKHOJQJo(+h9%hFCJKHOJPJQJnHo(tH+h9%hF5CJKHOJPJQJnHtH"h9%hf5CJKHOJQJo("h9%hF5CJKHOJQJo(.h9%hF5CJKHOJPJQJnHo(tH#h9%hF5CJKHOJQJaJ&h9%hF5CJKHOJQJaJo(,h9%hFB*CJPJaJnHo(phtH'%,%&F&Z&\&v&&&}oo$$1$Ifa$gd8 $Ifgd{/`kd$$IflF '!@ @  t!    4 la $$Ifa$gd{/ $$Ifa$gd{/V&Z&\&t&v&&&&&&&&&&&&.'>'@'P'R'T'''''DZviԱviԱviUUB$h9%h1SCJKHPJaJnHtH'h9%h1SCJKHPJaJnHo(tHh9%h1SOJQJaJ$h9%h1SCJKHOJQJ^JaJ'h9%h1SCJKHOJQJ^JaJo('h9%h1S5CJKHOJQJ^JaJ*h9%h1S5CJKHOJQJ^JaJo(h9%h1SCJKHaJh9%h1SCJKHaJo(h9%hFQJ(h9%hFCJKHOJPJQJnHtH&&&&&$$1$Ifa$gd8 $Ifgd{/`kd$$IflF '!@ @  t!    4 la&&.'@'R'$$1$Ifa$gd8 $Ifgd{/`kdj$$IflF '!@ @  t!    4 laR'T''''$$1$Ifa$gd8 $Ifgd{/`kd$$IflF '!@ @  t!    4 la'''''''O(U(b(c(h(o((¯vbVJ<&*h9%hF5CJKHPJaJnHo(tHh9%hF5CJKHaJh9%hF5CJaJh9%hFCJaJo(&h9%hF5CJPJaJnHo(tHh9%hF5CJaJo(h9%hF5CJaJ#h9%hFCJPJaJnHo(tHh9%h1SOJQJaJ$h9%h1SCJKHOJQJ^JaJ'h9%h1SCJKHOJQJ^JaJo('h9%h1S5CJKHOJQJ^JaJ*h9%h1S5CJKHOJQJ^JaJo('''b(c(h(((((}}}}} $$Ifa$gd{/gdF $da$gdFgdF`kdP$$IflF '!@ @  t!    4 la (((((((((((((((()))))()))Ƴo[J h9%hFCJPJaJnHtH&h9%h3]5CJPJaJnHo(tH#h9%hF5CJPJaJnHtHh9%hFCJaJo(#h9%hFCJPJaJnHo(tH&h9%hF5CJPJaJnHo(tH$h9%hFCJOJQJaJnHtH'h9%hF5CJOJQJaJnHtH*h9%hF5CJKHPJaJnHo(tHh9%hF5CJKHaJo((((())+) $$Ifa$gd{/ $Ifgd{/`kd$$If4F H&<<d&    4 af4))*)+),)T)`)a)n)o))))))))))))))))))*ȷyfyfWDyfyfW$h9%h1SCJOJQJaJnHtHh9%h1SCJOJQJaJ$h9%h1SCJKHOJQJ^JaJ'h9%h1SCJKHOJQJ^JaJo('h9%h1S5CJKHOJQJ^JaJ*h9%h1S5CJKHOJQJ^JaJo( h9%h1SCJPJaJnHtH$h9%hFCJOJQJaJnHtH#h9%hFCJPJaJnHo(tH#h9%h3]CJPJaJnHo(tH+),)T)a)o)))vm____$$1$Ifa$gd8 $Ifgd{/kdD$$If4rn H&d&4 af4))))){o7. $Ifgd{/7kde$$IfH&d&d&4 a $$Ifa$gd{/kd$$Ifrn H&d&4 a))))))**#*2*A*md $Ifgd{/kd$$Ifrn H&d&4 a$$1$Ifa$gd8 ***"*#*1*2*@*A*B****************++++++'+(+¯¯¯¯¯¯wfT#h9%hFCJPJaJnHo(tH h9%hFCJPJaJnHtH/h9%hFCJOJPJQJ^JaJnHo(tH h9%h1SCJPJaJnHtHh9%h1SCJOJQJaJ$h9%h1SCJKHOJQJ^JaJ'h9%h1SCJKHOJQJ^JaJo('h9%h1S5CJKHOJQJ^JaJ*h9%h1S5CJKHOJQJ^JaJo( A*B******{rdddd$$1$Ifa$gd8 $Ifgd{/kdI$$Ifrn H&d&4 a*****++{rdddd$$1$Ifa$gd8 $Ifgd{/kd$$Ifrn H&d&4 a+++i+j+,,m---{vnnbbbYQ$da$ $7$8$H$a$ $7$8$H$a$gdF$a$gdFgdFkda$$Ifrn H&d&4 a (+i+k+++++++++++,6,>,?,@,C,G,M,N,O,P,V,o,r,,,,,,---%-b-k-m-ݮݮݓݮtb#h9%htCJPJaJnHo(tH h9%hUeCJPJaJnHtHhUeCJPJaJnHtHh9%hFCJaJnHo(tHh9%hFCJaJ#h9%hSCJPJaJnHo(tHh9%hFCJaJo( h9%h\CJPJaJnHtH#h9%hFCJPJaJnHo(tH h9%hFCJPJaJnHtH&m-p-{-~---------------ûzhUD h9%h5B*CJaJph%h9%hB*CJOJQJaJph#h9%hCJPJaJnHo(tHh9%h5CJaJo(h9%h5CJaJ9h9%h5CJKHOJPJQJ\^JaJnHo(tHh9%h5o(h9%h5h9%h)i5PJnHo(tH+h9%hCJOJQJ^JaJnHo(tHh9%hnHo(tHh9%hnHtH--------------------. .$$If^a$ $If^7$8$H$$da$---.. . . . ..\.]..........// /9/E/F/M/U/V///////籾矱{{t{gg[{h9%h1dnHo(tHh9%h1dOJQJ^J h9%h1d h9%h1dOJQJ^JnHtHh9%h1dCJaJh9%h1do(#h9%h5B*CJaJo(phh9%hOJQJaJ h9%h5B*CJaJph/h9%h1d5B*CJPJaJnHo(phtH/h9%h5B*CJPJaJnHo(phtH# . ..'.6.S.l..uuuuu$$If^a$$$If^a$okd$$IfTl4TF "$  t1%6    44 laf4T.......i`QQBB$d$Ifa$gdF$d$Ifa$gdEE v$$Ifa$kdv$$IfTl4Tr ""$  t1%644 laf4T.......i`QQBB$d$Ifa$gdF$d$Ifa$gdEE v$$Ifa$kd+ $$IfTl4Tr ""$  t1%644 laf4T../////i`QQBB$d$Ifa$gdF$d$Ifa$gdEE v$$Ifa$kd $$IfTl4Tr ""$  t1%644 laf4T/ /9/=/?/C/E/i^OO@@$d$Ifa$gdF$d$Ifa$gdEE v$$G$Ifa$kd!$$IfTl4Tr ""$  t1%644 laf4TE/F/M/O/Q/S/U/i`QQBB$d$Ifa$gdF$d$Ifa$gdEE v$$Ifa$kdJ"$$IfTl4Tr ""$  t1%644 laf4TU/V//////i`QQBB$d$Ifa$gdF$d$Ifa$gdEE v$$Ifa$kd"$$IfTl4Tr ""$  t1%644 laf4T///////i`QQBB$d$Ifa$gdF$d$Ifa$gdEE v$$Ifa$kd#$$IfTl4r ""$  t1%644 laf4T//!0-030?0E0i`QQBB$d$Ifa$gdF$d$Ifa$gdEE v$$Ifa$kdi$$$IfTl4Tr ""$  t1%644 laf4T//!0E0F0`00000000000000001111ϽuaSSaa?S&h9%h&65CJPJaJnHo(tHh9%h5CJaJo(&h9%h@w5CJPJaJnHo(tH&h9%hEn5CJPJaJnHo(tH&h9%h1d5CJPJaJnHo(tH&h9%h5CJPJaJnHo(tHh9%h5CJaJ#h9%hCJPJaJnHo(tHh9%h1dOJQJ^Jh9%h1dCJaJh9%h1do( h9%h1dOJQJ^JnHtHE0F0`0l0s000i`QQBB$d$Ifa$gdF$d$Ifa$gdEE v$$Ifa$kd%$$IfTl4Tr ""$  t1%644 laf4T000111111 1!1ig_g______$da$kd%$$IfTl4Tr ""$  t1%644 laf4T 11/1B1C1D111111111İİs^C^1#h9%h5B*CJaJo(ph4h9%hGB*CJOJPJQJaJnHo(phtH(h9%hB*CJOJQJaJo(ph,h9%hB*CJPJaJnHo(phtH#h9%hCJPJaJnHo(tH&h9%h5CJPJaJnHo(tH&h9%h5CJPJaJnHo(tHh9%h5CJaJ&h9%h)i5CJPJaJnHo(tH5h9%h5CJOJPJQJ\^JaJnHo(tH!1"1#1$1%1&1'1(1)1*1+1,1-1.1/1111112+2V22$$If^a$^$da$11111122z2~22222222222!3-373òòÚ|oaoVoOo;oVo'h9%h*CJKHPJaJnHo(tH h9%h*h9%h*CJaJh9%h*5CJKHaJh9%h*CJKHaJ h9%h,h9%h5B*CJPJaJnHphtH/h9%h5B*CJPJaJnHo(phtH h9%h5B*CJaJph#h9%h5B*CJaJo(ph#h9%h5B*CJaJo(ph/h9%h5B*CJPJaJnHo(phtH22222kYD8 $$Ifa$gd8$d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_kd&$$IfTֈ ~4 T$ p T$aT222223VDd$1$7$8$H$Ifgd_kdA'$$IfTֈ ~4 T$ p T$aT$d$1$7$8$H$Ifa$gd83!3-3335373$d$1$7$8$H$Ifa$gd8 $$Ifa$gd8$d$1$7$8$H$Ifa$gd7383$kd($$IfTֈ ~4 T$ p  <T$ap<T738333334 4.484A4B4M4\4]4g4p4q4}4444444444444#5$5I5Q5Z5[5h5w5x5555555555555ϻϻ&h9%h5CJPJaJnHo(tHh9%h5CJaJ#h9%hCJPJaJnHo(tH'h9%h*CJKHPJaJnHo(tH#h9%h*CJPJaJnHo(tHh9%h*CJaJh9%h*CJKHaJ h9%h*383n333333$d$1$7$8$H$Ifa$gd8 $$Ifa$gd8$d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_33$kdL)$$IfTֈ ~4 T$ p  <T$ap<T3 4.484=4?4A4$d$1$7$8$H$Ifa$gd8 $$Ifa$gd8$d$1$7$8$H$Ifa$gdXd$1$7$8$H$Ifgd_A4B4$kd*$$IfTֈ ~4 T$ p  <T$ap<TB4M4]4g4l4n4p4$d$1$7$8$H$Ifa$gd8 $$Ifa$gd8$d$1$7$8$H$Ifa$gdXd$1$7$8$H$Ifgd_p4q4$kd+$$IfTֈ ~4 T$ p  <T$ap<Tq4}444444$d$1$7$8$H$Ifa$gd8 $$Ifa$gd8$d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_44$kd0-$$IfTֈ ~4 T$ p  <T$ap<T4444444$d$1$7$8$H$Ifa$gd8 $$Ifa$gd8$d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_44$kd|.$$IfTֈ ~4 T$ p  <T$ap<T4$5I5Q5V5X5Z5$d$1$7$8$H$Ifa$gd8 $$Ifa$gd8$d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_Z5[5$kd/$$IfTֈ ~4 T$ p  <T$ap<T[5h5x55555$d$1$7$8$H$Ifa$gd8 $$Ifa$gd8$d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgdm55$kd1$$IfTֈ ~4 T$ p  <T$ap<T5555555$d$1$7$8$H$Ifa$gd8 $$Ifa$gd8$d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_555$"kd`2$$IfTֈ ~4 T$ p  <T$ap<T5566263646G666666666777u7v7ྫྷ}peZpeZpeZH4'h9%h{Z|CJKHPJaJnHo(tH#h9%h{Z|CJPJaJnHo(tHh9%h{Z|OJQJh9%h{Z|CJaJh9%h{Z|CJKHaJh9%h5OJQJ#h9%h5B*CJaJo(ph h9%h5B*CJaJph#h9%hCJPJaJnHo(tH&h9%h5CJPJaJnHo(tHh9%h5CJaJo(h9%h5CJaJ&h9%h5CJPJaJnHo(tH53646H6v666666{o`$d,$Ifa$gdV $$Ifa$gd8d$1$7$8$H$Ifgd_]kd3$$IflFP" "    4 la $If^$da$ 66666t$d,$Ifa$gdV $$Ifa$gd8d$1$7$8$H$Ifgd_]kd!4$$IflFP" "    4 la66777t$d,$Ifa$gdV $$Ifa$gd8d$1$7$8$H$Ifgd_]kd4$$IflFP" "    4 la77v777t$d,$Ifa$gdV $$Ifa$gd8Xd$1$7$8$H$Ifgd8]kd#5$$IflFP" "    4 lav7777777777777;8<8D8E8M8N8[8l8m8z888888888899?9@9{9|9999꩟|mh9%hfsCJPJnHtHh9%hfsCJPJnHo(tHh9%hfsCJo(h9%hfsCJh9%hCJo(h9%hCJ#h9%hUnCJPJaJnHo(tH#h9%h{Z|CJPJaJnHo(tH'h9%h{Z|CJKHPJaJnHo(tHh9%h{Z|OJQJh9%h{Z|CJaJ(77777t$d,$Ifa$gdV $$Ifa$gd8Xd$1$7$8$H$Ifgd8]kd5$$IflFP" "    4 la77777t$d,$Ifa$gdV $$Ifa$gd8d$1$7$8$H$Ifgd8]kd%6$$IflFP" "    4 la77777t$d,$Ifa$gdV $$Ifa$gd8d$1$7$8$H$Ifgd8]kd6$$IflFP" "    4 la77<8D8M8t$d,$Ifa$gdV $$Ifa$gd8d$1$7$8$H$Ifgd8]kd'7$$IflFP" "    4 laM8N8[8c8l8t$d,$Ifa$gdV $$Ifa$gd8d$1$7$8$H$Ifgd8]kd7$$IflFP" "    4 lal8m8z888p$d,$4$Ifa$gdV $$Ifa$gd8d$1$7$8$H$Ifgd8_kd)8$$IflFP" "    4 la8888y:z:;;D<E<<<????? $da$gdfs$da$]kd8$$IflFP" "    4 la999999: :?:@:]:d:l:p:q:w:z:::::%;&;O;P;;;;;;;;;<<C<H<<<<<<<F=Q===ƼƼƼƼƼƼƼƼƼƼƼƼ}h9%h5CJ\h9%h:CJPJnHo(tHh9%hCJPJnHo(tHh9%hCJh9%hCJo(h9%hfsCJo(h9%hfsCJh9%hfsCJPJnHo(tHh9%hfsCJPJnHtH"h9%hfs5CJPJnHo(tH.=====>>*?+???????@@@@@@A@P@Q@W@X@n@@@¶¬¶¬x[R¬h9%h-CJ9h9%h5CJKHOJPJQJ\^JaJnHo(tHh9%h5o(h9%h5h9%h)i5PJnHo(tH#h9%hCJPJaJnHo(tHh9%hCJo(h9%h5CJ\h9%hCJh9%hCJPJnHo(tH%h9%h5CJPJ\nHo(tH"h9%h5CJPJ\nHtH?????????????????????????@@@7$8$H$$da$@@@@@@AAAZM$$If^a$kd/9$$Iflr4{"7m t64 la$If^gd7 $If^^@@@@@@@@@@@@@@@@@@AAAAA A AAAAAȰٰٰȰٰٰp[H%h9%hB*CJOJQJaJph(h9%hB*CJOJQJaJo(ph#h9%h5B*CJaJo(phh9%hOJQJh9%hmOJQJ/h9%h:5B*CJPJaJnHo(phtH/h9%hm5B*CJPJaJnHo(phtH h9%hm5B*CJaJph#h9%hm5B*CJaJo(ph(h9%hB*CJOJQJaJo(phAAA A A AAAAAA`kd9$$Iflr4{"7m t64 la $If^$$If^a$ AA-A6A:A>ABAwjj]]]$If^gd$$If^a$kd:$$Iflr4{"7m t64 laAAA,A-A5A6A9A:A>AAABACAQARAWAhAmApAqAuAvAAҢwaVҢ;ҢaV4h9%hyhB*CJOJPJQJaJnHo(phtHh9%hOJQJ+h9%h5B*CJOJQJaJo(ph+h9%hl&5B*CJOJQJaJo(ph(h9%hl&B*CJOJQJaJo(ph(h9%hB*CJOJQJaJo(ph4h9%hB*CJOJPJQJaJnHo(phtH%h9%hB*CJOJQJaJph4h9%hl&B*CJOJPJQJaJnHo(phtHBACARAiAmAqAuAwjj]]]$If^gd$$If^a$kd3;$$Iflr4{"7m t64 lauAvAAAAAAAwjZZMMM$If^gd$$If^a$gdl&$$If^a$kd;$$Iflr4{"7m t64 laAAAAAAAAAAAAA BBBBBB"B8B:B>BABBBFBGBTBjBkBlBpBsBtBxByB}BBBBBBBBB׼צ׼צ׼צ׼צ׼צh9%hl&OJQJnHtHh9%hl&OJQJ+h9%hl&5B*CJOJQJaJo(ph4h9%hl&B*CJOJPJQJaJnHo(phtH(h9%hl&B*CJOJQJaJo(ph%h9%hl&B*CJOJQJaJph,AAAAA BBBBwjjjj]]]$If^gd$$If^a$kd<$$Iflr4{"7m t64 laBB"B:B>BBBFBwjj]]]$If^gd$$If^a$kdC=$$Iflr4{"7m t64 laFBGBTBlBpBtBxBwjj]]]$If^gd$$If^a$kd=$$Iflr4{"7m t64 laxByBBBBBBwjj]]]$If^gd$$If^a$kd>$$Iflr4{"7m t64 laBBBBBBBwjj]]]$If^gd$$If^a$kdS?$$Iflr4{"7m t64 laBBBBBBBBBC6C7C8CECEFEGEKELEQESEXEYE]EcEdEeEEî֮îî֮||îî֮î֮|jah9%hCJ#h9%hCJPJaJnHo(tH7h9%hyh5B*CJOJPJQJaJnHo(phtH+h9%hyh5B*CJOJQJaJo(ph(h9%hyhB*CJOJQJaJo(ph%h9%hyhB*CJOJQJaJph4h9%hyhB*CJOJPJQJaJnHo(phtHh9%hyhOJQJnHtH$DDDEEE Ewjj]]]$If^gd$$If^a$kdCH$$Iflr4{"7m t64 la E!E-E?ECEGEKEwjj]]]$If^gd$$If^a$kdH$$Iflr4{"7m t64 laKELERESEYE]EcEwjj]]]$If^gd$$If^a$kdI$$Iflr4{"7m t64 lacEdEeE-F.F/F0F1F2F3F4F5F6Fwummmmmmmmmm$da$kdSJ$$Iflr4{"7m t64 la EEEEEEEEEEEF%F+F-F.F6FOFPFVFWFcFdFFFFFFFFFFFFFFFFFDGEGGGGGHH\H]HHHIIrIsIIIIIII̽ܭh9%h:CJPJnHo(tHh9%hCCJPJnHo(tHh9%hBCJPJnHtHh9%hBCJPJnHo(tHh9%hCJo(h9%hCJh9%hCJPJnHo(tH<6FII)J*JJJJJJJKKqLrLMMMM N NQQRRgdqgd{gd$ $da$gd$7$8$H$$da$II(J)J*JJJJJJJJJJJJJKKKKKKKBKó훑tkakkakQkaFh9%h$CJaJh9%h@CJPJnHo(tHh9%hCJo(h9%hCJ9h9%h5CJKHOJPJQJ\^JaJnHo(tHh9%h5o(h9%h5h9%hfsCJPJnHo(tHh9%hBCJPJnHo(tHh9%hCJPJnHo(tHh9%h5CJaJo(h9%h5CJaJ#h9%hCJPJaJnHo(tHBKCKDKKKKKKKKKKKKKKKKKKKKKLLLLL L*L,L-L/LZL[L_L`LfLgLkLlLqLLLаyyyyyyph9%h$CJ#h9%h.CJPJaJnHo(tH h9%h$CJPJaJnHtH'h9%h.CJPJQJaJnHo(tH'h9%h$CJPJQJaJnHo(tHh9%h$CJaJo(h9%h$CJaJ#h9%hCJPJaJnHo(tH#h9%h$CJPJaJnHo(tH+LLLLLLLLLLLLLMMMM#M$M0M4MMHMMMzM{M~MMMMMMMMMMMMMMM}mh9%h@CJPJnHo(tHh9%h{CJPJnHo(tHh9%hTxCJPJnHo(tHh9%h$CJo(h9%h$CJPJnHo(tHh9%h$CJh9%h$CJaJ#h9%h$CJPJaJnHo(tH'h9%hTxCJPJQJaJnHo(tHh9%hTxCJQJaJo()MMNN N N%N5NNNQQQQRR-T/TTTTTTTUUVVVVWW\X]Xӿvddddddd"h9%hqCJOJQJ\aJo(h3PrCJOJQJ\aJo(.h9%hqCJOJPJQJ\aJnHo(tHh9%hqCJOJQJ\aJ"h9%h{CJOJQJ\aJo(&h9%h$5CJPJaJnHo(tHh9%h$5CJaJh9%h$5CJaJo(#h9%h$CJPJaJnHo(tH!RTTTTUUVVWWYY Z Z_Z`Z[[]]^^ ``*`+`agd $da$gd$gdq]X^XXXXXXY YnYYYYY Z Z_Z`Z[[J\_\(]+]S]j]]]]]^^ɳɡɡɡɡɍyk_yh9%h$5CJaJh9%h$5CJaJo(&h9%h$5CJPJaJnHo(tH&h9%he95CJPJaJnHo(tH"h9%hqCJOJQJ\aJo(+h9%hqCJOJPJQJ\aJnHtHh9%hqCJOJQJ\aJ.h9%hqCJOJPJQJ\aJnHo(tHh9%hqCJOJQJaJ^^^^____ ``*`+```aaaabbcccceeee_fafhfofffffffffggzhhhhjjjj)j2jkjljkkHkPkkklk}k~kkklƶ"h9%hqCJOJQJ\aJo(h9%hqCJOJQJ\aJ"h9%hCJOJQJ\aJo(&h9%h$5CJPJaJnHo(tH&h9%h%n5CJPJaJnHo(tH@aabbcccceeffffhhjjkjljllllll ^`$da$gdqllllll'm(mDmEmMmNmmmmmmmmmmnnnnͻtttWNh9%hCJ9h9%h5CJKHOJPJQJ\^JaJnHo(tHh9%h5CJaJo(h9%h5CJaJ3h9%hCJKHOJ PJQJ ^J aJnHo(tHh9%hwjCJo(h9%hwjCJ#h9%hCJPJaJnHo(tHh9%h5o(h9%h5h9%hX5PJnHo(tHh9%h%nCJPJnHo(tHlmmnnoooor rrrssHtItttUuVuuuvv $da$gd2 $da$gdZ6$da$7$8$H$ $da$gdwjn nnnn>n?nAnCnDnGnKnZn[n]n^n`nfngnnnnnnnno oo/o0o1o3o4o6ooooooooo)p>p@pDpưư栰ưưưư斍h9%hwjCJo(h9%hwjCJh9%hCJo(h9%h*@CJPJnHo(tH*h9%h5bCJPJQJ]aJnHo(tHh9%hVCJQJ]aJo(h9%hCJPJnHo(tHh9%hCJh9%hCCJPJnHo(tH.DpEpLp\pkplp}p~ppppppppppppppppppppqqqFqQqUqVq]qmquqxqyq|qqqqqqqqqqqqqqqqqrrrr rr.róh9%hZ6CJh9%h 8CJPJnHo(tHh9%h=qCJPJnHo(tHh9%hCJh9%hwjCJh9%hwjCJo(h9%hwjCJPJnHo(tH>.r3rArBrrrrrrrrrrrrrrrrrsss&t't1t2tz?z@zCzOzzzzzzzzzzzzzzzzzzzzzzz{ {{{{{{{B{H{I{M{U{a{b{m{p{q{t{~{{{{{{{{{{| |"|'|(|,|-|3|4|8|9|M|N|W|Y|`|h|'h9%hJICJKHPJaJnHo(tHh9%hJICJPJnHo(tHh9%hJICJh9%hJICJo(Jh|v|||||||||}}#}$}J}K}}}}}}}}~~~~~~~~~~~~~~~ κ񺖍{p{p{fh9%hJICJo(h9%hJICJaJ#h9%hJICJPJaJnHo(tHh9%hJICJh9%hJICJPJnHo(tH'h9%h~CJKHPJaJnHo(tH'h9%hJICJKHPJaJnHo(tH$h9%hJICJKHPJaJnHtHh9%hJICJKHPJaJo(h9%hJICJKHPJaJ(  !$%&(9=@ADEFIJMW\ervwxz (*79:=JOPShiw{|~Ȁ̀ր׀܀߀-/047h9%hJICJo(h9%hJICJPJnHo(tHh9%hJICJU79<=@DW]`dfgjrstvwՁ&-SairsÂĂȂɂʂڷʷڷʷڷʨʷ~~~h9%h5CJaJo(h9%h5CJaJh9%hCJPJnHo(tHh9%hJICJPJnHtHh9%hJICJo(h9%hCJh9%hJICJPJnHo(tHh9%hJICJ#h9%hJICJPJaJnHo(tHh9%hJICJaJ0ʂ˂'(ചnZF3(h9%hCJKH$h9%hCJKHPJaJnHtH'h9%h0CJKHPJaJnHo(tH'h9%h@uCJKHPJaJnHo(tH'h9%hCJKHPJaJnHo(tH/h9%h5CJKHOJPJQJaJnHtH2h9%h05CJKHOJPJQJaJnHo(tH2h9%h5CJKHOJPJQJaJnHo(tH#h9%h5CJKHOJQJaJ&h9%h5CJKHOJQJaJo(h9%hQJ]o((.=C $$1$Ifa$$1$IfhkdK$$Ifl4?F  6    44 la]f4(-.<=BCDZjz{̃̓ԃ !"<=]^ƳƳzkzkzkz`z`Th9%hQJ]o(h9%hXCJKHh9%hXCJKHnHtHh9%hXCJKHaJh9%hX5CJKHaJ$h9%hXCJKHPJaJnHtHh9%hCJKH$h9%hCJKHPJaJnHtH'h9%hCJKHPJaJnHo(tH#h9%h5CJKHOJQJaJ&h9%h5CJKHOJQJaJo( CDZbjrzphZZZZ$$1$Ifa$gd8$1$Ifkd~K$$Ifl4?r)A644 la]f4z{sk]]]]$$1$Ifa$gd8$1$Ifkd L$$Ifl?r)A644 la]ẵsk]]]]$$1$Ifa$gd8$1$IfkdL$$Ifl?r)A644 la]̃̓ԃ܃sk]]]]$$1$Ifa$gd8$1$Ifkd M$$Ifl?r)A644 la]  sk]]]]$$1$Ifa$gd8$1$IfkdM$$Ifl?r)A644 la] !"=^se]RRR $$1$Ifa$$1$IfVDWD^`kd N$$Ifl?r)A644 la]^Մք  DEijϻnZNh9%h5CJaJ&h9%hC5CJPJaJnHo(tH&h9%hs'V5CJPJaJnHo(tHh9%hXCJKHaJo(h9%hXCJKHh9%hXCJKHaJ$h9%hXCJKHPJaJnHtH'h9%hXCJKHPJaJnHo(tHh9%hCJKH#h9%h5CJKHOJQJaJ&h9%h5CJKHOJQJaJo(Մ~ppp$$1$Ifa$gd8$1$IfxkdN$$Ifl?\644 la]Մք~ppp$$1$Ifa$gd8$1$IfxkdO$$Ifl?\644 la] (0D~ppp$$1$Ifa$gd8$1$IfxkdyO$$Ifl?\644 la]DEjrz~ppp$$1$Ifa$gd8$1$IfxkdO$$Ifl?\644 la]~ppp$$1$Ifa$gd8$1$IfxkdiP$$Ifl?\644 la]$~~~~sss $$1$Ifa$$da$xkdP$$Ifl?\644 la] #$%&234̾pV<2h9%hy5CJKHOJPJQJaJnHo(tH2h9%h5CJKHOJPJQJaJnHo(tH$h9%hCJKHOJQJ^JaJh9%hCJKH#h9%h5CJKHOJQJaJ&h9%h5CJKHOJQJaJo(h9%hCJo(h9%h5CJaJo(h9%h5CJaJ&h9%hy5CJPJaJnHo(tH&h9%h@u5CJPJaJnHo(tH$%&5:IN $$1$Ifa$$1$IfhkdYQ$$Ifl4?Fq && &  6    44 la]f445789:FGHIKLMNOͳlR8ͳ-h9%hCJKH2h9%hy5CJKHOJPJQJaJnHo(tH2h9%h5CJKHOJPJQJaJnHo(tH&h9%h5CJKHOJQJaJo(0h9%hCJKHOJPJQJ^JaJnHtH3h9%hyCJKHOJPJQJ^JaJnHo(tH3h9%h@uCJKHOJPJQJ^JaJnHo(tH3h9%hCJKHOJPJQJ^JaJnHo(tH/h9%h5CJKHOJPJQJaJnHtHNO`ir{ph\\\\ $$Ifa$gd8$1$IfkdQ$$Ifl4?rq &&&'& 644 la]f4O_`ir{†ʆ҆ӆ ʽʽʽʽʽʽ|h\Nh9%h5CJaJo(h9%h5CJaJ&h9%h|F85CJPJaJnHo(tHh9%hPJnHo(tH'h9%h.CJKHPJaJnHo(tH'h9%hWCJKHPJaJnHo(tHh9%hXCJKHh9%hXCJKHaJh9%hX5CJKHaJ$h9%hXCJKHPJaJnHtH'h9%hXCJKHPJaJnHo(tH†ʆ҆sk____ $$Ifa$gd8$1$IfkdR$$Ifl?rq '''''' 644 la]҆ӆ sk____ $$Ifa$gd8$1$IfkdES$$Ifl?rq '''''' 644 la]  +>skkkek_VV $$Ifa$^7$8$H$$da$kdS$$Ifl?rq '''''' 644 la]  lmABbdeٿٟٿvdvdJ2h9%h5CJKHOJPJQJaJnHo(tH#h9%h5CJKHOJQJaJ&h9%h5CJKHOJQJaJo((h9%hB*CJOJQJaJo(phh9%hXCJPJnHo(tHh9%hyCJPJnHo(tHh9%hCJPJnHo(tHh9%hCJo(h9%hCJ9h9%h5CJKHOJPJQJ\^JaJnHo(tH>Fgo݈^U $$Ifa$kdT$$Iflֈh  ^"9U{!64 la $$Ifa$ efgjk݈:DEb̸viYviJ@h9%hM;QJ\h9%hM;B*CJo(phh9%hM;OJQJ\nHtHh9%hM;CJKHaJh9%hM;CJ\aJ'h9%hM;CJKHPJaJnHo(tHh9%hOJQJ\nHtH#h9%h5CJKHOJQJaJ&h9%h5CJKHOJQJaJo(2h9%h5CJKHOJPJQJaJnHo(tH2h9%h(5CJKHOJPJQJaJnHo(tH݈Dkd\U$$Iflֈh  ^"9U{!64 la $$Ifa$$$1$Ifa$gd8 $$Ifa$gd8+2:D y$$Ifa$$$1$Ifa$gd8 $$Ifa$gd8 $$Ifa$DEck{g^RDDR$$1$Ifa$gd8 $$Ifa$gd8 $$Ifa$kdV$$Iflֈh  ^"9U{!64 labck։'()/7GIJKPpŊ͊ފߊMSf{{q{{q{bbh9%h~CJPJnHtHh9%h~CJo(h9%h~CJh9%h~CJPJnHo(tHh9%hCJPJnHo(tHh9%hM;OJQJ\nHtHh9%hM;OJQJ\'h9%hM;CJKHPJaJnHo(tHh9%hM;CJKHaJh9%hM;CJ\aJ$h9%hM;CJKHPJaJnHtH&ȉω^UI;;$$1$Ifa$gd8 $$Ifa$gd8 $$Ifa$kdV$$Iflֈh  ^"9U{!64 la $$Ifa$ω։RI;$$1$Ifa$gd8 $$Ifa$kdW$$Iflֈh  ^"9U{!64 la $$Ifa$ $$Ifa$gd8()/7D; $$Ifa$kdPX$$Iflֈh  ^"9U{!64 la $$Ifa$ $$Ifa$gd8$$1$Ifa$gd87=EGIJKK? $da$kdY$$Iflֈh  ^"9U{!64 la$$4$Ifa$gd$$1$Ifa$gd8KNJȊefˋ̋DEFGHIJKLhiXYyz ^`$da$$da$gd~fghijmxɋʋˋ̋CDEGLghiĻĥ}s^RD^h9%h5CJaJo(h9%h5CJaJ)h9%h5CJPJ\aJnHo(tHh9%h5o(h9%h5h9%hC5PJnHo(tHh9%hM;5PJnHo(tH+h9%hCJOJPJQJaJnHo(tHh9%hCJh9%hCJo(h9%h~CJPJnHtHh9%h~CJo(h9%h~CJPJnHo(tHh9%h~CJWY΍Ս֍ghqrxyzɎʎ )*>?st:=ːԐ㻫xh9%h~CJh9%h~CJo(h9%hCJPJnHo(tHh9%h~CJPJnHo(tHh9%h(CJPJnHo(tHh9%h` CJPJnHo(tHh9%h` CJnH o(tH h9%h` CJo(h9%h` CJh9%hCJh9%hCJo(/z;<ѓғǔȔRSjk789:;< $da$gdi $7$8$H$a$gdi $7$8$H$a$$da$!1Q]ْݒ"35kГѓғӓHI|ƔȔϔԔݔޔ1<=EQRM֓̊h9%hiCJh9%h)5CJPJnHo(tHh9%hiCJo(h9%hiCJPJnHtHh9%hiCJPJnHo(tHh9%hCJo(h9%hCJh9%h}CJPJnHo(tHh9%hCJPJnHo(tH3RSTikrw!&/068<@YZcORzܳ叁mmmbh9%hCJKH'h9%h5CJKHPJaJnHtHh9%h5CJKHaJ3h9%hCJKHOJ PJQJ ^J aJnHo(tHh9%h4$.CJo(h9%h4$.CJh9%hCCJPJnHo(tHh9%hCJPJnHo(tHh9%hCJh9%hCJo(h9%hAoCJPJnHo(tH# 0gz $$1$Ifa$7$8$H$ )!!$1$IfkdY$$Ifl %;IFC!%F1C*ppp$$$$44 laȗʗڗ%&+,:<Lyzʿʿʮʘʿ{rh9%hCJh9%hCJo($h9%hCJKHPJaJnHtH+h9%h)CJOJPJQJaJnHo(tH h9%h)CJPJaJnHtHh9%h)CJKH h9%h)CJPJaJnHtHh9%h)CJaJh9%h)CJPJaJh9%h)CJKHaJ&ȗʗڗ $$Ifa$ $$Ifa$gdkp$$1$Ifa$gd8 $$Ifa$gd_)!!$1$IfkdZ$$IflY %;IFC!%F1C*ppp$$$$44 la&,:<Lpy $$Ifa$ $$Ifa$gdkp$$1$Ifa$gd8 $$Ifa$gd_yz) $$1$Ifa$kd\$$IflY %;IFC!%F1C*ppp$$$$44 la $$Ifa$ $$Ifa$gd8 $$Ifa$gdkp $$Ifa$gd_Ι<6...$da$7$8$H$kd7]$$IflYִ%;IFC!%wC*ppp    44 lafhij™˙̙Ιϙ@AD,-0ּּּ֬֜֌|l|ּ֬֬h9%hleCJPJnHo(tHh9%hS4CJPJnHo(tHh9%hvhCJPJnHo(tHh9%hU0CJPJnHo(tHh9%h6CJPJnHo(tHh9%hCJo(h9%h" CJPJnHo(tHh9%hCJh9%hkMCJPJnHo(tHh9%h@uCJPJnHo(tH(Ιϙ DE[\lmמ؞ݠޠl7$8$H$$da$›!"xyz{~ɜʜ̼ܼܼ|tjh9%h5o(h9%h5h9%hKHPJnHo(tHh9%h{_CJPJnHo(tHh9%hiCJPJnHo(tHh9%h9CJPJnHo(tHh9%hS4CJPJnHo(tHh9%hvhCJPJnHo(tHh9%hCJh9%hCJo(h9%hCJPJnHo(tH CDEZ\nq !,[\klmyˮoUˮ3h9%hCJKHOJ PJQJ ^J aJnHo(tHh9%h`CJPJnHo(tHh9%hCJPJnHo(tHh9%h5CJ\h9%hCJo(h9%hCJ9h9%h5CJKHOJPJQJ\^JaJnHo(tHh9%h5CJaJo(h9%h5CJaJ3h9%hCJKHOJ PJQJ ^J aJnHo(tH!֞؞ܞݞab ܠݠޠ&-.6@Ab|sisish9%hiCJo(h9%hiCJ9h9%h5CJKHOJPJQJ\^JaJnHo(tHh9%h5CJaJo(h9%h5CJaJ3h9%hCJKHOJ PJQJ ^J aJnHo(tHh9%h`CJPJnHo(tHh9%hCJPJnHo(tHh9%hCJo(h9%hCJ)bfۡܡej\]klmty̼k`N#h9%hCJPJaJnHo(tHh9%hCJaJ9h9%h5CJKHOJPJQJ\^JaJnHo(tHh9%h5CJaJo(h9%h5CJaJ3h9%hCJKHOJ PJQJ ^J aJnHo(tHh9%h`CJPJnHo(tHh9%h-8CJPJnHo(tHh9%h*1CJPJnHo(tHh9%hCJh9%hCJo(lm}~*,>ħƧҧ $$1$Ifa$$7$8$H$]a$ ^`$da$ $da$gdo}_7$8$H$yDNݤ%&?}~*,02ʦ̦׻|pbpbpN&h9%h5CJPJaJnHo(tHh9%h5CJaJo(h9%h5CJaJ&h9%hC5CJPJaJnHo(tHh9%hC5CJaJ,h9%h5;CJPJ\aJnHo(tHh9%h5h9%hj5PJnHo(tHh9%ho}_CJaJo(h9%hCJaJo(#h9%hCJPJaJnHo(tHh9%hCJaJ:<§ħƧЧҧ۴tZB.'h9%hCJKHPJaJnHo(tH/h9%h5CJKHOJPJQJaJnHtH2h9%h85CJKHOJPJQJaJnHo(tH2h9%h5CJKHOJPJQJaJnHo(tH#h9%h5CJKHOJQJaJ&h9%h5CJKHOJQJaJo(h9%hPJnHo(tHh9%hCJh9%hCJPJnHo(tHh9%hCJo(4h9%h5;@KHOJPJQJ\nHo(tH "$<>Z\tvȨ LɶmmUE9h9%hkCJ\aJh9%hk5CJKH\aJ/h9%hkCJKHOJPJQJaJnHo(tH'h9%hCJKHPJaJnHo(tH#h9%h5CJKHOJQJaJ&h9%h5CJKHOJQJaJo(h9%hCJKHOJQJ$h9%hCJKHPJaJnHtH'h9%h8CJKHPJaJnHo(tH'h9%h| CJKHPJaJnHo(tHh9%hCJKHaJo( $>\v $$1$Ifa$$1$Ifekd<^$$IflF"&J &&J%6    44 la5Ȩ .Lsk]]QQ $$Ifa$gdF$$1$Ifa$gd8$1$Ifkd^$$Iflr>"&J &&&&%644 la5LN̩saSSGG $$Ifa$gdF$$1$Ifa$gd8L$1$IfWD^L`kdT_$$Iflr>"&J ''''%644 la5LN̩Aab|}ڪ۪+,Khiūƫ()78bfg񬙉}oh9%hkCJKHaJo(h9%hkCJ\aJh9%hk5CJKH\aJ$h9%hkCJKHPJaJnHtH'h9%hkCJKHPJaJnHo(tHh9%hkCJaJh9%hk5CJKHaJ/h9%hkCJKHOJPJQJaJnHo(tHh9%hkCJKHOJQJ+1ARask]]QQ $$Ifa$gdF$$1$Ifa$gd8$1$Ifkd_$$Iflr>"&J ''''%644 la5ab}sk]]QQ $$Ifa$gdF$$1$Ifa$gd8$1$Ifkd`$$Iflr>"&J ''''%644 la5۪sk]]QQ $$Ifa$gdF$$1$Ifa$gd8$1$Ifkd"a$$Iflr>"&J ''''%644 la5,<KZhsk]]QQ $$Ifa$gdF$$1$Ifa$gd8$1$Ifkda$$Iflr>"&J ''''%644 la5hiūsk]OOCC $$Ifa$gdF$$1$Ifa$gd8 $1$IfWD` $1$IfkdVb$$Iflr>"&J ''''%644 la5ūƫsaSSGG $$Ifa$gdF$$1$Ifa$gd8 $1$IfWDp^ `kdb$$Iflr>"&J ''''%644 la58Mbdfsk]]QQ $$Ifa$gdF$$1$Ifa$gd8$1$Ifkdc$$Iflr>"&J ''''%644 la5fg¬ĬsaSSGG $$Ifa$gdF$$1$Ifa$gd8 $1$IfWDp^ `kd$d$$Iflr>"&J ''''%644 la5ĬŬ$%gh9:UVsǮ4NOhűűűű퓇tűűű$h9%hkCJKHOJQJnHtHh9%hkCJ\aJh9%hk5CJKH\aJh9%hkCJKHaJo('h9%hkCJKHPJaJnHo(tHh9%hkCJKHOJQJh9%hkCJaJh9%hk5CJKHaJ$h9%hkCJKHPJaJnHtH-ĬŬ sk]]QQ $$Ifa$gdF$$1$Ifa$gd8$1$Ifkdd$$Iflr>"&J ''''%644 la5hvsaSSGG $$Ifa$gdF$$1$Ifa$gd8 $1$IfWDp^ `kdXe$$Iflr>"&J ''''%644 la5Эsm__SS $$Ifa$gdF$$1$Ifa$gd8$Ifkde$$Iflr>"J ''''%644 la5+9sk]]QQ $$Ifa$gdF$$1$Ifa$gd8$1$Ifkdf$$Iflr>"&J ''''%644 la59:VessaSSGG $$Ifa$gdF$$1$Ifa$gd8D$1$IfWD^`Dkd&g$$Iflr>"&J ''''%644 la5ǮծsaSSGG $$Ifa$gdF$$1$Ifa$gd8 $1$IfWDp^ `kdg$$Iflr>"&J ''''%644 la5(4ANsaSSGG $$Ifa$gdF$$1$Ifa$gd8 $1$IfWD^` kdZh$$Iflr>"&J ''''%644 la5NOiwsk]]QQ $$Ifa$gdF$$1$Ifa$gd8$1$Ifkdh$$Iflr>"&J ''''%644 la5hiگ*FGPQȰɰʰ˰Ѿ휑Ѿtݜ`L휑&h9%hkCJPJ\aJnHo(tH&h9%h3CJPJ\aJnHo(tHh9%hkCJKHaJo(h9%hkCJKHOJQJh9%hkCJaJh9%hk5CJKHaJ'h9%hkCJKHPJaJnHo(tH$h9%hkCJKHOJQJnHtHh9%hkCJ\aJh9%hk5CJKH\aJ$h9%hkCJKHPJaJnHtH̯گsk]]QQ $$Ifa$gdF$$1$Ifa$gd8$1$Ifkdi$$Iflr>"&J ''''%644 la5*8Fsk]]QQ $$Ifa$gdF$$1$Ifa$gd8$1$Ifkd(j$$Iflr>"&J ''''%644 la5FGȰʰsaSSGG $$Ifa$gdF$$1$Ifa$gd8$1$IfWD ^`kdj$$Iflr>"&J ''''%644 la5ʰ˰sk]]QQ $$Ifa$gdF$$1$Ifa$gd8$1$Ifkd\k$$Iflr>"&J ''''%644 la5. sk]]QQ $$Ifa$gdF$$1$Ifa$gd8$1$Ifkdk$$Iflr>"&J ''''%644 la5- HJdxzԲ$dڳ)*)89ȺȺغغ대대뺯n\뺯#h9%hkCJPJaJnHo(tH#h9%h3CJPJaJnHo(tHh9%hkCJ\aJh9%hk5CJKH\aJ$h9%hkCJKHOJQJnHtHh9%hkCJaJh9%hk5CJKHaJh9%hk5CJKHQJaJ$h9%hkCJKHPJaJnHtH'h9%hkCJKHPJaJnHo(tH$ JVdnxsaSSGG $$Ifa$gdF$$1$Ifa$gd8 $1$IfWD^` kdl$$Iflr>"&J ''''%644 la5xzƲԲ޲saSSGG $$Ifa$gdF$$1$Ifa$gd8 $1$IfWD^` kd*m$$Iflr>"&J ''''%644 la5$DdsaSSGG $$Ifa$gdF$$1$Ifa$gd8 $1$IfWD^` kdm$$Iflr>"&J ''''%644 la5ڳ)saSSGG $$Ifa$gdF$$1$Ifa$gd8 $1$IfWD^` kd^n$$Iflr>"&J ''''%644 la5)*saSSGG $$Ifa$gdF$$1$Ifa$gd8 $1$IfWD^` kdn$$Iflr>"&J ''''%644 la5)68saSSGG $$Ifa$gdF$$1$Ifa$gd8 $1$IfWD^` kdo$$Iflr>"&J ''''%644 la589:;BCsqg_q___q_$da$ T^kd,p$$Iflr>"&J ''''%644 la5 9:;BCDz{~ŵʵ޵9m}~«ueUKBh9%h CJh9%h CJo(h9%h CJPJnHo(tHh9%h6CJPJnHo(tHh9%hCJPJnHo(tHh9%hCJo(h9%hCJ$h9%hCJfHq &-jh9%hCJUfHq &h9%hCJaJnHtHh9%h5CJaJ'h9%h56PJ\]nHo(tHh9%hPJnHo(tHöضİykaVC/'h9%hlCJOJPJQJnHo(tH$h9%hlCJOJPJQJnHtHh9%hlCJaJh9%hl5CJh9%h5CJaJo(h9%h5CJo(h9%hCJaJ&h9%h5CJPJaJnHo(tHh9%h5CJaJ&h9%hC5CJPJaJnHo(tH#h9%hCJPJaJnHo(tHh9%hCJPJnHo(tHh9%h CJh9%h CJPJnHo(tH 9%$!d$4$Ifa$gd8%$!d$Ifa$gd8d$If^`gd8dgdl$da$  0189:>@ADEFGYZirtuyzݷ}n}`S`S`S`h9%hlCJnH tH h9%hlCJnH o(tH h9%hlCJPJnHtHh9%hlCJo(h9%hl>*CJPJnHtHh9%hlCJPJnHo(tHh9%hlCJ h9%hl#h9%hl>*CJOJQJnHtH'h9%hlCJOJPJQJnHo(tH'h9%hlCJOJPJQJnHo(tHh9%hl>*CJOJQJ 9:;<AF|dd$d$&dIfPa$gd8$d$Ifa$gd8Zd$If^Z`gd8_kdp$$IfFrp#n0 .$    44 aFGHIQYxiZZ$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8rkd?FGHJKLM[bcdijpqrvw¶ԬԢԒԃԢԬh9%hlCJPJnHtHh9%hlCJPJnHo(tH *h9%hlCJh9%hlCJo(h9%hlh,*NCJ#h9%hlCJPJaJnHo(tHh9%hlCJ h9%hlh9%hlCJnH tH h9%hlCJnH o(tH 3̸͸xiQQ$d$&dIfPa$gd8$d$Ifa$gd8Zd$If^Z`gd8rkdw$$If\rp#n.$44 axiZZ$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8rkd x$$If\rp#n.$44 a!xiZZ$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8rkdx$$If\rp#n.$44 a!"57?GxiQQ$d$&dIfPa$gd8$d$Ifa$gd8Zd$If^Z`gd8rkdy$$If\rp#n.$44 aGHIJKLxiZZ$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8rkdy$$If\rp#n.$44 aLMcdjqvgOO$d$&dIfPa$gd8$d$Ifa$gd8Xd$IfWD^X`gd8rkdz$$If\rp#n.$44 aqrstuvxiZZ$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8rkdz$$If\rp#n.$44 avwvgXX$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8tkd{$$IfG\rp#n.$44 awŹƹǹֹ׹ #$0123ȽȜҍyg#h9%hlCJPJaJnHo(tH&h9%hl5CJPJaJnHo(tHh9%hlCJPJnHtH'h9%hlCJOJPJQJnHo(tHh9%hlCJnH tH h9%hlCJaJh9%hlCJo( h9%hlh9%hlCJPJnHo(tHh9%hlCJnH o(tH h9%hlCJ(ƹzk\\$d$Ifa$gd8$d$Ifa$gd8d$IfVDG^gdlrkd{$$If\rp#n.$44 aƹǹzkSS$d$&dIfPa$gd8$d$Ifa$gd8d$IfVDG^gdlrkd|$$If\rp#n.$44 azk\\$d$Ifa$gd8$d$Ifa$gd8d$IfVDG^gdlrkd|$$If\rp#n.$44 axiQQ$d$&dIfPa$gd8$d$Ifa$gd8Zd$If^Z`gd8rkd}$$If\rp#n.$44 axiZZ$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8rkd}$$If\rp#n.$44 a 13<ExiLL'$ d$&dIfPa$gd8$d$Ifa$gd8Zd$If^Z`gd8rkd ~$$If\rp#n.$44 a3;<DEFGYž}cYN@,'h9%hlCJOJPJQJnHo(tHh9%hl>*CJOJQJh9%hlCJaJh9%hl5CJ3h9%h5B*CJOJPJQJnHo(phtH'h9%h5B*CJOJQJo(ph3h9%hC5B*CJOJPJQJnHo(phtH$h9%hB*PJnHo(phtH h9%hl$h9%hlCJOJPJQJnH tH $h9%hlCJOJPJQJnHtH'h9%hlCJOJPJQJnH o(tH EFGHIJKLMNOPeeeeeeeeee&9TPL HD@<+{d<^rkd~$$If\rp#n.$44 a PQRSTUVWXY%$!d$Ifa$gd8%$!d$Ifa$gd8d$If^`gd8dgdl&9TPL HD@<+{d<^κϺ޺ -6ž~q~q~qeUh9%hlCJaJnH o(tH h9%hlCJaJo(h9%hlCJnH tH h9%hlCJnH o(tH h9%hlCJPJnHtHh9%hlCJPJnHo(tHh9%hlCJo(h9%hlCJ h9%hl#h9%hl>*CJOJQJnHtH'h9%hlCJOJPJQJnHo(tH'h9%hlCJOJPJQJnHo(tH!zbb$d$&dIfPa$gd8$d$Ifa$gd8Zd$If^Z`gd8bkd$$IfFrp#F0 .$    44 aƺκvgXX$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8ukd$$If\rp#F.$44 aκϺкѺݺvgXX$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8ukd$$If\rp#F.$44 avgXX$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8ukd$$If\rp#F.$44 a teMM$d$&dIfPa$gd8$d$Ifa$gd8Xd$IfWD^X`gd8ukd $$If\rp#F.$44 avgXX$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8ukd$$If\rp#F.$44 a?@ABvgXX$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8ukd$$If\rp#F.$44 a67=>BC»ǻȻͻλϻ ĴzkbTGTbh9%h0&CJnH tH h9%h0&CJnH o(tH h9%h0&CJh9%h0&CJaJnH tH h9%h0&CJaJnH o(tH h9%hlCJnH tH h9%hlCJnH o(tH h9%hlCJPJnHtHh9%hlCJPJnHo(tHh9%hlCJaJnH tH h9%hlh9%hlCJh9%hlCJaJnH o(tH h9%hlCJaJo(BCteVV$d$Ifa$gd8$d$Ifa$gd8Jd$IfWDj^J`gd8ukd$$If\rp#F.$44 a»ȻλthYY$d$Ifa$gd8 d$Ifgd8$d$IfWD^`$gd8ukd$$If\rp#F.$44 aλϻ teVV$d$Ifa$gdm$d$Ifa$gdm&d$IfWD^&`gdmukd$$If\rp#F.$44 ahiorY7!$$d$&dIfPWD^`$a$gdm$d$IfWD^`a$gdm:$d$IfVDWD^:`$gdmukd$$If\rp#F.$44 a]^ghinovwx|}ƼǼͼμϼӼԼ TXYȽsfsfsfsh9%hlCJnH tH h9%hlCJnH o(tH h9%hlCJaJnH o(tH h9%hN+CJaJnH o(tH h9%hlCJaJo( h9%hlh9%hlCJh9%h0&CJaJh9%h0&CJaJnH tH "h9%h0&h[CJaJnH tH h9%h0&CJaJnH o(tH h9%h0&(owxyz{|hTE66$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8ukd$$If\rp#F.$44 a!$d$&dIfPWD^`a$gdm|}ǼμteMM$d$&dIfPa$gd8$d$Ifa$gd8d$IfWD^`gd8ukd$$$If\rp#F.$44 aμϼмѼҼӼvgXX$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8ukd$$If\rp#F.$44 aӼԼ teMM$d$&dIfPa$gd8$d$Ifa$gd8$d$IfWD^`$gd8ukd*$$If\rp#F.$44 avgXX$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8ukd$$If\rp#F.$44 aUVWXteVV$d$Ifa$gd8$d$Ifa$gd8$d$IfWD^`$gd8ukd0$$If\rp#F.$44 aXYopyrcTT$d$Ifa$gdm$d$Ifa$gdmnd$IfVDGWD2^`ngdmukd$$If\rp#F.$44 aYgnpxyýĽŽƽǽžž~pp~f~Yh9%h5B*ph *h9%hlCJh9%hlCJnH o(tH h9%hlh9%hlCJnH tH h9%hlCJh9%hlCJPJnHtH'h9%h0&CJOJPJQJnHo(tH h9%h0&h9%h0&CJnH tH h9%h0&CJnH o(tH h9%h0&CJh9%h0&CJaJo(h9%h0&CJo(!rcKK$d$&dIfPa$gdm$d$Ifa$gdmnd$IfVDGWD2^`ngdmukd6$$If\rp#F.$44 axiZZ$d$Ifa$gd8$d$Ifa$gd8d$IfVDG^gdlukd$$If\rp#F.$44 ateMM$d$&dIfPa$gd8$d$Ifa$gd8Zd$If^Z`gd8wkd<$$If \rp#F.$44 a½ýĽŽvgXX$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8ukdÉ$$If\rp#F.$44 aŽƽȽɽʽ˽̽ͽνϽнcXXXXXXXX $da$gdFJ`&9TPL HD@<+{d<^ukdF$$If\rp#F.$44 a ǽȽ޽$%()*69:;<>ͽײt^tI^tIB h9%hl(h9%hlCJOJPJQJaJnHtH+h9%hlCJOJPJQJaJnHo(tH+h9%hlCJOJPJQJaJnHo(tH(h9%hlCJOJPJQJaJnHtHh9%hlCJo(h9%hlCJh9%hlCJaJh9%h}j5PJnHo(tHh9%h5o(h9%hC5PJnHo(tH/h9%h5B*CJPJaJnHo(phtHнѽҽӽԽսֽ׽ؽٽڽ۽ܽݽ޽*%$!d8$&dIfPa$gd8 $$Ifa$gd8 $Ifgd8 $da$gdFJ`*;<=>FNh_S99%$!xd0$IfUD2]xa$gdl $$Ifa$gd8 $Ifgd8ukdɊ$$If\Y#0v$44 a"%$!xd0$&dIfPUD2]xa$gdl>EFMNOQ\]fghjlmžƾϾоپھ۾01ɴ۴ɴԦɕjɕjɕjɕ(h9%hlCJOJPJQJaJnH tH +h9%hlCJOJPJQJaJnH o(tH h9%hlCJPJaJnHtHh9%hl5CJ\aJ(h9%hlCJOJPJQJaJnHtHh9%hlCJaJ h9%hl+h9%hl>*CJOJPJQJaJnHtHh9%hlCJOJQJaJ)NOPQ]gu[[%$!xd0$IfUD2]xa$gdl $$Ifa$gd8 $Ifgd8ukdW$$If\Y#0v$44 aghijklu[[%$!xd0$IfUD2]xa$gdl $$Ifa$gd8 $Ifgd8ukdߋ$$If\Y#0v$44 almu[[%$!xd0$IfUD2]xa$gdl $$Ifa$gd8 $Ifgd8ukdg$$If\Y#0v$44 a{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukd$$If\Y#0v$44 ažƾоھ{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukdw$$If\Y#0v$44 aھ۾{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukd$$If\Y#0v$44 a019A{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukd$$If\Y#0v$44 a189@ABWXY_`fghtwԿv`Hv*CJOJPJQJaJnHtH(h9%hlCJOJPJQJaJnHtH(h9%hlCJOJPJQJaJnH tH +h9%hlCJOJPJQJaJnHo(tHABXY`g{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukd$$If\Y#0v$44 agh{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukd$$If\Y#0v$44 a{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukd$$If\Y#0v$44 a¿׿ݿ޿-./5=>@ʵʵuʵʘeVʘh9%hlCJaJnH tH h9%hlCJaJnH o(tH h9%hlCJPJaJnHtH#h9%hlCJPJaJnHo(tH h9%hl+h9%hl>*CJOJPJQJaJnHtH(h9%hlCJOJPJQJaJnHtH(h9%hlCJOJPJQJaJnH tH +h9%hlCJOJPJQJaJnH o(tH h9%hlCJaJ¿ֿ׿޿{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukd$$If\Y#0v$44 a{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukd/$$If\Y#0v$44 a./6=uSS"%$!xd0$&dIfPUD2]xa$gdl $$Ifa$gd8 $Ifgd8ukd$$If\Y#0v$44 a=>?@ABu[[%$!xd0$IfUD2]xa$gdl $$Ifa$gd8 $Ifgd8ukd?$$If\Y#0v$44 a@ABCENOXYZ\]^_nopqríwíeT h9%hlCJPJaJnHtH#h9%hgCJPJaJnHo(tHh9%hl5CJaJ(h9%hlCJOJPJQJaJnHtH(h9%hlCJOJPJQJaJnH tH +h9%hlCJOJPJQJaJnH o(tH h9%hlCJaJ h9%hl+h9%hl>*CJOJPJQJaJnHtH(h9%hlCJOJPJQJaJnHtH BCDEOYuSS"%$!xd0$&dIfPUD2]xa$gdl $$Ifa$gd8 $Ifgd8ukdǒ$$If\Y#0v$44 aYZ[\]^u[[%$!xd0$IfUD2]xa$gdl $$Ifa$gd8 $Ifgd8ukdO$$If\Y#0v$44 a^_nopqu[[%$!xd0$IfUD2]xa$gdl $$Ifa$gd8 $Ifgd8ukdד$$If\Y#0v$44 aqr~{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukd_$$If\Y#0v$44 a{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukd$$If\Y#0v$44 a{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukdo$$If\Y#0v$44 a"#()*;@AFGH`bhioιwhPιDιh9%hlCJaJo(.h9%hlhBCJOJPJQJaJnH tH h9%hlCJaJnH tH h9%hlCJaJnH o(tH h9%hl+h9%hl>*CJOJPJQJaJnHtH(h9%hlCJOJPJQJaJnHtH(h9%hlCJOJPJQJaJnH tH +h9%hlCJOJPJQJaJnH o(tH h9%hlCJPJaJnHtHh9%hlCJaJ#){oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukd$$If\Y#0v$44 a)*:;AG{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukd$$If\Y#0v$44 aGHabip{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukd$$If\Y#0v$44 aopqׂׂv^L#h9%hgCJPJaJnHo(tH.h9%hl5>*CJOJPJQJaJnHtHh9%hl5CJaJ(h9%hlCJOJPJQJaJnHtH(h9%hlCJOJPJQJaJnHtH(h9%hlCJOJPJQJaJnH tH +h9%hlCJOJPJQJaJnH o(tH h9%hlCJaJ h9%hl+h9%hl>*CJOJPJQJaJnHtHpq{oMM"%$!xd0$&dIfPUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukd$$If\Y#0v$44 au[[%$!xd0$IfUD2]xa$gdl $$Ifa$gd8 $Ifgd8ukd$$If\Y#0v$44 auSS"%$!xd0$&dIfPUD2]xa$gdl $$Ifa$gd8 $Ifgd8ukd$$If\Y#0v$44 au[[%$!xd0$IfUD2]xa$gdl $$Ifa$gd8 $Ifgd8ukd'$$If\Y#0v$44 au[[%$!xd0$IfUD2]xa$gdl $$Ifa$gd8 $Ifgd8ukd$$If\Y#0v$44 a{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukd7$$If\Y#0v$44 aABCHINOPlopstuįsįĒshPĒhįh.h9%hlhBCJOJPJQJaJnH tH h9%hlCJaJh9%hlCJaJnH tH h9%hlCJaJnH o(tH h9%hl+h9%hl>*CJOJPJQJaJnHtH(h9%hlCJOJPJQJaJnHtH(h9%hlCJOJPJQJaJnH tH +h9%hlCJOJPJQJaJnH o(tH h9%hlCJPJaJnHtH{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukd$$If\Y#0v$44 aBCIO{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukdG$$If\Y#0v$44 aOPklpt{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukdϛ$$If\Y#0v$44 atu{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukdW$$If\Y#0v$44 å̴måm⊃̊mh9%hlCJaJo(+h9%hl>*CJOJPJQJaJnHtH h9%hl(h9%hlCJOJPJQJaJnH tH (h9%hlCJOJPJQJaJnHtH.h9%hlhW"4CJOJPJQJaJnH tH +h9%hlCJOJPJQJaJnH o(tH h9%hlCJaJ#h9%hlCJPJaJnHo(tH{oUU%$!xd0$IfUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukdߜ$$If\Y#0v$44 a{oMM"%$!xd0$&dIfPUD2]xa$gdl $$Ifa$gd8$IfWDd`gd8ukdg$$If\Y#0v$44 auiOO%$!xd0$IfUD2]xa$gdl $$Ifa$gd8a$IfVDnWDc^a`gdlukd$$If\Y#0v$44 auSS"%$!xd0$&dIfPUD2]xa$gdl $$Ifa$gd8 $Ifgd8ukdw$$If\Y#0v$44 au[[%$!xd0$IfUD2]xa$gdl $$Ifa$gd8 $Ifgd8ukd$$If\Y#0v$44 a#$%'()*PQZ[defjkoptu·vaη·vaηVOVO h9%h`Bh9%h`BCJaJ(h9%hlCJOJPJQJaJnHtH(h9%hlCJOJPJQJaJnH tH +h9%hlCJOJPJQJaJnHo(tH+h9%hlCJOJPJQJaJnH o(tH h9%hlCJaJh9%hl5CJaJ h9%hl+h9%hl>*CJOJPJQJaJnHtH(h9%hlCJOJPJQJaJnHtH$uSS"%$!xd0$&dIfPUD2]xa$gdl $$Ifa$gd8 $Ifgd8ukd$$If\Y#0v$44 a$%&'()u[[%$!xd0$IfUD2]xa$gdl $$Ifa$gd8 $Ifgd8ukd$$If\Y#0v$44 a)*PQ[euSS"%$!xd0$&dIfPUD2]xa$gdl $$Ifa$gd8 $Ifgd8ukd$$If\Y#0v$44 aefghijvggg$d$Ifa$gd8Zd$If^Z`gd8ukd$$If\Y#0v$44 ajklmnovggg$d$Ifa$gd8Zd$If^Z`gd8ukd$$Ifl\Y#0v$44 laopqrstvggg$d$Ifa$gd8Zd$If^Z`gd8ukd&$$Ifl\Y#0v$44 latuvwxyvggg$d$Ifa$gd8Zd$If^Z`gd8ukd$$Ifl\Y#0v$44 lauyz~θ΢wawaaa+h9%he">*CJOJPJQJaJnHtHh9%he"CJOJQJaJ h9%he"(h9%he"CJOJPJQJaJnHtH+h9%he"CJOJPJQJaJnHo(tH+h9%he"CJOJPJQJaJnHo(tH(h9%he"CJOJPJQJaJnHtHh9%he"CJaJ h9%h\_h9%h\_CJaJ yz{|}~vggg$d$Ifa$gd8Zd$If^Z`gd8ukd$$$Ifl\Y#0v$44 la~vggg$d$Ifa$gd8Zd$If^Z`gd8ukd$$Ifl\Y#0v$44 lavggg$d$Ifa$gd8Zd$If^Z`gd8ukd"$$Ifl\Y#0v$44 lavjN%$!d8$&dIfPa$gd? $$Ifa$gd?Zd$If^Z`gd8ukd$$Ifl\Y#0v$44 lahTH.%$!xd0$IfUD2]xa$gd? $$Ifa$gd?Zd$If^Z`gd8ukd $$Ifl\Y#0v$44 la"%$!xd0$&dIfPUD2]xa$gd?p\P $$Ifa$gd?Zd$If^Z`gd8ukd$$Ifl\Y#0v$44 la%$!xd0$IfUD2]xa$gd?vjPP%$!xd0$IfUD2]xa$gd? $$Ifa$gd?Zd$If^Z`gd8ukd$$$Ifl\Y#0v$44 la '(123LMNSTUYZqv˳ˣ˳ˣ˳˂v˳Ăˣ˳h9%he"CJaJo(#h9%he"CJPJaJnHo(tHh9%he"CJaJnH tH h9%he"CJaJnH o(tH h9%he"CJPJaJnHtH h9%he"h9%he"CJaJh9%he"5CJ\aJ h9%h\_(h9%h\_CJOJPJQJaJnHtH.vgXX$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8ukd$$Ifl\Y#0v$44 la xiZZ$d$Ifa$gd8$d$Ifa$gd8d$IfWDd`gd8ukd"$$Ifl\Y#0v$44 la(2rcTT$d$Ifa$gd8$d$Ifa$gd8nd$IfVDGWD2^`ngdlukd$$Ifl\Y#0v$44 la23KLNTrcKK$d$&dIfPa$gd8$d$Ifa$gd8nd$IfVDGWD2^`ngdlukd $$Ifl\Y#0v$44 laTUVWXYvgXX$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8ukd$$Ifl\Y#0v$44 laYZvgXX$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8ukd$$Ifl\Y#0v$44 lavgOO$d$&dIfPa$gd8$d$Ifa$gd8Zd$If^Z`gd8ukd$$Ifl\Y#0v$44 lavgXX$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8ukd$$Ifl\Y#0v$44 lavgOO$d$&dIfPa$gd8$d$Ifa$gd8Zd$If^Z`gd8ukd$$Ifl\Y#0v$44 la */0678Z\cdlmȔsdYR h9%hPh9%hPCJaJh9%hPCJaJnH tH h9%hPCJPJaJnHtHh9%hPCJaJnH o(tH h9%he"CJaJnH o(tH h9%he"5CJ\aJo(h9%he"5CJ\aJ h9%he" h9%he"CJPJaJnHtHh9%he"CJaJh9%he"CJaJnH tH h9%he"CJaJo(vgXX$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8ukd$$Ifl\Y#0v$44 la vgXX$d$Ifa$gd8$d$Ifa$gd8Zd$If^Z`gd8ukd$$Ifl\Y#0v$44 la)*07rcTT$d$Ifa$gd8$d$Ifa$gd8nd$IfVDGWD2^`ngdlukd$$Ifl\Y#0v$44 la78[\dlrcTT$d$Ifa$gdm$d$Ifa$gdmnd$IfVDGWD2^`ngdmukd$$Ifl\Y#0v$44 lalmxyrcTT$d$Ifa$gd8$d$Ifa$gd8nd$IfVDGWD2^`ngdlukd$$Ifl\Y#0v$44 lamwxyѫѫѫѫѫoA *h9%hK5@B*CJOJPJQJ\aJnHo(phtHh9%he"CJOJQJaJh9%he"CJaJo( h9%he"h9%he"CJaJnH tH h9%he"CJaJnH o(tH h9%he"CJPJaJnHtHh9%he"CJaJ#h9%he"CJPJaJnHo(tH'rcKK$d$&dIfPa$gd8$d$Ifa$gd8nd$IfVDGWD2^`ngdlukd$$Ifl\Y#0v$44 laxiZZ$d$Ifa$gd8$d$Ifa$gd8d$IfVDG^gdlukd$$Ifl\Y#0v$44 laqbJJ$d$&dIfPa$gd8$d$Ifa$gd8%!Zd$If^Z`gd8ukd$$Ifl\Y#0v$44 laqbSS$d$Ifa$gd8$d$Ifa$gd8%!Zd$If^Z`gd8ukd$$Ifl\Y#0v$44 lavgOO$d$&dIfPa$gd8$d$Ifa$gd8Zd$If^Z`gd8ukd$$Ifl\Y#0v$44 la!";<}pgXXXX$d^a$gd`Bd^ d^`^gdFJ`wkd$$Ifl?\Y#0v$44 la !"%9:;<mopyz絕ϵ~papaVJ?J?J?J?h9%h`BCJaJh9%h`BCJaJo(h9%hCJaJh9%h5CJ\aJo(h9%h5CJ\aJ,h9%hB*CJPJaJnHo(phtH>h9%hY5B*CJKHOJPJQJ\aJnHo(phtH2h9%hFJ`5B*CJKHOJQJ\aJo(ph/h9%hY5B*CJKHOJQJ\aJph/h9%hFJ`5B*CJKHOJQJ\aJph1Pv?@DIJLr ;<2˹˜˜ˑoc˜˜c˹h9%hCic5CJaJ#h9%hY!CJPJaJnHo(tHh9%hFJ`CJaJnH o(tH h9%hFJ`CJaJh9%hCicCJaJo( h9%hCicCJPJaJnHtH#h9%hCicCJPJaJnHo(tHh9%hCicCJaJ#h9%h`BCJPJaJnHo(tHh9%h`BCJaJh9%h`BCJaJo(&RT?@67UW$$7$8$H$IfVDWD^`a$gdhn $d^a$gdhn d & Fd1$$d^a$gd= $da$gd`B$d^a$gd`B234567UVW[eBCD;a̺tttttttttttttc h9%hhn CJPJaJnHtHh9%hhn CJaJo(h9%hhn CJaJh9%h5CJ\aJh9%h5CJ\aJo(#h9%hOCJPJaJnHo(tH#h9%hyCJPJaJnHo(tH h9%hCicCJPJaJnHtH#h9%hhn CJPJaJnHo(tHh9%hCicCJaJnH o(tH $*bcijkz<=>]_ijkշ䒷ՆxxՒk[h9%hhn CJH*aJnH tH h9%hhn CJPJ aJh9%hhn CJPJaJo(h9%hhn CJH*aJ h9%hhn h9%hhn CJPJ aJnH tH h9%hhn CJPJ aJh9%hhn CJPJaJ h9%hhn CJPJaJnHtHh9%hhn CJaJnH tH h9%hhn CJaJh9%hhn CJaJnH o(tH #q$d$7$8$H$IfVDWD^`a$gdhn Ukd$$Ifl0@p#0 t!644 la$d$G$IfWD^`$gd8=q$d$G$IfWD^`$gd8$d$7$8$H$IfVDWD^`a$gdhn Ukd$$Ifl0@p#0 t!644 la=>kq$d$G$IfWD^`$gd8$d$7$8$H$IfVDWD^`a$gdhn Ukdc$$Ifl0@p#0 t!644 laq$d$G$IfWD^`$gd8$d$7$8$H$IfVDWD^`a$gdhn Ukd˱$$Ifl0@p#0 t!644 la,-}'Ukd$$Ifl0@p#0 t!644 la d$Ifgd8$d$7$8$H$IfVDWD^`a$gdhn Ukd3$$Ifl0@p#0 t!644 la+,-6`abk 789LMY΄vffh9%hhn h^CJPJaJh9%hhn CJPJ aJo(h9%hhn CJPJaJo(#h9%hhn CJH*PJ aJnH tH h9%hhn CJH*aJnH tH h9%hhn CJaJh9%hhn CJaJnH tH h9%hhn h9%hhn CJPJ aJnH tH h9%hhn CJPJ aJh9%hhn CJPJaJ(-6abk}Ukd$$Ifl0@p#0 t!644 la d$Ifgd8$d$7$8$H$IfVDWD^`a$gdhn q d$IfVDWD^ `gd8$d$7$8$H$IfVDWD^`a$gdhn Ukdk$$Ifl0@p#0 t!644 laq$d$G$IfWD^`$gd8$d$7$8$H$IfVDWD^`a$gdhn Ukdӳ$$Ifl0@p#0 t!644 la 8v$d$If^a$gd8$d$7$8$H$IfVDWD^`a$gdhn Ukd;$$Ifl0@p#0 t!644 la89Mv$d$If^a$gd8$d$7$8$H$IfVDWD^`a$gdhn Ukd$$Ifl0@p#0 t!644 lasGd$IfWD^`Ggd8$d$7$8$H$IfVDWD^`a$gdhn Ukd $$Ifl0@p#0 t!644 la|}~j$d$G$IfWD^`$gd8d$G$IfWD^`gd8$d^a$gdhn Ukds$$Ifl0@p#0 t!644 la|}~ !"#@ABCKLVWX˺yppch9%hhn aJnH tH h9%hhn CJh9%hhn CJH*aJnH tH "h9%hhn CJH*aJnH o(tH h9%hhn CJaJnH o(tH h9%hhn CJaJnH tH h9%hhn CJPJ aJnH tH h9%hhn CJPJaJnH tH h9%hhn CJaJ#h9%hhn CJPJaJnHo(tH h9%hhn "~|+Qkd:$$Ifl0x"k t9!644 la$d$G$IfWD^`$gd8d$G$IfVDWDl^`gdhn Qkd۵$$Ifl0x"k t9!644 la"#+B|Qkd$$Ifl0x"k t9!644 la$d$G$IfWD^`$gd8d$G$IfVDWDl^`gdhn BCX7QkdW$$Ifl0x"k t9!644 la d$Ifgd8d$G$IfVDWDl^`gdhn Qkd$$Ifl0x"k t9!644 laX()JKklnopz{йййЫɹЫ߫ɹйЫКɈ|h9%hhn CJH*aJ"h9%hhn CJH*aJnH o(tH h9%hhn CJPJ aJnH tH h9%hhn CJPJ aJo(h9%hhn CJaJnH o(tH h9%hhn h9%hhn CJaJnH tH &h9%hhn CJH*PJ aJnH o(tH h9%hhn CJPJ aJ,Ko~r``d$IfWDd`gd8 d$Ifgd8d$G$IfVDWDl^`gdhn Qkd$$Ifl0x"k t9!644 la$d$IfWD^`$gd8op7Qkdt$$Ifl0x"k t9!644 la d$Ifgd8d$G$IfVDWDl^`gdhn Qkd$$Ifl0x"k t9!644 latGd$IfWD^`Ggd8QkdӸ$$Ifl0x"k t9!644 la d$Ifgd8d$G$IfWD^`gd8klst|j|j|WdG$UD]`gdhn $`7$8$H$VDh^`a$gdhn $7$8$H$^a$gdhn 7hdG$^hgd=7hdG$^hgdhn Qkd2$$Ifl0x"k t9!644 la kst ;?u~zfZOCOCOCOCOCh9%hhn CJaJo(h9%hhn CJaJh9%hhn 6CJaJ&h9%hhn 56CJOJPJQJaJ#h9%hhn 5CJOJPJQJaJh9%hhn CJh9%hhn 56CJ\]#h9%hOCJPJaJnHo(tH#h9%hhn CJPJaJnHo(tH"h9%hhn CJH*aJnH o(tH h9%hhn CJH*aJh9%hhn CJaJnH tH h9%hhn CJaJtmnOPVW$d^a$gdhn $d1$7$8$H$^a$gdhn !$ & F d1$7$8$H$^`a$gdhn $d7$8$H$^a$gdhn $d7$8$H$^a$gdhn dG$UD]`gdhn $%~AB;< #:fg9Cny`a'(1;23klvV/1DFah9%h =CJaJo(h9%hhn 56CJaJ)h9%h=56CJPJaJnHo(tHh9%hhn CJaJo(h9%hhn CJaJFW./D)*`aBCZ[ $d^a$ d^`^$d^a$gdP$ & Fd1$a$gdhn $ & Fd1$^`a$gdhn $d^a$gdhn a7:ABCFZ[st}~@GTZ[BŸp_p_p_p_p_p_TH_TH_h9%h =CJaJo(h9%h =CJaJ h9%h =CJPJaJnHtH#h9%h =CJPJaJnHo(tH#h9%h,CJPJaJnHo(tH#h9%h,5CJPJaJnHtH#h9%hCJPJaJnHo(tHh9%h5CJ\o(h9%h5CJ\,h9%hB*CJPJaJnHo(phtHh9%hPCJaJh9%hPCJaJo([st@AWANkd$$If06" 44 a$nd$IfVDWD^n`a$gd =Vd$IfVD^Vgd =$d^a$gd =$9d^9a$gd =$d^a$gd, & FH7$8$H$^`Hgd,BWX-.IJKLMNcfq bcl俯n&h9%h =>*CJPJaJnHo(tHh9%h =>*CJaJnH tH h9%h59CJaJ#h9%h595CJPJaJnHtHh9%h59PJaJnHo(tH#h9%h =CJPJaJnHo(tHh9%h =CJ]aJ h9%h = h9%h =CJPJaJnHtHh9%h =CJaJ&q$Vd$IfVD^Va$gd =Nkd$$If06" 44 and$IfVDWD^n`gd =Vd$IfVD^Vgd =7Nkd$$If06" 44 and$IfVDWD^n`gd =Vd$IfVD^Vgd =NkdW$$Ifn06" 44 aJKLMknd$IfVDWD^n`gd =Vd$IfVD^Vgd =Nkd/$$If06" 44 a$nd$IfVDWD^n`a$gd =MNef4Nkd$$If06" 44 a$nd$IfVDWD^n`a$gd =Vd$IfVD^Vgd =Nkd$$If06" 44 a bckW&d$$If^`&gd8$\d$VDQ^\`a$gd =$\#d$VDQ^\`#a$gd =A7$8$H$VD^`Agd =7$8$H$VD^gd59 & FH7$8$H$^`Hgd59 ,]^gdO$RndVDbWD2^R`na$gd =$d^a$gd = l9:ABIJNǹǹxxxfZKh9%h =CJaJnH tH h9%h =CJ]aJ#h9%h =CJPJ]aJnHtH h9%h =#h9%h =CJPJaJnHo(tH h9%h =CJPJaJnHtHh9%h =CJaJh9%h =>*CJaJh9%h =>*CJaJo(&h9%h =>*CJPJaJnHo(tH"h9%h =>*CJaJnH o(tH #h9%h =>*CJPJaJnHtH$d$$&dIfPa$gd8 *&d$$If^`&gd8kdp$$If֞ ^:!%nnnn0p#44 a8 !)19$d$$Ifa$gd89:;*&d$$If^`&gd8kdJ$$If֞ ^:!%nnnn0p#44 a8;<=>?@A$d$$Ifa$gd8ABJ*&d$$If^`&gd8kd$$$If֞ ^:!%nnnn0p#44 a8JKLMNOP$d$$Ifa$gd8NOPQSbijqryzIJߢزߢߢߢߢ؄y؄ߢߢߢߢh9%h =CJaJh9%h =CJ]aJ"h9%h =hewCJaJnH tH h9%h =CJaJnH o(tH #h9%h =CJPJ]aJnHtH&h9%h =CJPJ]aJnHo(tH h9%h =h9%h =CJaJnH tH "h9%h =h CJaJnH tH /PQb*&d$$If^`&gd8kd$$If֞ ^:!%nnnn0p#44 a8bjrz$d$$Ifa$gd8*kd$$If֞ ^:!%nnnn0p#44 a8$d$$&dIfPa$gd8qd$$IfVD&WD^`qgd =*&d$$If^`&gd8kd$$If֞ ^:!%nnnn0p#44 a8$d$$Ifa$gd8*kd$$If֞ ^:!%nnnn0p#44 a8$d$$&dIfPa$gd8qd$$IfVDWD^`qgd = .45;<ABIJKQRSTYZ[fostz{|ȼȼϋȼȟzȟfz&h9%h =CJPJ]aJnHo(tH h9%h =CJPJaJnHtH&h9%h =hewCJPJaJnHtH#h9%h =CJPJ]aJnHtHh9%h =CJaJh9%h =CJ]aJ h9%h =h9%h =CJaJnH tH h9%h =CJaJnH o(tH "h9%h =hewCJaJnH tH &*&d$$If^`&gd8kd$$If֞ ^:!%nnnn0p#44 a8$d$$Ifa$gd8*kdd$$If֞ ^:!%nnnn0p#44 a8.5<BJKR$d$$Ifa$gd8$d$$&dIfPa$gd8qd$$IfVDWD^`qgd =RST*&d$$If^`&gd8kdD$$If֞ ^:!%nnnn0p#44 a8TUVWXYZ$d$$Ifa$gd8Z[o*&d$$If^`&gd8kd$$$If֞ ^:!%nnnn0p#44 a8opqrst{$d$$Ifa$gd8{|*&d$$If^`&gd8kd$$If֞ ^:!%nnnn0p#44 a8$d$$Ifa$gd8ʹʁo_Th9%h =CJaJh9%h =CJ]aJnH tH "h9%h =CJ]aJnH o(tH &h9%h =CJPJ]aJnHo(tHh9%h =CJaJnH o(tH &h9%h =hewCJPJaJnHtH h9%h =CJPJaJnHtHh9%h =CJ]aJ h9%h =h9%h =CJaJnH tH %h9%h =hOJCJaJnH o(tH *&d$$If^`&gd8kd$$If֞ ^:!%nnnn0p#44 a8$d$$Ifa$gd8*&d$$If^`&gd8kd$$If֞ ^:!%nnnn0p#44 a8$d$$&dIfPa$gd8$d$$Ifa$gd8*&d$$If^`&gd8kd$$If֞ ^:!%nnnn0p#44 a8$d$$Ifa$gd8*&d$$If^`&gd8kd$$If֞ ^:!%nnnn0p#44 a8 89;DEGHIJ`anȸ~l~^~^RG55#h9%h =CJPJaJnHo(tHh9%h =CJaJh9%h =>*CJaJh9%h =>*CJaJo(#h9%h =>*CJPJaJnHtH&h9%h =>*CJPJaJnHo(tHh9%h =>*CJaJnH tH h9%h =h9%h =CJaJnH tH h9%h =CJaJnH o(tH &h9%h =hewCJPJaJnHtH h9%h =CJPJaJnHtH#h9%h =CJPJ]aJnHtH $d$$&dIfPa$gd8$d$$Ifa$gd8*$\#d$VDQ^\`#a$gd =kdd$$If֞ ^:!%nnnn0p#44 a8FGHI^_`mn$d$$&dIfPa$gd8&d$$If^`&gd8$\d$VDQ^\`a$gd =A7$8$H$VD^`Agd =n"#*+123ʸܘʸtbtbtStbth9%h =CJaJnH tH "h9%h =hewCJaJnH tH h9%h =CJaJnH o(tH &h9%h =CJPJ]aJnHo(tH&h9%h =h CJPJaJnHtHh9%h =CJ]aJ#h9%h =CJPJ]aJnHtH h9%h =h9%h =CJaJ h9%h =CJPJaJnHtH#h9%h =CJPJaJnHo(tH*&d$$If^`&gd8kdR$$If֞ ^:!%nnnn0p#44 a8$d$$Ifa$gd8*&d$$If^`&gd8kd,$$If֞ ^:!%nnnn0p#44 a8$d$$Ifa$gd8*&d$$If^`&gd8kd$$If֞ ^:!%nnnn0p#44 a8$d$$Ifa$gd8*&d$$If^`&gd8kd$$If֞ ^:!%nnnn0p#44 a8#+24>$d$$Ifa$gd834=>?@SXY`afgnoxyz{|}ñܖܖܖܖ܅åzåܖܖܖܖܖåzåܖܖܖh9%h =CJaJ h9%h =CJPJaJnHtHh9%h =CJaJnH tH h9%h =CJ]aJ#h9%h =CJPJ]aJnHtH h9%h ="h9%h =hewCJaJnH tH h9%h =CJaJnH o(tH &h9%h =hewCJPJaJnHtH0>?*kd$$If֞ ^:!%nnnn0p#44 a8?SYagoy{$d$$&dIfPa$gd8qd$$IfVDWD^`qgd ={|}*&d$$If^`&gd8kd$$If֞ ^:!%nnnn0p#44 a8}~$d$$Ifa$gd8*kd$$If֞ ^:!%nnnn0p#44 a8$d$$&dIfPa$gd8qd$$IfVDWD^`qgd =*&d$$If^`&gd8kdf$$If֞ ^:!%nnnn0p#44 a8$d$$Ifa$gd8*kdF$$If֞ ^:!%nnnn0p#44 a8$d$$Ifa$gd8$d$$&dIfPa$gd8qd$$IfVDWD^`qgd = "#)*+7?@DEMNO]abjklu|˿ˢ}ˢi}˿}˿i&h9%h =CJPJ]aJnHo(tH&h9%h =hewCJPJaJnHtH h9%h =CJPJaJnHtH#h9%h =CJPJ]aJnHtHh9%h =CJaJh9%h =CJ]aJ h9%h =h9%h =hewCJaJh9%h =CJaJnH tH h9%h =CJaJnH o(tH "*&d$$If^`&gd8kd&$$If֞ ^:!%nnnn0p#44 a8 $d$$Ifa$gd8 *&d$$If^`&gd8kd$$If֞ ^:!%nnnn0p#44 a8 !"#*$d$$Ifa$gd8*+@*&d$$If^`&gd8kd$$If֞ ^:!%nnnn0p#44 a8@ABCDEN$d$$Ifa$gd8NO]*&d$$If^`&gd8kd$$If֞ ^:!%nnnn0p#44 a8]^_`abk$d$$Ifa$gd8kl*&d$$If^`&gd8kd$$If֞ ^:!%nnnn0p#44 a8ʹyny\Hyn&h9%h =hewCJPJaJnHtH#h9%h =CJPJ]aJnHtHh9%h =CJaJh9%h =CJ]aJ h9%h =h9%h =CJaJnH tH h9%h =CJaJnH o(tH h9%h =hewCJaJ h9%h =CJPJaJnHtHh9%h =CJ]aJnH tH &h9%h =CJPJ]aJnHo(tH"h9%h =CJ]aJnH o(tH $d$$&dIfPa$gd8$d$$Ifa$gd8*&d$$If^`&gd8kd$$If֞ ^:!%nnnn0p#44 a8$d$$Ifa$gd8*&d$$If^`&gd8kdf$$If֞ ^:!%nnnn0p#44 a8$d$$&dIfPa$gd8$d$$Ifa$gd8*&d$$If^`&gd8kdF$$If֞ ^:!%nnnn0p#44 a8$d$$Ifa$gd8*$\#d$VDQ^\`#a$gd =kd4$$If֞ ^:!%nnnn0p#44 a8 CDG̺ܺܺܺܫܺuaPܫ h9%hPCJPJaJnHtH&h9%hP5CJPJaJnHo(tH#h9%hP5CJPJaJnHtH#h9%hPCJPJaJnHo(tH#h9%h_CJPJaJnHo(tHh9%h =CJaJnH tH #h9%h =CJPJaJnHo(tHh9%h =CJaJnH o(tH h9%h =CJPJaJnHtH#h9%h =>*CJPJaJnHtHCD`aqlgd =$d$`a$gd =$\d$VDQ^\`a$gd =$d$WD`a$gd = $d$a$gdP & FH7$8$H$^`HgdP$d$^a$gd59$7$8$H$WD`a$gd_$7$8$H$UD,VD]^a$gd = GNORUX^_`abcvwxyήrgrrgrrg`g`g` h9%h =h9%h =CJaJ h9%h =CJPJaJnHtH#h9%h =CJPJaJnHo(tHh9%h =CJ]aJh9%h =PJnHtHh9%h =>*CJaJ&h9%h =>*CJPJaJnHo(tHh9%h =>*CJaJo(#h9%h =>*CJPJaJnHtH"h9%h =>*CJaJnH o(tH abwx$d$$&dIfPa$gd8&d$$If^`&gd8dPAAAAA$d$$Ifa$gd8&d$$If^`&gd8kd"$$Ifֈq mG$ nt"44 a8dPAAAAA$d$$Ifa$gd8&d$$If^`&gd8kd$$Ifֈq mG$ nt"44 a8 ",dPAAAAA$d$$Ifa$gd8&d$$If^`&gd8kd$$Ifֈq mG$ nt"44 a8 !"+,-./0234@IPQU\]^_deqy}»¤»»»h9%h =CJaJnH tH &h9%h =CJPJ]aJnHo(tHh9%h =CJaJh9%h =CJ]aJ h9%h =h9%h =CJaJnH tH h9%h =CJaJo(h9%h =CJaJnH o(tH #h9%h =CJPJ]aJnHtH0,-./0123dPAAAAA$d$$Ifa$gd8&d$$If^`&gd8kd;$$Ifֈq mG$ nt"44 a834QRSTUdPAAAA$d$$Ifa$gd8&d$$If^`&gd8kd$$Ifֈq mG$ nt"44 a8U]^_`L8)$d$$Ifa$gd8&d$$If^`&gd8kd$$Ifֈq mG$ nt"44 a8$d$$&dIfPa$gd8`abcdeyzUA&d$$If^`&gd8kdT$$Ifֈq mG$ nt"44 a8$d$$Ifa$gd8z{|}=kd$$Ifhֈq mG$ nt"44 a8$d$$&dIfPa$gd8$d$$Ifa$gd8$d$$&dIfPa$gd8&d$$If^`&gd8gd =$d$`a$gd =$\d$VDQ^\`a$gd = 01278Fϻϻ᠔qfqqfqqf_f_f_ h9%h =h9%h =CJaJ h9%h =CJPJaJnHtH#h9%h =CJPJaJnHo(tHh9%h =CJ]aJh9%h =PJnHtHh9%h =>*CJaJo(&h9%h =>*CJPJaJnHo(tH"h9%h =>*CJaJnH o(tH h9%h =>*CJaJ#h9%h =>*CJPJaJnHtH (0dPAAAAA$d$$Ifa$gd8&d$$If^`&gd8kd$$Ifֈq mG$ nt"44 a801234567dPAAAAA$d$$Ifa$gd8&d$$If^`&gd8kdm$$Ifֈq mG$ nt"44 a878GQYaisdPAAAAA$d$$Ifa$gd8&d$$If^`&gd8kd $$Ifֈq mG$ nt"44 a8FGPQXY`ahirstuz{ ̡퐵n] h9%h =CJPJaJnHtH#h9%h =>*CJPJaJnHtHh9%h =CJ]aJnH tH h9%h =CJPJaJnHtH&h9%h =CJPJ]aJnHo(tHh9%h =CJaJh9%h =CJ]aJ h9%h =h9%h =CJaJnH tH h9%h =CJaJ#h9%h =CJPJ]aJnHtH$stuvwxyzdPAAAAA$d$$Ifa$gd8&d$$If^`&gd8kd$$Ifֈq mG$ nt"44 a8z{dPAAAA$d$$Ifa$gd8&d$$If^`&gd8kd$$Ifֈq mG$ nt"44 a8L8)$d$$Ifa$gd8&d$$If^`&gd8kd9$$Ifֈq mG$ nt"44 a8$d$$&dIfPa$gd8UA&d$$If^`&gd8kd$$Ifֈq mG$ nt"44 a8$d$$Ifa$gd8$&d$$&dIfP^`&a$gd8$&d$$If^`&a$gd8dU@;. d^`d$d$UDs]^a$gd =$d$`a$gd =kd$$Ifֈq mG$ nt"44 a8 %/0ܹxn^Sh9%h =CJaJh9%h =CJPJ\nHtHh9%h =CJ\"h9%h =CJPJ\nHo(tHh9%h =CJ\o(h9%hCJ\h9%h5CJ\o(h9%h5CJ\%h9%h5>*CJPJnHo(tHh9%h =CJaJnH o(tH h9%h =CJPJaJnHtH#h9%h =CJPJaJnHo(tH xbJ$d$&dIfPa$gd8#qd$IfWD^`qgd8QkdR$$If440#eT"44 a8f4$d$Ifa$gd8 d$Ifgd8$d`a$gd = $d^a$ '()ABCEFRtu{|!GHMNQRSTVWntu{ҟҟҟҟҟh9%h =CJaJnH o(tH h9%h =CJPJaJnHtH#h9%h =CJPJaJnHo(tHh9%h =CJaJnH tH h9%h =h9%h =CJaJh9%h =CJaJo(>'m^^$d$Ifa$gd8#qd$IfWD^`qgd8dkd$$If44FY#T"    44 a8f4$d$&dIfPa$gd8'()5Avv$d$Ifa$gd8#qd$IfWD^`qgd8dkd8$$If44FY#T"    44 a8f4ABCDEvv$d$Ifa$gd8#qd$IfWD^`qgd8dkd$$If44FY#T"    44 a8f4EFu|vv$d$Ifa$gd8#qd$IfWD^`qgd8dkd@$$If44FY#T"    44 a8f4vv$d$Ifa$gd8#qd$IfWD^`qgd8dkd$$If44FY#T"    44 a8f4vv$d$Ifa$gd8#qd$IfWD^`qgd8dkd<$$If44FY#T"    44 a8f4HNRmm$d$&dIfPa$gd8#qd$IfWD^`qgd8dkd$$If44FY#T"    44 a8f4RSTUVvv$d$Ifa$gd8#qd$IfWD^`qgd8dkd8$$If44FY#T"    44 a8f4VW{mm$d$&dIfPa$gd8#qd$IfWD^`qgd8dkd$$If44FY#T"    44 a8f4ve$d$4$Ifa$gd8$d$Ifa$gd8#qd$IfWD^`qgd8dkd4$$If44FY#T"    44 a8f4256;<=>?BTUVZҲsg]Sh9%h8<CJ\h9%hCJ\h9%hCJ\o(h9%h5CJ\o(h9%h5CJ\%h9%h0^5CJPJ\nHo(tH%h9%h t5CJPJ\nHo(tH h9%h =CJPJaJnHtHh9%h =CJaJnH tH h9%h =CJaJnH o(tH h9%h =CJaJo( h9%h =h9%h =CJaJve$d$4$Ifa$gd8$d$Ifa$gd8#qd$IfWD^`qgd8dkd$$If44FY#T"    44 a8f4vv$d$Ifa$gd8#qd$IfWD^`qgd8dkd0$$If44FY#T"    44 a8f426<mm$d$&dIfPa$gd8#qd$IfWD^`qgd8dkd$$If44FY#T"    44 a8f4<=>?UVzhh\ d$Ifgd8VdUD]V^gd8< $d^a$ d^`dgdKUldkd,$$If44FY#T"    44 a8f4Z '?BDEKϼÛÛϼϼϼ~l~l~l`h9%h8<5CJaJ#h9%h8<CJPJ]aJnHtHh9%h8<CJ]aJ h9%h8<CJPJaJnHtH#h9%h8<CJPJaJnHo(tHh9%h8<CJaJnH tH h9%h8<h9%h8<CJaJo(h9%h8<CJaJh9%h8<CJPJ\nHtHh9%h8<CJ\h9%h8<CJ\o( qq$d$&dIfPa$gd8#qd$IfWD^`qgd8Qkd$$If440B# T"44 a8f4$d$Ifa$gd8vv$d$Ifa$gd8#qd$IfWD^`qgd8dkd$$If44FBY#T"    44 a8f4 vv$d$Ifa$gd8#qd$IfWD^`qgd8dkd$$If44FBY#T"    44 a8f4 vv$d$Ifa$gd8#qd$IfWD^`qgd8dkd$$If44FBY#T"    44 a8f4EKQvv$d$Ifa$gd8#qd$IfWD^`qgd8dkd$$If44FBY#T"    44 a8f4KPQR[beflqrsvw .1AEgr}ѿѰݤ݇}q}q}q}q}q}q}q}q}q}q}h9%h8<CJ\o(h9%h8<CJ\h9%h8<5CJ\ h9%h8<CJPJaJnHtHh9%h8<CJaJo(h9%h8<CJaJnH tH #h9%h8<CJPJ]aJnHtHh9%h8<CJ]aJ h9%h8<h9%h8<CJaJh9%h8<CJaJnH o(tH ,QRflryaa$d$&dIfPa$gd8#qd$IfWD^`qgd8okd$$If44FBY#T"    44 a8f4prstuvyjj$d$Ifa$gd8#qd$IfWD^`qgd8okd$$If44FBY#T"    44 a8f4pvwy\D$d$&dIfPa$gd8$}d$&dIfPa$gd8#qd$IfWD^`qgd8okd@$$If44FBY#T"    44 a8f4pDEop  !~~~~oi\ d^`^$d^a$gd8<$VdUD]V^a$gd8<dgd8<dkd$$If44FBY#T"    44 a8f4 nopGo     !"59qȿri_h9%hCJo(h9%hCJ%h9%h5CJPJ\nHo(tHh9%h5CJ\h9%h5CJ\o(,h9%hB*CJPJaJnHo(phtHh9%h8<CJo(h9%h8<CJh9%h8<CJPJ\nHtH"h9%h8<CJPJ\nHo(tHh9%h8<CJ\h9%h8<CJ\o(%!"@Ad^ d^`^$d^a$gd8< $d^a$  A}ͿͿͭ孢zgZh9%h5CJ\o(%h9%h0^5CJPJ\nHo(tH,h9%hB*CJPJaJnHo(phtH h9%h8<CJPJaJnHtHh9%h8<CJaJ#h9%h8<CJPJaJnHo(tHh9%h8<CJnH o(tH h9%h8<CJh9%h8<CJPJnHtHh9%h8<CJPJnHo(tHh9%h8<CJo(!HQls #$%&)Ź}}rfr_Pfh9%h8<CJaJnH tH h9%h8<h9%h8<CJaJo(h9%h8<CJaJh9%h8<CJPJ\nHtH"h9%h8<CJPJ\nHo(tHh9%h8<CJ\nH o(tH h9%h8<CJ\h9%h8<CJ\o(h9%h5>*CJh9%hCJPJnHo(tH%h9%h5CJPJ\nHo(tHh9%h5CJ\   $%&mW#qd$IfWD^`qgd8QkdS$$If440B# T"44 a8f4$d$Ifa$gd8 d$Ifgd8$d^a$gd8<$HdVDWD8^`Ha$gd8<)*+./012BCD]^_abcef"#&+/56789;EɺɺɺɺПкɈui\h9%h5CJ\o(h9%h5CJ\%h9%h5CJPJ\nHo(tH,h9%hB*CJPJaJnHo(phtHh9%h8<CJaJnH o(tH h9%h8<CJaJh9%h8<CJaJnH tH h9%h8<h9%h8<CJaJo( h9%h8<CJPJaJnHtH#h9%h8<CJPJaJnHo(tH$&+012:Bm^^$d$Ifa$gd8#qd$IfWD^`qgd8dkd$$If44FBY#T"    44 a8f4$d$&dIfPa$gd8BCDP]vv$d$Ifa$gd8#qd$IfWD^`qgd8dkd9$$If44FBY#T"    44 a8f4]^_`avv$d$Ifa$gd8#qd$IfWD^`qgd8dkd$$If44FBY#T"    44 a8f4abcdevv$d$Ifa$gd8#qd$IfWD^`qgd8dkdA$$If44FBY#T"    44 a8f4ef#$%&,-./6kkkkkkkk$d$&dIfPa$gd8#d$IfVDWD^`gd8<dkd$$If44FBY#T"    44 a8f4 678WXYbgy|pXXX$d$&dIfPa$gd8 d$Ifgd8 d^gdc d^`^dkd=$$If44FBY#T"    44 a8f4EKVWXY[befgijtwxyz !"%&¶¶¶¶‹‹‹{jj¤{jj‹ h9%hcCJPJaJnHtHh9%hcCJaJnH o(tH h9%hc#h9%hc>*CJPJaJnHtH#h9%hcCJPJaJnHo(tHh9%hcCJaJo(h9%hcCJaJh9%hcCJh9%hCJh9%h5CJ\o(%h9%h5CJPJ\nHo(tH(yz{$d$Ifa$gd8 d$Ifgd8_kd$$IflF#&T"    44 la#$d$Ifa$gd8 d$Ifgd8_kd$$IflF#&T"    44 la#$d$Ifa$gd8 d$Ifgd8_kdw$$IflF#&T"    44 lao#$?d$Ifa$gd8#$d$Ifa$gd8 d$Ifgd8_kd$$IflF#&T"    44 la!ss#$d$&dIfPa$gd8d$If^`gd8_kd3$$IflF#&T"    44 la!"#$%#$d$Ifa$gd8 d$Ifgd8_kd$$IflF#&T"    44 la%&'/7vv$d$&dIfPa$gd8%!d$Ifgd8_kd$$IflF#&T"    44 la&'./6789;<hnopvwx9:оžЎо|mW|mUU+h9%hcCJOJPJQJaJnHo(tHh9%hcCJaJnH tH "h9%hchNCJaJnH tH h9%hcCJOJ PJ ^J aJh9%hcCJaJo($h9%hcCJOJQJaJnHtH h9%hch9%hcCJaJ h9%hcCJPJaJnHtHh9%hcCJaJnH o(tH h9%hcCJOJQJaJ!789:; $$Ifa$gd8%!$Ifgd8_kdM$$IflF#&T"    44 la;<how $$Ifa$gd8%!$Ifgd8_kd$$IflF#&T"    44 lawx $$Ifa$gd8%!$Ifgd8_kd $$IflF#&T"    44 la $$Ifa$gd8 %$Ifgd8_kdg$$IflF#&T"    44 la9AIss#$d$&dIfPa$gd8d$If^`gd8_kd$$IflF#&T"    44 laLess : Allowance for doubtful debts of other receivables(8,790)(8,790)82,35088,030Total trade and other receivables567,962428,468The Groups revenue from export sales is on letter of credit or documents against payment. The credit period is agreed upon and stipulated in the sales contract. Except for some particular customers where payment in advance is normally required, the Group allows an average credit period of 30 days to its local trade customers and 90 days for local hospital customers. The following is an aged analysis of the trade and bills receivables net of allowance for doubtful debts presented based on the invoice date, which approximated to the revenue recognition dates, at the end of the reporting period.30 June 201331 December 2012RMB000RMB000(unaudited)(audited) Within one year479,641333,317More than one year but within two years5,7546,904More than two years but within three years217217485,612340,438 9. Trade and other payablesThe following is an aged analysis of accounts payable presented based on the invoice date at the end of the reporting period.30 June 201331 December 2012RMB000RMB000(unaudited)(audited)Within one year413,380382,711More than one year but less than two years6,4266,294More than two years but less than three years1,6801,707Over three years3,7903,719425,276394,431Other payables and accrued charges149,590128,316574,866522,747i!. DOCUMENTS FOR INSPECTION AND PLACE FOR INSPECTION(1) DOCUMENTS FOR INSPECTION1. The original copy of the Company s 2013 Interim Report signed by the Chairman of the Board.2. Financial statements for the six months ended 30 June 2013 signed by the Chairman of the Board, the financial controller and the chief of the accounting department of the Company.(2) PLACE FOR INSPECTIONOffice of the Secretary to the Board of the Company.By Order of the BoardShandong Xinhua Pharmaceutical Company LimitedZhang DaimingChairman30 July 2013, Zibo, PRCAs at the date of this announcement, the Board comprises: Executive Directors:Mr. Zhang Daiming (Chairman)Mr. Du DepingMr. Zhao SongguoIndependent Non-executive Directors:Mr. Zhu BaoquanMr. :@AHIJKMNOUV\]^_ab":IЛ|jjjjjj#h9%hcCJPJaJnHo(tHh9%hcCJ\(h9%hcCJOJPJQJaJnHtH+h9%hcCJOJPJQJaJnHo(tHh9%hcCJaJnH o(tH h9%hcCJOJQJaJ h9%hch9%hcCJaJ h9%hcCJPJaJnHtHh9%hcCJaJo()IJKLM $$Ifa$gd8%!$Ifgd8_kd#$$IflF#&T"    44 laMNOV]||$$&dIfPa$gd8%!$Ifgd8_kd$$IflF#&T"    44 la]^_`a $$Ifa$gd8%!$Ifgd8_kd$$IflF#&T"    44 laab||$$&dIfPa$gd8%!$Ifgd8_kd=$$IflF#&T"    44 la   $d^a$gdc d^gdc_kd$$IflF#&T"    44 la  AK   -./FGHJKƼzkzkzkzh9%hcCJaJnH tH h9%hc h9%hcCJPJaJnHtHh9%hcCJaJo(h9%hcCJ\o("h9%h0^CJPJ\nHo(tHh9%hcCJ\h9%hch (CJ\h9%hcCJaJnH o(tH #h9%hcCJPJaJnHo(tHh9%hcCJaJ* %-{eVV$d$Ifa$gd8#qd$IfWD^`qgd8_kd$$IfF#&U"    44 a8$d$&dIfPa$gd8 d$Ifgd8-./;Fzz$d$Ifa$gd8#qd$IfWD^`qgd8_kdn$$IfF#&U"    44 a8FGHIJzz$d$Ifa$gd8#qd$IfWD^`qgd8_kd$$IfF#&U"    44 a8JK[ckzz$d$Ifa$gd8#qd$IfWD^`qgd8_kdX$$IfF#&U"    44 a8KZ[bckl  ðrrhh9%hCJ\h9%h5CJ\o(h9%h5CJ\%h9%h5CJPJ\nHo(tH"h9%hCJPJ\nHo(tH h9%hh9%hcCJaJo( h9%hc *h9%hcCJaJh9%hcCJaJnH o(tH h9%hcCJaJnH tH h9%hcCJaJ(klzz$d$Ifa$gd8#qd$IfWD^`qgd8_kd$$IfF#&U"    44 a8qq$d$&dIfPa$gd8#qd$IfWD^`qgd8_kdB$$IfF#&U"    44 a8zz$d$Ifa$gd8#qd$IfWD^`qgd8_kd$$IfF#&U"    44 a8qq$d$&dIfPa$gd8#qd$IfWD^`qgd8_kd,$$IfF#&U"    44 a8  whh\ d$Ifgd8$d^a$gdc $d^a$ d^`$d^a$gdg_kd$$IfF#&U"    44 a8 @v$ % * + 1 2 _ ` e f l m } ~              ҟҟh9%hcCJaJnH tH h9%hch9%hcCJaJnH o(tH h9%hcCJaJo(h9%hcCJPJ\nHtH h9%hcCJPJaJnHtH#h9%hcCJPJaJnHo(tHh9%hcCJaJ8qbb$d$Ifa$gd8#qd$IfWD^`qgd8_kd$$IfFBY#T"    44 a8$d$&dIfPa$gd8zz$d$Ifa$gd8#qd$IfWD^`qgd8_kd$$IfFBY#T"    44 a8zz$d$Ifa$gd8#qd$IfWD^`qgd8_kd$$IfFBY#T"    44 a8zz$d$Ifa$gd8#qd$IfWD^`qgd8_kdu$$IfFBY#T"    44 a8% + 1 zz$d$Ifa$gd8#qd$IfWD^`qgd8_kd$$IfFBY#T"    44 a81 2 ` f l zz$d$Ifa$gd8#qd$IfWD^`qgd8_kd_$$IfFBY#T"    44 a8l m ~   qq$d$&dIfPa$gd8#qd$IfWD^`qgd8_kd$$IfFBY#T"    44 a8     zz$d$Ifa$gd8#qd$IfWD^`qgd8_kdI$$IfFBY#T"    44 a8     zz$d$Ifa$gd8#qd$IfWD^`qgd8_kd$$IfFBY#T"    44 a8     qq$d$&dIfPa$gd8#qd$IfWD^`qgd8_kd3$$IfFBY#T"    44 a8                     T V j l огг}bRH@H@Hh9%h5h9%h5o(h9%h0^5PJnHo(tH4h9%h\B*CJOJPJQJaJnHo(phtH7h9%hzKB*CJOJPJQJ\aJnHo(phtH%h9%hc5CJPJ\nHo(tH h9%hch9%hcCJaJ#h9%hcCJPJaJnHo(tH h9%hcCJPJaJnHtHh9%hcCJaJnH o(tH h9%hcCJaJnH tH      zz$d$Ifa$gd8#qd$IfWD^`qgd8_kd$$IfFBY#T"    44 a8     qq$d$&dIfPa$gd8#qd$IfWD^`qgd8_kd$$IfFBY#T"    44 a8              xxxxxxxxx$da$^gd\^gd0^ d^`_kd$$IfFBY#T"    44 a8         l n   h j l m       ^ gd}^$7$8$H$WD^`a$gd{u $7$8$H$a$gd{u7$8$H$$da$l n           J L f j      B F b c k l m     о~~rо[,h9%hB*CJKHOJQJ\aJphh9%h{uCJ\o("h9%h5TCJPJ\nHo(tH"h9%h<CJPJ\nHo(tH"h9%h{uCJPJ\nHo(tHh9%h{uCJ\"h9%hCJPJ\nHo(tHh9%h5o(h9%h59h9%h5CJKHOJPJQJ\^JaJnHo(tH     йtXB$:h9%h6B*CJOJPJQJ]aJnHo(phtH+h9%h6B*CJOJQJ]aJph7h9%h5B*CJOJPJQJ\aJnHphtH7h9%hG5B*CJOJPJQJ\aJnHphtH+h9%h5B*CJOJQJ\aJph%h9%hB*CJOJQJaJph,h9%h0^B*CJPJaJnHo(phtH,h9%hB*CJPJaJnHo(phtH/h9%hB*CJKHOJQJ\aJo(ph  34op\'\(\ $$G$Ifa$$G$a$$^a$ $ ^ a$gd7"$0TPL HD@< ^ a$$ ^ a$"&'234ıĖı}fYL>Y>Y>Y0h9%hPJnHo(tHh9%hGPJnHo(tHh9%hGPJnHtHh9%hPJnHtH,h9%hB*CJPJaJnHo(phtH1h9%hB*CJOJPJQJaJnHphtH4h9%h3AB*CJOJPJQJaJnHo(phtH%h9%hB*CJOJQJaJph4h9%h)mB*CJOJPJQJaJnHo(phtH@h9%h0^56B*CJOJPJQJ\]aJnHo(phtH\ \\B\C\Q\R\V\\\]\j\k\m\n\o\q\r\t\u\w\x\z\{\\\\\\\\\\\\\\\󦞚{u hUeCJ hM=q0J$mHnHuhUe hUe0J$jhUe0J$Uht<}jht<}Uh9%hnHo(tHh9%ho(h9%h]={PJnHtHh9%h]={PJnHo(tHUh9%hGPJnHo(tHh9%hPJnHo(tHh9%hPJnHtH)Bai HuiliangMr. Kwong Chi Kit, VictorNon-executive Directors: Mr. Ren FulongMr. Xu Lie Mr. Zhao BinPAGE PAGE 23(\)\C\R\^\k\l\m\n\p\q\fa__gd7Gkdd$$If0!64 a $$G$Ifa$Gkd$$If0!64 a q\s\t\v\w\y\z\\\\\\\\\gd7#$a$##&`#$/0P/ =!"H#$n% nu*l?xK-PNG  IHDRryJzgAMA pHYsLLXtcPLTE#$ 84*&'"51;7.*?;2-2./+40)%(#,(=9950,+'=83.627383B>B?A=C?@=QNUQNJFBJFXU\Y^[DAZWIF]ZOKHDWSQMMJKHSOD@YUVSLISPFCYV[W^ZROLHOLWTb_`\a^b^`]iftrfc}pn|ymjxupmvtywc`li~{}{wt}{rogdvsda~{xuebnkkgkholtqheqnpnspzw{x~}ƵG'IDATx}|yNg˲$Dz6d[r^ 8&!iP*`Ԙ˒lbh^ZQ@!M#'MI4mt/kvӦMO$nwvgyfgwgt7<3(Z8˱!}t%O_dKU}*meDW܇lL7{]+>IcMC|l4IzO̚*Irìi.! gKz8T*%,佫X ˏ<&K$]vUtɑ,VEzIyH.#Ϛ!tifPIѳf$]Nfx$]F䜳fX$]>.fpHl]Κatg&o#K>k.8ietgƾUFI9|֌4&(D2I$ʴ[K\Co~$]YgȎ*FC$A#eY/c#"OFj+ <#۠1kZǮWM?f5$=Y!R+K.>k*qبPެM`$oY _&I1k̊/ 6/~"G̚J]Y͠E-%B$cJME.s`SϒrĬ9ö"^}2JOfdGʶ*Fwt%YSYw-V21 1y oU2l"lJK=G5ڠ}>i&{1kF%03%)Iy?|Tjzώ|vK{Áw돳L&)sI:i<";ZKܔ{< 5$1FT=twLW|^2? 6{) _%R;I1fI~3Dv F)+I3kFf4b[jNv)I3k* 5lc557{"bcfMsWz_&[lJ@E"̚ K,iM%]r̬IUlr̙p +颐cfM ߽٨Ɇ7t1QQai˿.9fdUll)] @5mB*ëN* tQ~͗26w_pS Iw5km{ޕCL3u B]!G͚,6gt9fִ: qsѪ”%(Y(iD TW#fMA$)/pY AA8z=CfMQ`J/{]MYS:Naq&(D08J;0tCfMQ@ "4\ҝfȶsidz?t;"G͚DtGaJJrܬs"paL IE5yBRlLB ͚.BSl鱊1;K;O9kz~"bsz s[QG#gMe~6iDjcLI!GΚ~ؤS\m%]Κ~$N#)}BܬQ`]j]|sa\Q#y0Y >/ <ʔ>&FzQœt/8EXlFt<ʔ_k=+= 071ox ɕpAqQj] *>~.6Q,tzM (Q_6\#frRLQB]uIRvpzM eۣ|mwJ63;VVX RԣLQ']iѧ3O޵ˍznq(ybE>)ΉFIX88S:U ,U3sdθT`"NBBonaEBORVV+x2j ' s%NR08E=ƓGVhbf#i+zbiӪ8SR"DKnb5rSWMu;6rH[!V#3S0Ow.Bd.A#[̕`XPg #ȂE#/93fZeɌ\S{<03Ol#4 2)J{d<=`[Sԗ ˀ\S%-x,-|@u=݅}55FJ77(\dcs'`}IIFKgnFmNڳw8B?Hz,s-ډ-}ֽ-V,a \954O|\*Kѹ\nW"ZO_^6MSa&y <07t|-s<7{<2*C6m,^YZ=@9Q(iE0b+ANlzQ~O9Q_\jVv^X !*y{F0DiR#ϲӓO5||@c|ȋA^Ɍ=t*"GIgPݙ-M> 9RP86uimڰJsp>/;|(|=i :\2noi@ Wߍ}kj qg@>a19i?K]~되>>7xlgߗ@g sh.~K|~ xs>"¹7U­Ůһ4vvg^i4so8xgkSdpG+'rmS}̈́ð)wh39jkku?ʒa@VfN6:%BwSTjc9u h5#p%k _=ANWvm)eͯlW+RuKw)]zYv})K-_%)kxb[nZ TVdxN~Uwjb;? bPVWȵ!|,<}qP ~9kZgL/g}lIV6z tNyPw\ܵ!1[gtwA[h%#N0y@d z|+C ŕ5G.Yn1<'`MMM7}dy(B#,yKg\7S;w²n r<0w :ҹ0)oux9֖~e⯖gs4[_Sۿ[ rf;G^8}EO{뢂G\Y/XId(Wp=Lh+ve7(so+}Gi'Mp_kk'KD74mфG-1 >cUƱe9 +5?r/:i@~D Gu݅fIZ`UEN 'D%=u\ 3A~ YoaEٷs7Dޠ_E8@-J1|s )rOAO.мE%!185<Ӧi_r`/qc/*!wR?̱+[=aǎ0{̱~}ee];Mf-nz1_W<o5O_cc>YF3>xפ@r.GΏcM]G}EuT)My+78ϻﵱ7Wa=U=_sYjr uK7xCuQ_?Yf n% ؜G-Y`n9 R9؆۳˔F„܀?mG^ {:Fߘ2C7CTk=\@pFk}j&'jv r5qC[:+@ުv߈MarCij BNԓ~P-w9j| 4E"G9 eljUc9!~sS̊PSFF:"YeSC\yHf GL2;6h3c&TiWyf|;tk$o59Yh{w{QȉJN,tΐH#\2*ّ$ʥ ~G0M}"'߇ǽ#FCx#;]vkr"']yVjMN\wn^ZǡWZ#Oo3w,J1G%EBOM_!X#ׯͦۡ"'rLQ5r})mx }M(%r3>QH}/yfN^܌ur"ȹOf5Z.\F|ߩch !~ kn*e#7vReUS8%!G~e`[pCheeAUsn+dz.~#GF3ܟ 9fu<' tW:H<:Kg I;N]:֜op?vԼ,Bkm܍VE8'w c$a_SPTVn58pi.7Ȋ|֜N)meX>wK*)07f^xz)G4w0oVjtP\RQ^so= PկMAwoIң_:û]ul#t0tHq}g:v.;'ѻ\^Vz9WʽRm5ݪ~yv N}Y!Pr&lj&(9f4@k|9!KE\oEqo*<#Z8kcu#QMe"w,:p/ė%"'W+S3'rN"Cr{\]^-P:~pOqL /r[+:@0#ֳ!9bb0,~[;|oB-l$rS't| !G4>ޱ ANg\RSVtDåZ-rTuif=˿1ȭ$K!O8f;`ŽsݦFvzozpWލ+++^=aG>@W2۱ή^=":۷{Eeu}sǂX>h#'Jg 3'U y>K ;rMyUQ v77- ?r*3arCޛ}u7^=n^n7]Vjz~T,PT|' %zo^ IL]" *^e6rg2OCy|l oPVmR rK?1f>B7pvk^77eT$r*gFE/AFj69iF= )N75u cy~iFƧ s|n14#kꑎ,EwA"^(m<x$|Drn=2P Wʻ Sp J<񉲋Jܔ3U=F/5>JtM"@4j|:@ !,rE/*քU5lώU}Mmy=wMu%{nA܇+ߒnzkݼhMBt#`+iyWw T?%EeM}'jӖb76f5`D<$Z $}7uQdk"%Z CrŃ⏤79#㦪5ǥDxOQEWaTnePu}?L(*hc^*R^QbEP/{ |%.#;f?d ?iKz $"l+is=x(J|kc.85`(hJ(l_sY^c%NQHiЕĶXĻCY#+=raDF+CBb~X?ĉx >< ptAwEԜӇjZRI7f. qmZ8CbeA!x%%p/ =K5Q$ݴkG\#^UC6I7rfU;o6n^6 _)ꊝeml 1vi,w.x4̉J.8IoIýlw'kmb JSQ>c釐<7 HһGGZSKG{WD{s{i\^6 <$=ߍq3htcS<W} 4|lMbϛvU*=8N1g,3{6]"Iqԋ[$|V'[g 4rgrH:X^6rWoqH8*n+t0E}hW f%&PQ U籤CE<L%.Iq`JmDCBO> NotesdB*CJaJphHOH Subhead 1Td^T ;CJaJ~O~ Subhead 2B$'PL HD@<Q^`a$5B*\phO Body textc$>TPL HD@<Td1$7$8$H$^Ta$-B*CJOJQJ_HaJmH nHphsH tHDZ@D ~e,g$a$CJOJPJQJaJnHtH<O< write $a$CJPJnHtHpOpChar Char Char Char!d1$CJKHPJaJmHnHtHu.". yblFhe,g"CJaJ6 @26 u#9r G$CJaJ)@A uxP@RP u w%!d1$CJKHOJPJQJaJtH 0b0 le,g&G$CJaJPOrP Anrede' 1$KHOJPJQJaJtH VOV W[CQ W[CQ(d1$CJKHPJaJmHnHtHuPQ@P ckee,g 3)$a$!B*CJOJPJaJnHphtHBL@B eg*$a$CJOJPJQJaJnHtHvOv Report Text-+$d1$5$7$8$9DH$^a$KHPJaJmH sH tH VT@V e,gWW!,$:d1$]:^a$CJKHPJaJtH `O` Default-1$7$8$H$)B*CJPJ_HaJmH nHphsH tH*U@* c >*B*phXOX xl137/dd1$[$\$ CJKHOJPJQJaJnHtHpOp Body Single0$ (1$a$$B*CJPJ_HhmH phsH tH 2V@2 ]vc >*B* ph0`@"0 HTML 0W@W26]Be@2B  HTML @BP h4$<@&a$5CJ OJPJQJ\^JaJ K@ y|T5([@b( 5uP[N~{T6\J@r\ oRh7$d8<@&a$"5CJ KHOJPJQJ\^JaJ - [e,g48 ` @ 1$3$5$7$8$G$0CJKHOJPJQJ^J_HaJmH nHsH tH6%@6 [ON0W@W9G$ OJQJ^J.?@. ~_g:dVD4^d4/@4 Rh;8WD8^`8<2@< Rh 2<d8VDWD8^d`8<3@< Rh 3=d8VDWD8^d`8<4@< Rh 4>d8VDXWD8^d`8<5@< Rh 5?d8VD WD8^d`8,1@, RhS @ & F 0:@0 RhS 2 A & F 0;@"0 RhS 3 B & F 0<@20 RhS 4 C & F0=@B0 RhS 5 D & F4D@R4 Rhc~ExVD^8E@b8 Rhc~ 2FHxVD^H8F@r8 Rhc~ 3GxVDX^8G@8 Rhc~ 4HxVD ^8H@8 Rhc~ 5I4xVD^400@0 Rhyv&{S J & F46@4 Rhyv&{S 2 K & F47@4 Rhyv&{S 3 L & F48@4 Rhyv&{S 4 M & F49@4 Rhyv&{S 5 N & F$$vU_ 1O00vU_ 2PVD^00vU_ 3QHVD^H00vU_ 4RVDX^00vU_ 5SVD ^00vU_ 6T4VD^400vU_ 7U VD^ 00vU_ 8V| VDx^| 00vU_ 9W VD@^ $@$ ybleW[X*j* ybl;NY5\(^@( nf(Qz)Z,@@, ~{T[dVD4^dX$@X 6eON0W@W(\d&+D/G$VDx^d OJQJ^J$ $"}_ 1]0 0"}_ 2^VD^0 0"}_ 3_VD^00"}_ 4`XVDX^X00"}_ 5a VD ^ 00"}_ 6bVD^00"}_ 7cVD^00"}_ 8dxVDx^x00"}_ 9e@VD@^@6!6 "}_hf5OJQJ\^J8"8 lgCJOJPJQJ^JaJ4#4 VhvU_h8VDWD8`8(+( >\le,giG$8Y8 ech~gVj-D M I@ Oo`hok8$d%d&d'd-DM NOPQVDWD ^8` OJQJ^J0,0 _evU_lVD^<.< _evU_hmxOJPJQJ^J(B@( ckee,gnx4M@4 ckeL)ۏoWDd`8C@8 ckee,g)ۏpxVD^8N@8 ckeL)ۏ 2qWD`0@"0 cke)ۏrWD`2P@22 ckee,g 2 sdxBR@BB ckee,g)ۏ 2tdxVD^DS@RD ckee,g)ۏ 3uxVD^CJaJ*O@* lʑhv$a$TOrT 7h_1wdd1$XDdCJKHPJaJhmH sH tH 6O6 short_text1CJaJZOZ Table Texty$a$$B*CJPJ_HhmH phsH tH ZOZ Table Text Char$B*CJPJ_HhmH phsH tH JOJ body text{xx1$CJKHaJtH VOV RQk=|d1$WD`CJKHOJPJQJaJtH <O< tw4winMark<B* H*phVOV gnUk=~d1$WD`CJKHOJPJQJaJtH 8O8 c!apple-style-spanO c!hpsBOB c!apple-converted-space:O!:  highlight1q PO1P #- Char Char$CJKHPJ_HaJmH nHsH tH&OA& 1hps atn$OQ$ >st1d>Oa> = Char Char1OJPJQJtH &b \]}~45=co _AB"#Jr6ھ۾+,LM|}KL YZ9:UV'K00)0 K00@)@0K00PX=@0 K00X=@ OJQJo(K00X=@&K00X=@0K00 0Y=B2!J!P!\!b!c!}!!!!!!!7"8"9":";"<"=">"?"@"A"B"C"D"E"F"G"H"I"J"K"L"""""#+#H#s##### $$$$$.$>$J$P$R$T$U$$$$$$$$&%K%U%Z%\%^%_%j%z%%%%%%%%%%%%%%%%%%%%A&f&n&s&u&w&x&&&&&&&&&&&&&&&&P'Q'e''''''''''''%(/(8(9(((((((((((((((()Y)a)j)k)x))))))))))++,,a-b---000000000000000000000000000110111111111!2"2#2$2%2&2'2(2324252627282J2S2W2[2_2`2o2222222222222223'3+3/33343?3W3[3_3c3d3q3333333333333 4444414U4Y4]4a4b4c4d4e4f4g4h4u4v4w4x4y4z44444444444445555#5$525F5J5N5R5S5T5U5V5W5X5Y5j5k5l5m5n5o5~5555555555555566 6 66-63676=6>6J6\6`6d6h6i6o6p6v6z6666J7K7L7M7N7O7P7Q7R7S7;;F;G;;;;;;;;<<<==>>??&?'?CC8C9CEEFFFFGGIIJJ&K'K|K}KLLNN.O/O)Q*QGQHQRRSSTTTTVVWWXXYY[[[[]]]]]]^^!_"_````%c&cddddeefeffrfsfggggCjDjEjjjoosssst!t4t5t6tEtKtZt`tatwttttttttttttttttttttuuuuuu)u3u=u>u?uZu{uuuuuuuuuvvv$v%v=vEvMvavbvvvvvvvvvvvvvwww/wAwBwCwRwWwfwkwlw}wwwwwwwwwwwwxxxx&x'x(x)xZhvƞԞ3AVdfgʟ̟ΟϟПџ'-49>?\l|ǠנTdyСޡ  #$%&2>?@ABCDLNXbcqr~¤ȤΤϤܤݤ12<FG_`jtuĥťƥǥȥɥʥܥޥ -.4;<=>?@AhijklƦͦΦϦЦѦҦӦ !"#\]^_xyz{ϧЧ֧ݧާߧ LMNOP֨ר239ABCDEFGҩөܩ !"#9:CJKeflrstuvwxyzߪ'1234567JKLMNabipqǫϫЫ "#*12KLSZ[z{ƬǬ #$%&'()89:;<HIQYZvx +,3:;RS[cdefghijkuȮɮۮܮ 56:>?fgnuvįůƯǯȯɯʯݯޯ%/0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUbstuv~̰Ͱհݰް !"#$QR\fgֱױرٱڱ%&.67BCJRScdlstuvwxyz{z{̵͵mn !uvLMNbý5ھ۾+,5LMj|}ֿKLrFGHIj "YZo9:MUVWXYZ[\56ab=>\]78 !wpq*+ $%=> ![\]^_m/0tuv,-_`abwxy ,4<DLNXYms{  !"#$%9:;<=>EF[\]^_`jkyz{|}~()*78Nklmz{| #+19CEFGHIJKLMNU]emu '()*+,56WXYZ[\bcdefghijk~tu*+,ABOe'()*+,-./CDEFGQRSqrs#+3=>?@ABCDEbcdefnopqrstuv^_uv ?FMNu{ !ELSTUVWX  06<=>?@ATZ`ab9: rs '()*+,-./0!"#,1CDEMUVWcnopqrs29ABRX_`#+,-+178cgklmnopqy !*/ABCKSTUaklmnop!"#$%&'/78[cklmnopqyJKRSTj8FWX} "#$'0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000 00 00 0 0 0 0 0 0 0 0 0 0 0 0 w 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0-------- - -- 0 w 0 w 0 w 0 w 0 w 0 w 0 w 0 0 0 w 0 0 0 w 0 0 0 0 0 0 0 0000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0  0 0 0 00000000 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 00 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000000000000000000000000000 0 0 0 0 00 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 000000000000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X0 0 0 0 0 0 0 X0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X0 0 0 0 X0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000000000000000000000000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000000 00 00 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 y0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000000000000000000000000000000000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000000000000000000000000000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 00000000000000000 %0 %0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 '0 '0 0 0000000000000000000000 %0 %0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0     0 0 0 0 0 0  0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000000000000000000000 0 %0 % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 %0 % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0 %0 0 0 0 0 %0 0 0 0 0 0 0 0 0 0 00000000000000000 000000000  0   0   0   0   0  0 0  0 0  0 0   0   0  0 0  0 0   0 00  0   0   0   0  0 0   0  0 0  0 0  0 0   0 000000000 00 000000000000 0 0 0000000000 0000  0   0   0   0   0   0   0 0,0 00 00 000 00 0 000 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 000 00 0 000 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000000 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 00000 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 0000000000000000000000000000 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0000 0000 0 0000 00 0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 0 #0 #0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 0000000000000 00 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 000000 00 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 0000000000000000000000000000000000000000000000 00000 0 0000 0 0 0@0I00@0I00@0I00@0I00@#0@#0@0@#0@#0@0I00` qrsuv"DE+;<deMNYZno  T U  N O q r ( ) l m r   , 3 4 k }  +17MNOmy056GXfop\lz'(QV[pqT[`uv   38EL\]9J}~ !24567`a ,4<=SZbc )@JKXcno     3HIq~ *5@O^_#567()9DSp   ! # % & V Z \ ` b c j l n p r s !!!!>!J!P!\!b!c!}!!!!!!!7"8"""""#+#H#s##### $$$$$.$>$J$P$R$T$U$$$$$$$$&%K%U%Z%\%^%_%j%z%%%%%%%%%%%%%%%%%%%%A&f&n&s&u&w&x&&&&&&&&&&&&&&&&P'Q'e''''''''''''%(/(8(9(((((((((((((((()Y)a)j)k)x)))))))))),a-b---000111111111!2"2#2$2%2&2'2(2324252627282J2S2W2[2_2`2o2222222222222223'3+3/33343?3W3[3_3c3d3q3333333333333 4444414U4Y4]4a4b4c4d4e4f4g4h4u4v4w4x4y4z44444444444445555#5$525F5J5N5R5S5T5U5V5W5X5Y5j5k5l5m5n5o5~5555555555555566 6 66-63676=6>6J6\6`6d6h6i6o6p6v6z6666J7K7;;F;G;;;;;;;;<<<==>>??&?'?N.O/O]]]]]^!_"_````&cddddeefeffrfsfggggEjjjssst!t4t5t6tEtKtZt`tatwttttttttttttttttttttuuuuuu)u3u=u>u?uZu{uuuuuuuuuvvv$v%v=vEvMvavbvvvvvvvvvvvvwww/wAwBwCwRwWwfwkwlw}wwwwwwwwwwwwxxxx&x'x(x)xZhvƞԞ3AVdfgʟ̟ΟϟПџ'-49>?\l|ǠנTdyСޡ  #$%&2>?@ABCDLNXbcqr~¤ȤΤϤܤݤ12<FG_`jtuĥťƥǥȥɥʥܥޥ -.4;<=>?@AhijklƦͦΦϦЦѦҦӦ\]^_xyz{ϧЧ֧ݧާߧ LMNOP239ABCDEFGҩөܩ !"#JKeflrstuvwxyz'1234567JKLMNabipqǫϫЫ "#*12KLSZ[z{ƬǬ #$%&'()89:;<HIQYZvx +,3:;RS[cdefghijkuȮɮۮܮ 56:>?fgnuvįůƯǯȯɯʯݯޯ%/012345>?TUbstv~̰Ͱհݰް !"#$QR\fgֱױرٱڱ67BCJRScdlstuvwxyz{!uvLMNbý5ھ۾+,5LMj|}ֿKLrFGHIj "YZo9:MUVWXYZ[\56ab=>\]78 !wpq*+$%=> ![\]^_m/0tuv,-_`abwxy ,4<DLNXYms{  !"#$%9:;<=>EF[\]^_`jkyz{|}~()*78Nklmz{| #+19CEFGHIJKLMNU]emu '()*+,56WXYZ[\bcdefghijk~tu*+,ABOe'()*+,-./CDEFGQRSqrs#+3=>?@ABCDEbcdefnopqrstuv^_uv ?FMNu{ !ELSTUVWX 06<=>?@ATZ`ab9: rs '()*+,-./0!"#,1CDEMUVWcnopqrs29ABRX_`#+,-+178cgklmnopqy !*/ABCKSTUaklmnop!"#$%&'/78[cklmnopqy'00000000000000000000000000000000000000000000000000000000000000000000000000000 000 00 000 0 w0 0 0 0 00 0 0 0 000 0 0 0 0 00 00 0 00 000 00 000 00 000 00 000 00 000 00 000 00 000 00000 0 0 00000 0 0 0 0 0 00000 0 0 0 0 0 000 00 000 00-0-0-0 -0 -0-0 0 w0 0w0 0 w0 0w0 0 w0 0w0 0 w0 0 0 0 w00 00 w00 00 00 00 0000000000 00 0 0 00 0 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 00000000 00 0 0 00 0 0 00 0 0 00 0 0 000000000  000000 00 0 0 0 0 00 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 000000000000 0 0 00 00 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v00 0 0 0 0000@0@000 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0X0 0 0 0 0 0 0X0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0000 0 0000 0 0 0 0 0 00000 0 0 00 0 0 00 0 0 00 0 0 0X0 0 0 0X0 0 0 00 0 0 00 0 000 0 0 000 0 00 0 0 000000000000000 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 00 0 0 0 0 0 000 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 0000000000000000000000000000000000000000000000000000000000000 0 0 0 0 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 000 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00000 0 0 0 0 0 0 0 0 00 000000 000000 000000000000 00 00 00 0 0 00 0 0 0 00 00 0 0 0 0y0 00 0 0 0 00 00 0 0 0 00 00 0 0 0 00 00 0 0 0 0 0 00000000000000000000000000000000000000 0 0 0 0 0 0 0 0 00 0 0 0 00 00 0 00 0 0 0 00000 00 0 0 0 0 000 00000000000000000000000000000000000000000000 0 0 00 0 0 0 0 00 000000 000000 000000 000000 000000 000 0000 000 000 000 000 000 0 00 000 0 00 000000 000000000 0 0000000000000000000000000000000000000000000000000000000 000000 000000 000000 000000 000000 0000000000 0 0 0000000000000 %0 %0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 '0 '0 00000 %0 %0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 K05"@0 K05$K05# K05" K05! @0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 K05@0 K05K05 K05 K05 @0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0@00 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 0 0 0 K06 @%0 K06 L@0 @%0 @%0 @0 @0 @%0 @%0 @0 @0 @%0 @%0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 K06@0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @%0 @0 @0 @0 @0 @%0 @0 @0 @0 @0 @0 @0 @0 @0 @0 000000 0000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 0 0 0 0 0 0 0 0 0 0 000000000000 00 00000000000 0 0 000000000 00000 0 00 0 00 0 00 0 000 0 00 0 000 0 00,0 0000000 00 000 00 0 000 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 00 000 00 0 000 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 0000000 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 000000 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 00000000000000000000 0 0#0 0 0 0#0 0 0 0#0 0 0 0#0 0 0 0#0 0 0 0#0 0000 0000 00000 00 0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 0 #0 #0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 000000 00 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 000000 00 0 0#0 0 0 0#0 0 0 0#0 0 0 0#0 0 0 0#0 0 0 0#0 0 0 0#0 0 0 0#0 0 0 0#0 0 0 0#0 0 0 0#0 0 0 0#0 0 0 00K03(w}0 K03`w}0  %%%(2  UQ3q+,"B#$$&%V&'())*(+m--/11735v79=@AABKCDDEIBKLM]X^lnDp.rZtu&y.zh| 7ʂ(^4OebfRbyLh9w36Yǽ>1@oum2XaBlNn3GF ZK)E&:K  l  \  !',./0134689:;<>?@ABCELSUW[]aghjknuwxyz|}~ $.4;<>?EMQVXZ\bjs~#()+,  *dT1nV&H8*Y !!,"v""#$9$]$$$$'%&&R''(+)))A**+- ..../E/U///E00!1223738333A4B4p4q44444Z5[555556677777M8l88?@AABAuAABFBxBBBDCJC\CCCD5D;DQDDDD EKEcE6FRalvCz̃ ՄD$N҆ >݈Dω7KzyΙlLahūfĬ9NFʰ x)89FYtyŷ!D|̸!GLqvƹEPκBλo|μӼXŽн*NglھAg=BY^q)GpOt$)ejoty~2TY7l=-8~BotW[M 9;AJPbRTZo{>?{} *@N]ka,3U`z07sz'AERV< Qrv!&B]ae6y!%7;wIM]a-FJk1 l         (\q\\   "#$%&()*+-257=DFGHIJKMNOPQRTVXYZ\^_`bcdefilmopqrstv{    !"#%&'()*+,-/012356789:=@ABCDFGHIJKLNOPRSTUWY[]^_`acdefghiklmnopqrtuvwxyz{|}     !"$%&'*/0\;K  &XXXX !(!!l,b$l?xK-}*1b@(  f  c 6A!SHANDONB S  ?s&`8t_Hlt267921118_Hlt267921119 OLE_LINK13 OLE_LINK14 OLE_LINK17 OLE_LINK18 OLE_LINK19 OLE_LINK29 OLE_LINK10 OLE_LINK11_Hlk267059321_Hlk361991755 OLE_LINK8 OLE_LINK9 OLE_LINK6 OLE_LINK7mBmBDDEJDN߸߸'@@ uBuBDD&EJ'-FTTLmTT   ["  !DDU"\D"̞["ʏ?h!  m!܄"#/ a a FVV VBfIfZfZfdfhl2mlttttx!_K<X'     !"#$%&'()*+,<FF8 i i FV$V$VHfMfcfhfhfh l?muttttx&dPA]'   !"#$%&'()*+, 9,,*urn:schemas-microsoft-com:office:smarttagsState:%%*urn:schemas-microsoft-com:office:smarttagsStreet8***urn:schemas-microsoft-com:office:smarttagsCity=*urn:schemas-microsoft-com:office:smarttags PlaceName=*urn:schemas-microsoft-com:office:smarttags PlaceType9--*urn:schemas-microsoft-com:office:smarttagsplaceB''*urn:schemas-microsoft-com:office:smarttagscountry-region;&&*urn:schemas-microsoft-com:office:smarttagsaddress<*urn:schemas-microsoft-com:office:smarttagschmetcnvV++*urn:schemas-microsoft-com:office:smarttags PersonNamehttp://www.microsoft.com t 01 1010990001720000201220132325525000263.132330000006394641000a Cao ChangqiuFalseHasSpaceinNegative NumberType ProductID SourceValueTCSCTrueUnitName-,+*,-'&%-*,--,-----' -'   -'-*V`\c~| 37 j p  nw't} ##U$\$]$c$$$d%i%%%%%%%~&&&&&&''''9(A((((((())q)w)))))B2I2d2g2h2n222222283:33333334 4444444(5*5+515w5}55555556666B6E6N&NpUwUVVccmcocxcBfHfZfcfhhhhz{qwai<D(0!ct '03<%,2r{Yb-3NTDO(5MW T]( 8Dlv$XaV_sy%,<>?EOV $'v!   (@I7B!!O"Q"&&66EEFFfNsNbbeeh hjjkklllmuuxxxyy8;ѷٷ{Q $'s33333333333333333333333333v<eZo r 4 k m6Gp\(QqTv KL]9J6a c )@K Iq_7)DSp& V s !>!!"+##U$$$K%%f&&Q'e'''%(9(()Y))11(22222243?3W3^3d3q33333334414\4z44444455$5R5o5~5555555566 6 66-6>6p66t?uZu{uubvvvwBwCwww=x8yyyyyh{pՇ$%iԉ t~ș&j}2؜AZ3oʟӟ '?\TСAlӦ_ר3Gө#abЫ"#Ǭ6?g0ṴͰ$R&!Ný,ֿIj"Zo\>!_m0b6\?X b0#2`-+8c!8[ $' $'|qD}NDC~(B* A@eNrޚMr0Liv@KS}@07JZ" A5TV`0 R " H2<,|E;(whcr >evV %V[S& q-4#f\e;7v`R70^uEY`Q\F`9 Gt5iUԽ^ c"V$FB`[z.1nrvr VD WD8^`. TTVDXWD8^T`. VDWD8^`.   VDWD8^ `. VD WD8^`OJQJo(l TTVDXWD8^T`OJQJo(l VDWD8^`OJQJo(l   VDWD8^ `OJQJo(lhhWD8^h`. hhWD8^h`OJQJo(l ^` CJOJQJaJo(l  ^` OJQJo(n  ^` OJQJo(u b  ^b ` OJQJo(l B  ^B ` OJQJo(n " ^"` OJQJo(u  ^` OJQJo(l  ^` OJQJo(n  ^` OJQJo(u--^-`o(()  ^` hH0 e e^e` hH. E  E ^E ` hH. %  % ^% ` hH0  ^` hH.  ^` hH.  ^` hH0  ^` hH.^`OJPJQJ^Jo(- t  ^t ` OJQJo(n T  ^T ` OJQJo(u 4 ^4` OJQJo(l  ^` OJQJo(n  ^` OJQJo(u  ^` OJQJo(l  ^` OJQJo(n  ^` OJQJo(u8^8`o(. \^`\hH) \^`\hH. ` \^` `\hH.  \^ `\hH)  \^ `\hH. L\^L`\hH. \^`\hH) \^`\hH.   ^ ` CJOJQJo(l  ^` OJQJo(n e e^e` OJQJo(u E  E ^E ` OJQJo(l %  % ^% ` OJQJo(n  ^` OJQJo(u  ^` OJQJo(l  ^` OJQJo(n  ^` OJQJo(u8^8`PJo(.  ^` hH0 p ^p` hH. P  ^P ` hH. 0  ^0 ` hH0  ^` hH.  ^` hH.  ^` hH0  ^` hH.9^9`o(() \^`\hH) \^`\hH. a\^a`\hH.  \^ `\hH)  \^ `\hH. M\^M`\hH. \^`\hH) \^`\hH.0^`0o(. H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH.hh^h`PJo(0 H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH.hh^h`o(.  ^` hH0  ^` hH.  ^` hH. `  ` ^` ` hH0 @  @ ^@ ` hH.    ^ ` hH.  ^` hH0  ^` hH. ^` o(hH.  ^` hH0  ^` hH.  ^` hH. `  ` ^` ` hH0 @  @ ^@ ` hH.    ^ ` hH.  ^` hH0  ^` hH.hh^h`o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .p^p`PJo(() P\^P`\hH) \^`\hH.  \^ `\hH. < \^< `\hH)  \^ `\hH. \^`\hH. (\^(`\hH) \^`\hH.0^`0PJo(. H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH.^`o(. ^` 0 ^` .   ^ ` .   ^ ` 0v v^v` .V V^V` .6 6^6` 0 ^` .hh^h`PJo(. H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH.--^-`o(() ^` 0e e^e` .E  E ^E ` .%  % ^% ` 0 ^` . ^` . ^` 0 ^` .^`PJo(() \^`\hH) @\@^@`\hH. \^`\hH.  \ ^ `\hH) , \, ^, `\hH.  \ ^ `\hH. t\t^t`\hH) \^`\hH. ^` PJo(.  ^` hH0  ^` hH.  ^` hH. `  ` ^` ` hH0 @  @ ^@ ` hH.    ^ ` hH.  ^` hH0  ^` hH.e;7S&iU`[c"V A5vV %\FR7~}|1nrcr uEq-E;(<0 R Z G^RJ        N        Lz        U                 |:        TL        ^n                m2o                 4S        |d0]        kP                                         ހ        4qAP } GrP b b**h40p{~,h40!xqSwN!EOEb[!.}R"LkW= ,'DZ4+GQF.. ^9mMP3go63QF.. ^9} >:! LkW=@X]'4?WelCc8lEz#3e EOE ,'G$-_H~aOvR8QvR(qo.}RuaeMSv }nxKU4+uprW8QDZ@X]uprW$-_aeMSz#3eb[!We~v jbc8lEl"v }n(qoHgo>:xq63Gro {u~aO~v$IlwqAt${z$Ilwo {p{~'4?bSwN!76)8|.6 ;4l=e 6?XIWX!\0de"S4M;h:C- ! 5 " $ #: ` %/ u/ @ hn @ _ d9-bPq9E ;%8<^}1CeUel~ :8kM$]e3A}89AEET d ),%o >1 h | +!{q!x!1"p"#A$u|$@C%!S%[d%t%~%0&l&&S("v(5)%*+\I,- I-4$.9.)/9`/{/U0X0_21h1X2!4.4E4)5ua5B5&6]6Z7i8|F8959B9K9e9:;=;7 <<I=S=]> >X>H>X>T,?N^?@@*@+@?@KP@[@e@A&ABAB`B{CD!DFIJITI 5JMJKlIT}6+Tl'g)mqu_)i+g9Yw@w5[[L]=q_^ezt )&;\WXzK5bM/' 17<m^\'P\ 3IZ2iIi7vY!U4SdX';D70^.y&Opr]x5TAen/t (jqVCOt"}=TY`i'x{_y} nF'k*15g@u~x#w+z ,Tcx %?(.L@f*)WX+Ln_+9XjV;8?yhxCpv7CGC7}~^c`(7 t :4k |/rSX },~0fs^N+26 {!=2~:) /8 =2;<Er^mUn{2C1Si_ 8FH9%Z6?5|x1F}'MnT5O:wm:L{;M4N:Yv!J!P!\!b!c!}!!!!!!""#+#H#s##### $$$$$.$>$J$P$R$T$U$$$$$$$$&%K%U%Z%\%^%_%j%z%%%%%%%%%%%%%%%%%%%%A&f&n&s&u&w&x&&&&&&&&&&&&&&&Q'e''''''''''''%(/(8(9(((((((((((((((()Y)a)j)k)x)))))))),11111!2"2#2$2%2&2'2(2324252627282J2S2W2[2_2`2o2222222222222'3+3/33343?3W3[3_3c3d3q3333333333333 4444414U4Y4]4a4b4c4d4e4f4g4h4u4v4w4x4y4z44444444444445555#5$525F5J5N5R5S5T5U5V5W5X5Y5j5k5l5m5n5o5~5555555555555566 6 66-63676=6>6J6\6`6d6h6i6o6p6v6z666K7;<<=BGQ]^%c5hsst!t4t5t6tEtKtZt`tatwttttttttttttttttttttuuuuuu)u3u=u>u?uZu{uuuuuuuuuvvv$v%v=vEvMvavbvvvvvvvvvvvww/wAwBwCwRwWwfwkwlw}wwwwwwwwwwwwxxxx&x'x7y8yHycyyyyyyyzzzzzz1z8zHzOzWzazbzzzzzzzzzzzzzzz{{,{3{;{E{F{L{T{Z{b{d{f{g{XYՇ)MĈш׈$%,5CIWYiΉЉ҉Ӊ]ʗח"3BC`r͘ݘ+;L[\wșؙ&6ESab}Ԛ2G\^`a~ -:;Wlǜ՜֜+,GUcq~ĝНݝ!/=>ZhvƞԞ3AVdfgʟ̟ΟϟПџ'-49>?\l|ǠנTdyСޡ #$%&2>?@ABCDLNXbcqr~¤ȤΤϤܤݤ12<FG_`jtuĥťƥǥȥɥʥܥޥ -.4;<=>?@AhijklƦͦΦϦЦѦҦӦ#\]^_xyz{ϧЧ֧ݧާߧ LMNOP֨ר239ABCDEFGҩөܩ !"#9:CJKeflrstuvwxyz'1234567JKLMNabipqǫϫЫ "#*12KLSZ[z{ƬǬ #$%&'()89:;<HIQYZvx +,3:;RS[cdefghijkuȮɮۮܮ 56:>?fgnuvįůƯǯȯɯʯݯޯ%/0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUbstuv~̰Ͱհݰް !"#$QR\fgֱױرٱڱ%&.67BCJRScdlstuvwxyz{ѲMNbý5ھ۾+,5LMj|}ֿKLrFGHIj "YZo9:MUVWXYZ[\\ > ![\]^_m0tu-_`aw ,4<DLNXYms{  !"#$%9:;<=>EF[\]^_`jkyz{|}~(7Nkz #+19CEFGHIJKLMNU]emu '()*+,56WXYZ[\bcdefghijk~*+,AOe'()*+,-./CDEFGQRqrs#+3=>?@ABCDEbcdefnopqrstuvv ?FMNu{ !ELSTUVWX06<=>?@ATZ`as '()*+,-./0!"#1CDEMUVWcnopqrs29ABRX_`#+,+178cgklmnopqy !/ABCKSTUaklmnop!"#$%&'/78[cklmnopqyX'ZswW1P &!1w1w1w 1wYZ!7%!A-0!7Q!7!7!7a2)r@vv ʟʠ&0@0 0@00$@000@0"0H@0&0P@000T@00h@0 @0 0 @0 @UnknownGz Times New Roman5Symbol3& z ArialKM  DFKai-SBPMingLiU;[SOSimSunC .PMingLiUe0}fԚ9: ZWAdobeF3TimesC Times-Bold[SO_ Times-RomanTimes New Romanc HelveticaNeueLTStd-LtMingLiUU Arial Unicode MSArialc HelveticaNeueLTStd-BdMingLiU;ўSOSimHei?5 z Courier New[DFPFangSongW4-B5PMingLiU?E  eckwiSO_GBKўSO;Wingdings F'I%%!xxd~~**2qHX?O2 2006 ANNUAL RESULTS ANNOUNCEMENTWonderful SkyhggSf                        Oh+'0(8 HT t  $2006 ANNUAL RESULTS ANNOUNCEMENTWonderful Sky$generated by an Adobe applicationNormal329Microsoft Office Word@x@NՀ@D[3-@zA5%՜.+,D՜.+,  `h Wonderful Sky~  8@ _PID_HLINKSARF http://www.cninfo.com.cn/?mailto:xhzy@xhzy.comOGhttp://www.xhzy.com/yPmailto:guolei@xhzy.com  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry F E5Data G1TablejWordDocumentSummaryInformation(DocumentSummaryInformation8CompObjm  FMicrosoft Office Word ĵ MSWordDocWord.Document.89q